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ABSTRACT	  	  The	  Impact	  of	  Social	  Stress	  on	  Central	  Nervous	  System	  Inflammation	  and	  T	  Cell	  Response	  to	  Theiler’s	  Virus	  Infection.	  (May	  2011)	  Elisabeth	  Good	  Vichaya,	  B.S.,	  Wayland	  Baptist	  University;	  M.S.	  Texas	  A&M	  University	  Chair	  of	  Advisory	  Committee:	  Dr.	  Mary	  W.	  Meagher	  	   A	   growing	   body	   of	   evidence	   suggests	   that	   social	   stress	   contributes	   to	   the	  pathogenesis	   of	   neurodegenerative	   diseases,	   such	   as	  multiple	   sclerosis	   (MS).	   For	  example,	  prior	  research	  has	  shown	  that	  social	  disruption	  (SDR)	  stress	  behaviorally	  and	  immunologically	  exacerbates	  Theiler’s	  murine	  encephalomyelitis	  virus	  (TMEV)	  infection.	  TMEV	   infection	   results	   in	   acute	   infection	  of	   the	   central	  nervous	   system	  (CNS)	   followed	   by	   a	   chronic	   demyelinating	   autoimmune	   disease,	   similar	   to	   that	  seen	  in	  MS.	  Research	  suggests	  that	  social	  stress	  exerts	  these	  effects	  by	  altering	  the	  immune	   response	   to	   infection.	   More	   specifically,	   it	   is	   hypothesized	   that	   SDR	  sensitizes	   the	   acute	   inflammatory	   response	   to	   infection	   and	   suppresses	   T	   cell	  effector	   function	   in	   the	   acute	   phase	   of	   disease.	   It	   was	   demonstrated	   that	   SDR	   is	  sufficient	  to	  alter	  inflammation.	  Exposure	  to	  a	  single	  session	  of	  SDR	  increases	  IL-­‐1β	  mRNA	  expression;	  however,	   IL-­‐6	  mRNA	  expression,	  but	  not	  IL-­‐1β,	   is	  up	  regulated	  in	  response	  to	  chronic	  SDR.	  Furthermore,	  chronic	  SDR	  prior	  to	  infection	  resulted	  in	  increased	   infection	   related	   central	   IL-­‐6	   and	   IL-­‐1β	  mRNA	   expression,	   and	   central	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administration	  of	   IL-­‐6	  neutralizing	   antibody	  during	   SDR	   reverses	   this	   increase	   in	  neuroinflammation.	   	   This	   suggests	   that	   SDR	   sensitizes	   infection	   related	   CNS	  inflammation	  through	  an	  up-­‐regulation	  of	  IL-­‐6.	  Chronic	  SDR	  prior	  to	  infection	  also	  resulted	   in	  enhanced	  CNS	  viral	   titers	  and	  suppression	  of	  virus-­‐induced	  CD4+	  and	  CD8+	  T	  cell	   IFN-­‐γ	  release	  within	   the	  CNS.	  As	  a	  whole,	   this	  research	   indicates	   that	  SDR	  exacerbates	  the	  disease	  course	  of	  TMEV	  infection	  by	  altering	  the	  central	  innate	  and	   adaptive	   immune	   response	   to	   infection.	   This	   research	   enhances	   our	  understanding	   of	   the	   mechanisms	   by	   which	   social	   stress	   exacerbates	  neurodegenerative	  disease	  pathogenesis.	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CHAPTER	  I	  INTRODUCTION	  	  
Multiple	  Sclerosis	  
Prevalence	  and	  Natural	  History	  of	  Multiple	  Sclerosis	  Multiple	   Sclerosis	   (MS)	   is	   a	   chronic	   autoimmune	   demyelinating	   disease	   of	  the	   central	   nervous	   system	   (CNS)	   that	   affects	   approximately	   2	   million	   people	  worldwide	  (Anderson	  et	  al.,	  1992;	  Hirtz	  et	  al.,	  2007;	  Noonan	  et	  al.,	  2002;	  Sospedra	  and	  Martin,	  2005;	  WHO	  and	  MSIF,	  2008).	   It	   is	  characterized	  by	  intensive	   immune	  cell	  activation	  and	  inflammation	  within	  the	  white	  matter,	  resulting	  in	  degeneration	  of	   the	  myelin	   sheath	  and	   subsequent	   sensory	   (e.g.,	   loss	  of	   sensation	   in	   limbs	  and	  enhanced	  pain)	  and	  motor	  deficits	   (e.g.,	   loss	  of	  motor	  control	  and	   loss	  of	  bladder	  control).	  An	  individual	  is	  generally	  diagnosed	  in	  early	  adulthood	  and	  there	  is	  a	  2:1	  preponderance	  for	  females.	  	  	  There	   is	   significant	   variability	   in	   disease	   prognosis	   after	   diagnosis.	   	   Four	  categories	   of	   disease	   have	   been	   described:	   (1)	   relapse-­‐remitting,	   (2)	   primary-­‐progressive,	   (3)	   secondary-­‐progressive,	   and	   (4)	   progressive-­‐relapsing.	   	   Relapse-­‐remitting	  disease	  course	  is	  most	  common,	  with	  approximately	  80-­‐85%	  of	  patients	  presenting	  with	  this	  form.	  	  	  It	  is	  characterized	  by	  symptom	  attacks	  that	  last	  days	  to	  weeks	  followed	  by	  a	  gradual,	  partial	  to	  full	  recovery.	  	  	  	  This	  disease	  course	  generally	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presents	   with	   sensory	   disturbances,	   unilateral	   neuritis,	   diplopia	   	   (double	   vision,	  generally	  due	  to	  impairment	  of	  eye	  adduction),	  Lhermitte’s	  sign	  (pricking,	  tingling,	  and	   numbness	   of	   trunk	   and	   limbs	   evoked	   by	   neck	   flexion),	   limb	   weakness,	  clumsiness,	  gait	  ataxia,	  and	  neurogenic	  bladder	  and	  bowel	  symptoms	  (Noseworthy	  et	  al.,	  2000).	  	  Relapses	  are	  associated	  with	  lesions	  of	  the	  CNS	  white	  matter	  (Neema	  et	   al.,	   2007)	   and	   inflammatory	   events,	   including	   microgliosis,	   activation	   of	  macrophages,	  and	  the	  presence	  of	  CD4+	  and	  CD8+	  T	  cells	  (Frohman	  et	  al.,	  2006).	  	  Primary-­‐progressive	   disease	   affects	   10-­‐15%	   of	   MS	   patients	   and	   is	  characterized	   by	   gradual,	   steady	   progression	   of	   disability	   without	   significant	  periods	  of	  unchanged	  or	  remission	  of	  disease	  course.	   	  This	  disease	  course	  is	  more	  likely	   to	   be	   observed	   in	   individuals	   who	   have	   a	   later	   disease	   onset	   and,	   unlike	  relapse-­‐remitting	   disease,	   is	   equally	   common	   in	   men	   and	   women.	   	   The	   primary	  early	  symptom	  observed	   is	  chronic	  progressive	  myelopathy,	  a	   slow	  upper-­‐motor-­‐neuron	   syndrome	   that	   leads	   to	   increasing	   stiffness	   and	   weakness	   of	   the	   legs	  (Noseworthy	  et	  al.,	  2000).	  	  The	   final	   two	   disease	   courses,	   secondary-­‐progressive	   and	   progressive-­‐relapsing,	  are	  a	  merging	  of	  these	  two	  more	  common	  types.	  	  Secondary-­‐progressive	  disease	   begins	   as	   relapse-­‐remitting	   and	   eventually	   evolves	   into	   progressive	  disease.	   	   To	   date,	   the	  mechanism	   underlying	   this	   switch	   is	   unknown.	   	   However,	  multiple	   lesions	   at	   disease	   onset	   are	   predictive	   of	   a	  more	   rapid	   switch	   (Kantarci	  and	   Weinshenker,	   2005).	   Progressive-­‐relapsing	   is	   characterized	   by	   a	   steady	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progression,	   like	  primary	  progressive,	  with	  the	  acute	  attacks	  observed	  in	  relapse-­‐remitting	  disease.	  	  	  Given	   the	   high	   heterogeneity	   and	  unpredictability	   of	   disease	   course,	   these	  categories	  are	  of	  limited	  help	  in	  developing	  a	  prognosis	  for	  an	  individual.	  	  However,	  generally	  primary	  progressive	  disease	  course	  is	  predictive	  of	  poor	  outcomes,	  as	  are	  an	  age	  of	  onset	  greater	  than	  40	  years,	  multiple	  sites	  of	  initial	  involvement,	  cerebral	  symptoms,	  prolonged	  initial	  symptoms	  (>	  1	  year),	  and	  less	  than	  six	  months	  before	  first	   relapse	   (Weinshenker	   and	   Sibley,	   1992).	   	   Furthermore,	   for	   reasons	   not	   yet	  fully	  understood,	  males	  have	  a	  more	  severe	  disease	  course	  than	  females	  (Kantarci	  and	   Weinshenker,	   2005).	   	   Factors	   predictive	   of	   a	   more	   favorable	   outcome	   are	  isolated	  optic	  neuritis	  and	  brainstem	  syndromes	  (Weinshenker	  and	  Sibley,	  1992).	  	  Studies	  provide	  a	  wide	   range	  of	   survival	   statistics;	   conservative	   estimates	  suggest	  a	  50%	  survival	  rate	  at	  25	  years	  post-­‐diagnosis,	  (Phadke,	  1987;	  Riise	  et	  al.,	  1988)	  while	  the	  most	  optimistic	  study	  suggests	  this	  rate	  may	  be	  as	  high	  as	  76.2%	  (Wynn	  et	  al.,	  1990).	  Weinshenker	  et	  al.	  (1989)	  report	  an	  average	  increase	  of	  0.5	  +/-­‐	  0.02	  points	  per	   year	  within	   the	   first	   five	   years	  on	   the	  Expanded	  Disability	   Status	  Scale	  (EDSS).	  	  The	  EDSS	  is	  a	  widely	  utilized	  ordinal	  clinical	  rating	  scale	  to	  assess	  MS	  from	   0	   (normal	   neurologic	   examination)	   to	   10	   (death	   due	   to	   MS)	   in	   half-­‐point	  increments	  (Kurtzke,	  1983).	  As	  the	  disease	  progresses,	  symptom	  burden	  increases	  to	  include	  cognitive	  deficits,	  sexual	  dysfunction,	  paralysis,	  gait	  ataxia,	  incontinence,	  enhanced	  pain,	  depression,	  and	  fatigue	  (Noseworthy	  et	  al.,	  2000).	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Diagnosis	  and	  Biological	  Markers	  The	   complexity	   and	   variability	   of	   MS	   continues	   to	   challenge	   investigators	  who	  seek	  to	  explicate	  the	  pathogenesis	  of	  the	  disease	  and	  prevent	  its	  progression.	  	  Despite	   the	   long	   history	   and	   high	   incidence	   of	   the	   disease,	  MS	   can	   be	   difficult	   to	  diagnosis.	   	   This	   is	   primarily	   due	   to	   the	   lack	   of	   symptoms	   and	   biological	  markers	  that	  are	  specific	  to	  MS.	  	  For	  example,	  optic	  neuritis	  is	  a	  common	  initial	  symptom	  of	  MS,	  however,	  only	  38%	  of	  patients	  who	  present	  with	  optic	  neuritis	  will	  go	  on	  to	  be	  diagnosed	  with	  MS	  (Kantarci	  and	  Weinshenker,	  2005).	  Another	  diagnostic	  measure	  is	  the	  presence	  of	  oligoclonal	  bands	  within	  the	  cerebral	  spinal	  fluid	  (CSF).	  	  	  As	  many	  as	   90%	  of	   patients	  with	  MS	  have	   these	  bands;	   however,	   they	   are	   also	   found	   in	   a	  variety	   of	   other	   disorders	   of	   the	   CNS,	   including,	   Lyme	   disease,	   systemic	   lupus	  erythematosus,	  Syphilis,	  primary	  CNS	  lymphoma,	  Sjögren’s	  Syndrome,	  and	  Guillain-­‐Barre	  Syndrome.	  	  	   Given	  the	  failure	  to	  identify	  exclusive	  markers,	  the	  diagnosis	  of	  MS	  requires	  significant	   time.	   	   The	   protracted	   nature	   of	   this	   process	   becomes	   clear	   when	   the	  marked	   time	  between	   relapses	   in	   early	   disease	   is	   considered.	   	   A	   swift	   diagnostic	  procedure	   is	   important	   in	   that	   it	   allows	   for	   a	   more	   rapid	   start	   of	   potentially	  beneficial	  treatments.	   	  Treatments	  include	  agents	  aimed	  at	  symptom	  management	  as	  well	  as	  agents	  intended	  to	  delay	  disease	  progression.	  For	  example,	  some	  patients	  are	   prescribed	   drugs	   that	   are	   intended	   to	   manage	   particular	   symptoms	   such	   as	  spasticity,	   fatigue,	   and	   depression.	   	   For	   the	   management	   of	   acute	   attacks,	  glucocorticoids,	  such	  as	  methylprednisolone,	  prednisone,	  and	  dexamethasone,	  are	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commonly	  used.	   	  These	  agents	  act	  by	  inhibiting	  CNS	  inflammatory	  events	  that	  are	  thought	  to	  underlie	  these	  attacks.	  	  Although	  they	  are	  often	  effective	  at	  resolving	  the	  symptom	   exacerbation	   induced	   by	   the	   attack,	   there	   is	   no	   evidence	   that	   such	  treatment	   results	   in	   a	   delay	   of	   disease	   progression.	   	   Treatments	   aimed	   at	  attenuating	   disease	   progression	   include	   immunosuppressive	   drugs,	   such	   as	  interferon	  (IFN)	  therapy.	  	  
	  
The	  Immunology	  of	  Multiple	  Sclerosis	  In	   1933	   it	   was	   first	   suggested	   that	   MS	   was	   an	   autoimmune	   disease.	  	  Autoimmunity	  develops	  when	  the	  immune	  system	  begins	  to	  function	  in	  an	  aberrant	  fashion	   and	   attacks	   the	   body	   it	   is	   intended	   to	   protect.	   	   This	   can	   occur	  when	   the	  immune	  system	  fails	  to	  recognize	  a	  part	  of	  the	  individual	  as	  “self”	  and	  attacks	  as	  if	  it	  were	  foreign.	  	  In	  multiple	  sclerosis	  the	  immune	  system	  attacks	  the	  myelin	  sheaths	  around	   nerve	   axons.	   	   Rivers	   (1933)	   discovered	   that	   injections	   of	   spinal	   cord	   or	  brain	  homogenates	   into	  primates	  resulted	   in	  a	  disease	  course	  that	  resembled	  MS.	  	  He	   suggested	   this	   injection	   resulted	   in	   the	   development	   of	   anti-­‐brain	   antibodies	  and,	   subsequently,	   the	  destruction	  of	  nervous	   system	   tissue.	  Decades	   later	   it	  was	  established	   that	   protein	   components	   of	   the	   myelin	   sheath,	   such	   as	   myelin	   basic	  protein	   (MBP),	   were	   the	   essential	   component	   to	   the	   induction	   of	   this	   MS-­‐like	  disease,	   this	   disease	   model	   is	   now	   known	   as	   experimental	   autoimmune	  encephalomyelitis	  (EAE)	  (Einstein	  et	  al.,	  1962;	  Fritz	  et	  al.,	  1983;	  Kibler	  et	  al.,	  1977;	  Laatsch	  et	  al.,	  1962).	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It	   has	   also	   been	   demonstrated	   that	   EAE	   can	   be	   induced	   by	   transferring	  myelin-­‐specific	   CD4+	   T	   cells	   into	   a	   host,	   however	   the	   transfer	   of	   myelin-­‐specific	  antibodies	   is	   insufficient	   (Pettinelli	   and	  McFarlin,	   1981).	   	   This	  provided	   evidence	  that	  MS	   is	   likely	   a	   T	   cell-­‐mediated	   autoimmune	  disease.	   T	   cells	   are	   an	   important	  component	   of	   the	   adaptive	   immune	   response.	   There	   are	   two	  major	   classes	   of	   T	  cells:	  helper	  T	  cells	  and	  cytotoxic	  T	  cells.	  Helper	  T	  cells	  become	  activated	  when	  they	  are	   presented	  with	   antigens	   by	  MHC	   class	   II	  molecules	   on	   the	   surface	   of	   antigen	  presenting	   cells	   (APCs).	   	   These	   T	   cells	   divide	   and	   differentiate,	   based	   upon	   the	  extracellular	  milieu,	   and	   secrete	   cytokines	   to	   recruit	   and	   assist	  with	   the	   immune	  response.	   	  They	  are	  referred	  to	  as	  CD4+	  T	  cells	  because	  they	  express	  CD4	  protein	  on	  their	  surface.	  	  Cytotoxic	  T	  cells,	  also	  known	  as	  CD8+	  T	  cells,	  attack	  virus-­‐infected	  cells.	  They	  recognize	  their	  target	  through	  binding	  to	  antigens	  when	  presented	  by	  a	  cell	  on	  their	  MHC	  class	  I	  molecules.	  	  	  Further	  evidence	  for	  the	  role	  of	  T	  cells	  in	  the	  development	  of	  MS	  comes	  from	  the	  prominence	   of	   CD8+	  T	   cells	   in	   the	  CNS	  of	  MS	  patients	   (Jacobsen	   et	   al.,	   2002;	  Skulina	  et	  al.,	  2004;	  Zang	  et	  al.,	  2004).	  	  Additionally,	  it	  has	  been	  demonstrated	  that	  T	  cells	  from	  MS	  patients	  exhibit	  heightened	  activity	  against	  MBP	  (Cabarrocas	  et	  al.,	  2003)	  and	  secrete	  increased	  levels	  of	  chemoattractants	  for	  CD4+	  myelin	  specific	  T	  cells	  (Biddison	  et	  al.,	  1998).	  However,	  T	  cells	  specific	  to	  MBP	  can	  be	  found	  both	  in	  MS	  patients	  and	  healthy	  controls,	  which	  suggests	  that	  this	  relationship	  is	  complex	  (Burns	  et	  al.,	  1983).	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B	   cells	   may	   also	   be	   involved	   in	   the	   pathogenesis	   of	   MS.	   	   The	   primary	  functions	  of	  B	  cells	  are	  to	  produce	  antibodies	  (also	  known	  as	  immunoglobulin,	  [Ig]),	  present	   antigen,	   and	  become	  memory	  B	   cells.	   	   Although	   antibodies	   alone	   are	  not	  sufficient	  to	  induce	  MS-­‐like	  symptoms,	  they	  may	  be	  involved	  in	  the	  progression	  of	  the	  disease.	  	  For	  example,	  it	  has	  been	  determined	  that	  the	  CSF	  from	  MS	  patients	  has	  increased	  levels	  of	  antibodies	  and	  that,	  in	  some	  patients,	  these	  increased	  levels	  are	  related	  to	  symptom	  exacerbations	  (Corcione	  et	  al.,	  2005).	  Although,	  these	  cells	  do	  not	  typically	  cross	  the	  blood-­‐brain	  barrier,	   inflammatory	  process	  can	  permit	  their	  entry	  into	  the	  CNS.	  	  	  These	  cells	  may	  contribute	  to	  the	  disease	  process	  by	  serving	  as	  APCs	  for	  autoreactive	  T	  cells,	  recruiting	  autoreactive	  T	  cells	  to	  the	  CNS,	  producing	  myelin-­‐specific	   antibodies,	   and	   destroying	   myelin	   within	   plaques	   (Sospedra	   and	  Martin,	  2005).	  	   The	   innate	   immune	   system	   also	   appears	   to	   be	   important	   within	   the	  immunology	  of	  multiple	  sclerosis.	  The	   innate	   immune	  response	   is	   the	  body’s	   first	  line	  of	  defense;	  it	  responds	  quickly	  to	  contain	  infection	  until	  the	  adaptive	  immune	  system	  has	  been	  recruited.	  Unlike	  the	  adaptive	   immune	  response	  of	  T	  cells	  and	  B	  cells,	   the	   innate	   immune	  system	  responds	  nonspecifically	   to	  antigens	   through	   the	  development	   of	   barriers,	   mechanical	   removal,	   activation	   of	   the	   complement	  pathway,	   phagocytosis,	   and	   inflammation.	   	   Inflammation	   is	   a	   complex	   cascade	   of	  events	   intended	   to	   recruit	   immune	   cells	   to	   kill	   potential	   pathogens	   and	   promote	  tissue	  repair.	  	  The	  powerful	  nature	  of	  this	  immune	  response	  is	  essential	  to	  survival.	  	  However,	   if	   the	   inflammatory	   response	   is	   not	   properly	   restrained,	   damage	   to	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healthy	  tissue	  can	  result.	  For	  example,	  chronic	  inflammation	  has	  been	  shown	  to	  be	  involved	   in	   a	   variety	   of	   diseases	   processes	   including	   MS,	   Alzheimer’s	   disease,	  Parkinson’s	   disease,	   rheumatoid	   arthritis,	   atherosclerosis,	   diabetes,	   and	   cancer	  (Bitsch	  et	  al.,	  2000;	  Coussens	  and	  Werb,	  2002;	  Duncan	  et	  al.,	  2003;	  Foell	  and	  Roth,	  2004;	  Hansson	  et	  al.,	  2006;	  Liu	  and	  Hong,	  2003;	  Minghetti,	  2005).	  	  Cytokines	   are	   an	   especially	   important	   component	   of	   the	   inflammatory	  response.	  The	  immune	  system	  tightly	  regulates	  the	  immune	  response	  through	  the	  release	  of	  proinflammatory	  (e.g.,	   IL-­‐1β,	  TNF-­‐α,	   IFN-­‐γ)	  and	  anti-­‐inflammatory	  (e.g.,	  IL-­‐10,	  IL-­‐4)	  cytokines.	  	  Other	  cytokines,	  such	  as	  IL-­‐6,	  can	  serve	  both	  pro-­‐	  and	  anti-­‐inflammatory	   functions.	   	   Proinflammatory	   cytokines	   allow	   leukocytes	   to	   exit	   the	  blood	  stream	  and	  enter	  into	  infected	  tissue,	  trigger	  neutrophils	  to	  kill	  infected	  cells,	  and	   stimulate	   natural	   killer	   (NK)	   cells	   and	   T	   cells.	   	   Cytokines	   also	   orchestrate	   a	  behavioral	   response	   designed	   to	   promote	   healing	   (Kent	   et	   al.,	   1992;	   Laye	   et	   al.,	  2000).	   	   For	   example,	   cytokines	   induce	   a	   febrile	   response	   that	   results	   in	   a	  temperature	  less	  suitable	  for	  pathogen	  replication	  (Hart,	  1988;	  Murray	  and	  Murray,	  1979).	  	  Furthermore,	  fatigue-­‐like	  symptoms,	  such	  as	  reduced	  motivation,	  increased	  need	   to	   sleep,	   and	   social	   withdrawal,	   are	   effective	   means	   to	   conserve	   energy	  needed	  to	  mount	  an	  immune	  response	  (Maier	  and	  Watkins,	  1998).	  As	  previously	  mentioned,	  MS	  is	  not	  merely	  an	  autoimmune	  disease	  but	  also	  an	   inflammatory	   disease	   of	   the	   central	   nervous	   system.	   	   Increased	   levels	   of	  inflammation	   appear	   to	   accompany	   disease	   relapses	   (Frohman	   et	   al.,	   2006)	   and	  agents	   that	   decrease	   rate	   of	   relapse	   also	   decrease	   CNS	   inflammation	   (Stüve	   and	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Oksenberg,	   2010;	   Warnke	   et	   al.,	   2010).	   Furthermore,	   there	   is	   evidence	   that	  enhancing	  inflammation,	  by	  infection	  (Buljevac	  et	  al.,	  2002;	  Panitch,	  1994;	  Sibley	  et	  al.,	  1985)	  or	  administration	  of	  a	  proinflammatory	  cytokine	   (Panitch	  et	  al.,	  1987).,	  exacerbates	  disease.	  However,	  this	  relationship	  is	  clearly	  complex	  and	  there	  is	  data	  to	   suggest	   that	   a	   compromised	   inflammatory	   response	   results	   in	   exacerbated	  disease	   (Martino	   et	   al.,	   2002;	  Willenborg	   et	   al.,	   1996).	   Overall,	   the	   data	   suggests	  that	  (1)	  there	  is	  an	  optimal	  level	  of	  inflammation	  and	  deviation	  in	  either	  direction	  is	  detrimental	   and/or	   (2)	   different	   levels	   of	   inflammation	   are	   needed	   at	   different	  points	  in	  the	  disease	  progression.	  	  Cytokines	  are	  thought	  to	  play	  an	  important	  role	  in	  the	  disease	  process	  both	  through	  the	  activation	  of	  immune	  cells	  and	  their	  direct	  damage	  to	  myelin.	  	  Several	  different	  ideas	  have	  been	  proposed	  concerning	  the	  mechanisms	  through	  which	  pro-­‐inflammatory	   cytokines	   enhance	   demyelination.	   	   For	   example,	   high	   levels	   of	  cytokines	   may	   be	   directly	   toxic	   to	   oligodendrocytes,	   the	   cells	   that	   produce	   the	  myelin	   sheath.	   	   It	   is	  also	  possible	   that	   the	  cytokines	  may	  cause	  macrophages	  and	  microglia	   to	   phagocytose	  myelin	   (Sospedra	   and	  Martin,	   2005).	   	  Macrophages	   are	  phagocytic	  cells	  that	  act	  to	  engulf	  and	  digest	  cellular	  debris	  and	  pathogens.	  	  Despite	  the	  protection	  conferred	  by	  the	  blood	  brain	  barrier	  (BBB),	  they	  appear	  to	  be	  able	  to	  enter	  the	  CNS	  during	  times	  of	  inflammation.	  	  Microglia,	  enter	  the	  brain	  during	  fetal	  development,	  and	  serve	  as	  resident	  immune	  cells	  within	  the	  CNS.	  	  	  Once	  in	  the	  CNS,	  these	   two	   cell	   types	   are	   virtually	   indistinguishable.	   	   Not	   only	   are	   these	   cells	  recruited	  by	  cytokines,	  but	  are	  also	  the	  primary	  producers	  of	  CNS	  cytokines.	  	  
	   10	  
Genetic	  Risk	  Factors	  for	  Multiple	  Sclerosis	  	   The	  etiology	  of	  the	  disease	  is	  clearly	  complex	  involving	  both	  the	  innate	  and	  adaptive	   immune	   systems.	   	  A	   single	   element	   alone	   appears	   insufficient	  but	  when	  genetic	   and	   environmental	   risk	   factors	   combine	   the	   disease	   appears	   to	   develop.	  	  Evidence	   for	   a	   genetic	   contribution	   is	   provided	   by	   twin	   studies	   that	   reveal	   a	   20-­‐30%	   concordance	   rate	   among	   monozygotic	   twins	   and	   only	   a	   3-­‐5%	   concordance	  rate	  in	  dizygotic	  twins	  (Ebers	  et	  al.,	  1986;	  Hansen	  et	  al.,	  2005;	  Willer	  et	  al.,	  2003).	  	  However,	   this	   genetic	   relationship	   does	   not	   appear	   to	   be	   attributable	   to	   a	   single	  gene,	  rather	  it	  is	  thought	  to	  result	  from	  a	  combination	  of	  many	  genes.	  	  This	  concept	  is	  highlighted	  by	  a	  study	  showing	  that	  at	  least	  one	  locus	  of	  all	  chromosomes	  except	  one	   have	   been	   linked	   to	   MS	   (Dyment	   et	   al.,	   2004).	   	   One	   locus	   that	   has	   recently	  received	  attention	  is	  the	  human	  leukocyte	  antigen	  (HLA)	  located	  on	  chromosome	  6.	  	  HLA	   is	   associated	   with	   the	   major	   histocompatability	   complex	   (MHC),	   which	   is	  involved	  in	  antigen	  presentation.	  Having	  particular	  alleles	  at	  this	  locus	  (e.g.,	  DR15	  and	  DQ6)	  are	  associated	  with	   increased	   risk	  of	  developing	  MS,	  while	  others	   (e.g.,	  C554	  and	  DRB1*11)	  are	  associated	  with	  decreased	  risk	  of	  developing	  MS	  (Haines	  et	  al.,	  1998;	  Hauser,	  2006).	  Estimates	  suggest	  that	  the	  HLA	  region	  accounts	  for	  20	  to	  60%	  of	  genetic	  susceptibility	  (Haines	  et	  al.,	  1998).	  	  Apart	  from	  the	  HLA	  region,	  the	  non-­‐synonymous	  coding	  SNP	  (T2441)	  in	  the	  IL-­‐7	   receptor	   α	   chain	   gene	   on	   chromosome	   5	   represents	   the	   most	   consistently	  replicated	  susceptibility	  gene	  for	  MS	  (Akkad	  et	  al.,	  2009;	  Gregory	  et	  al.,	  2007;	  Hafler	  et	  al.,	  2007;	  Lundmark	  et	  al.,	  2007;	  O’Doherty	  et	  al.,	  2008;	  Weber	  et	  al.,	  2008).	  IL-­‐7	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and	  its	  receptor	  are	  involved	  in	  T-­‐cell	  genesis,	  survival,	  expansion,	  and	  memory	  T-­‐cell	   development.	   	   	   Patients	   carrying	   the	   risk	   allele	   are	   at	   increased	   risk	   of	  producing	   high	   levels	   of	   the	   soluble	   form	   of	   the	   receptor	   (Gregory	   et	   al.,	   2007).	  Another	  gene	  showing	  strong	  association	  with	  MS	  are	  two	  SNPs	  within	  the	  intron	  2	  of	   the	   IL-­‐2	   receptor	  α	  chain	  on	  chromosome	  10	   (Hafler	  et	  al.,	  2007;	  Weber	  et	  al.,	  2008;	  Akkad	  et	  al.,	  2009).	  These	  studies	  have	  been	  more	  complicated	  to	  replicate	  and,	  consequently,	  require	  further	  evaluation	  to	  elucidate.	  	  	  
	  
Environmental	  Risk	  Factors	  for	  Multiple	  Sclerosis:	  Viral	  Infection	  and	  Stress	  	   Given	   that	  only	  20-­‐30%	  of	  disease	   susceptibility	   can	  be	  explained	   through	  genetic	   variations,	   much	   of	   disease	   vulnerability	   must	   relate	   to	   environmental	  factors.	   	   Both	   viral	   infection	   and	   psychological	   stress	   have	   been	   linked	   to	   the	  development	  of	  MS.	   	  Even	  before	  the	  autoimmune	  and	  inflammatory	  nature	  of	  MS	  had	   been	   described,	   researchers	   and	   physicians	   speculated	   about	   the	   role	   of	  viruses.	   	   This	   association	   was	   primarily	   considered	   because	   the	   majority	   of	  demyelinating	   diseases	   observed	   in	   humans	   and	   animals	   are	   of	   viral	   origin	  (Fazakerley	  and	  Walker,	  2003).	  	  For	  example,	  demyelinating	  disease	  is	  induced	  by	  canine	  distemper	  virus	  in	  dogs,	  Maedi-­‐visna	  in	  sheep,	  Theiler’s	  virus	  in	  mice,	  and	  JC	  virus	   in	  humans	  (Dal	  Canto	  and	  Rabinowitz,	  1982;	  Fazakerley	  and	  Walker,	  2003).	  	  However,	  this	  association	  alone	  is	  insufficient	  to	  assume	  causation.	  	  	  	   Epidemiological	   studies	   add	   further	   support	   for	   the	   role	   of	   viruses	   in	  multiple	   sclerosis.	   	   Research	   suggests	   that	   viral	   infection,	   such	   as	   Epstein	   Barr,	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during	   adolescence	   is	   associated	   with	   the	   development	   of	   multiple	   sclerosis	  (Ascherio	  and	  Munger,	  2007;	  Hernan	  et	  al.,	  2001;	   Jilek	  et	  al.,	  2008;	  Kurtzke	  et	  al.,	  1995).	  	  Furthermore,	  exacerbations	  in	  disease	  course	  are	  often	  preceded	  by	  a	  viral	  infection	  (Buljevac	  et	  al.,	  2002;	  Panitch,	  1994;	  Perry	  et	  al.,	  2003;	  Sibley	  et	  al.,	  1985).	  	  MS	  does	  not,	  however,	  appear	  to	  be	  associated	  with	  any	  single	  infection,	  rather	  the	  data	  suggest	  that	  a	  variety	  of	  viruses	  may	  be	  able	  to	  increase	  susceptibility	  to	  and	  exacerbate	  multiple	  sclerosis.	  Viruses	  that	  induce	  persistent	  infection	  appear	  to	  be	  the	   best	   candidates.	   A	   variety	   of	   such	   viruses	   have	   been	   isolated	   from	   the	   post-­‐mortem	  brains	  of	  MS	  patients,	  including	  measles,	  mumps,	  parainfluenza	  type	  I,	  and	  human	  herpes	  virus	  simplex	  (Allen	  and	  Brankin,	  1993).	  	  However,	  these	  viruses	  can	  also	  be	  detected	  in	  the	  brains	  of	  individuals	  who	  do	  not	  have	  MS	  and	  the	  presence	  of	   particular	   viruses	   associated	   with	   MS,	   such	   as	   Epstein	   Barr,	   often	   fail	   to	   be	  detected	  in	  the	  brains	  of	  MS	  patients.	  	  	  	  	  	  	  	  	   Psychological	   stress	   is	   another	   environmental	   factor	   that	   has	   been	  repeatedly	   associated	   with	   development	   and	   exacerbation	   of	   multiple	   sclerosis	  (Ackerman	  et	  al.,	  2002;	  Brown	  et	  al.,	  2005;	  Brown	  et	  al.,	  2006;	  Grant	  et	  al.,	  1989;	  Li	  et	  al.,	  2004;	  Mohr	  et	  al.,	  2004).	   	  This	  relationship	  is	  not	  a	  new	  consideration;	  over	  130	   years	   ago	   Charcot	   (1877)	   reported	   that	   stressful	   experiences	   precipitate	   the	  onset	  of	  MS.	   	  This	   relationship	  has	  been	  experimentally	  confirmed;	   for	  example	  a	  study	  of	  bereaved	  parents	  demonstrated	  that	  the	  loss	  of	  a	  child	  results	  in	  increased	  risk	  for	  developing	  MS	  and	  those	  who	  unexpectedly	  lost	  a	  child	  were	  at	  even	  higher	  risk	   (Li	   et	   al.,	   2004).	   Not	   only	   is	   stress	   related	   to	   disease	   onset,	   but	   also	   disease	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exacerbation.	  	  A	  meta-­‐analysis	  of	  14	  studies	  evaluating	  stress	  and	  MS,	  conclude	  that	  stressful	   life	  events	  significantly	  increased	  the	  risk	  of	  disease	  exacerbation	  (Mohr,	  2007).	  	  	  	   However,	   the	   effect	   of	   a	   stressor	   on	   disease	   may	   depend	   on	   the	   type	   of	  stress.	   	   While	   mild	   to	   moderate	   chronic	   stressors	   have	   repeatedly	   been	  demonstrated	   to	   exacerbate	   disease	   (Mohr,	   2007),	   the	   threat	   of	   missile	   attack	  during	  the	  Persian	  Gulf	  War,	  a	  severe	  life-­‐threatening	  stressor,	  was	  found	  to	  reduce	  the	   rate	   of	   relapse	   (Nisipeanu	   and	   Korczyn,	   1993).	   	   This	   was	   the	   only	   stressor	  found	   to	  decrease	   the	   rate	   of	   relapse	   and	   its	   effect	   only	   lasted	   for	   approximately	  two	  months	  after	  the	  war.	  	  Furthermore,	  other	  larger	  studies	  examining	  war-­‐stress	  on	  MS	  have	  failed	  to	  replicate	  this	  finding	  and	  instead	  suggest	  that	  war	  exacerbates	  disease	   (Golan	   et	   al.,	   2008).	   The	   effects	   of	   stress	   on	   multiple	   sclerosis	   are	   most	  likely	  to	  occur	  through	  stress-­‐induced	  modification	  of	  the	  immune	  system.	  	  	   Due	  to	  the	  complexity	  of	  these	  relationships	  and	  the	  ethical	  limits	  of	  human	  studies	   (e.g.,	   generally	   limited	   to	   correlational	   relationships	   due	   to	   ethics	   of	  withholding	  treatment	  and	  limited	  to	  easily	  assessable	  tissue	  samples),	  this	  area	  of	  research	   benefits	   from	   investigation	   of	   the	   role	   of	   stress	   in	   the	   pathogenesis	   of	  animal	  models	   of	  MS.	   Animals	   studies	   provide	   allow	   for	   true	   control	   groups	   and	  concrete	   behavioral	   and	   physiological	   markers.	   	   Furthermore,	   given	   the	  abbreviated	  lifespan	  of	  rodent	  models,	  they	  allow	  the	  entire	  lifespan	  of	  the	  disease	  to	   be	   studies	   in	   a	   more	   rapid	   time	   course.	   	   This	   improves	   the	   efficiency	   of	  identifying	  underlying	  mechanisms	  and	  testing	  potential	  therapeutic	  strategies.	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Theiler’s	  Virus	  	   Theiler’s	   murine	   encephalomyelitis	   virus	   (TMEV)	   one	   of	   the	   best-­‐characterized	   models	   of	   virus-­‐initiated	   CNS	   demyelination	   in	   mice.	   	   It	   is	   a	  picornavirus	   and	   natural	   pathogen	   of	   mice	   that	   can	   be	   used	   experimentally	   to	  model	   multiple	   sclerosis	   (Theiler,	   1934).	   	   When	   contracted,	   TMEV	   results	   in	   a	  gastrointestinal	  infection.	  However,	  the	  virus	  can	  cross	  the	  blood-­‐brain	  barrier	  and	  results	   in	   an	   infection	   of	   the	   CNS.	   	   For	   experimental	   purposes,	   this	   agent	   is	  administered	   intracranially	   in	   order	   to	   avoid	   the	   uncertainty	   of	   CNS	   infection.	  	  There	   are	   different	   stains	   of	   the	   virus,	   some	   (e.g.,	   GDVII	   and	   FA)	   are	   fatal	   in	  approximately	  a	  week	  while	  others	  lead	  to	  a	  more	  protracted	  disease	  process.	  	  For	  example,	   infection	  with	  the	  BeAn	  strain	  results	  in	  a	  biphasic	  disease	  of	  the	  CNS	  in	  susceptible	   strains	   of	   mice	   (e.g.,	   SJL	   and	   BALB/cJ).	   	   The	   acute	   phase	   of	   TMEV	  infection	   is	   characterized	   by	   viral-­‐mediated	   encephalomyelitis,	   while	   an	  autoimmune-­‐mediated	  demyelinating	  disease,	  similar	  to	  MS,	  characterizes	  chronic	  phase	  disease	  (Lipton,	  1975;	  Oleszak	  et	  al.,	  2004).	  	  	  The	  acute	  phase	  involves	  the	  virus	  spreading	  to	  infect	  both	  neurons	  and	  glial	  cells,	   which	   results	   in	   microglial	   proliferation	   and	   motor	   neuron	   degeneration.	  	  This	  can	  cause	  a	  poliomyelitis-­‐like	  syndrome,	  characterized	  by	  motor	  deficits	  and	  sickness	  behavior	  (Chang	  et	  al.,	  2000;	  Dal	  Canto	  and	  Lipton,	  1982;	  Meagher	  et	  al.,	  2007;	  Njenga	  et	  al.,	  1997;	  Oleszak	  et	  al.,	  1995).	  	  The	  virus	  spreads	  through	  the	  CNS	  gray	  matter	  and	  results	  in	  microglial	  proliferation	  and	  motor	  neuron	  degeneration.	  This	   phase	   generally	   remits	   in	   approximately	   four	   weeks,	   however	   susceptible	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strains	   of	   mice	   fail	   to	   completely	   clear	   the	   virus	   resulting	   in	   persistent	   CNS	  infection.	  	  Approximately	  three	  to	  five	  months	  after	  inoculation	  with	  the	  virus,	  this	  persistent	   infection	   initiates	   an	   inflammatory	   autoimmune	  demyelinating	   disease	  that	   is	   similar	   to	   multiple	   sclerosis	   (Aubert	   et	   al.,	   1987;	   Brahic	   et	   al.,	   1981;	  Campbell	   et	   al.,	   2001;	   Fiette	   et	   al.,	   1995;	  McGavern	   et	   al.,	   2000;	   Rodriguez	   et	   al.,	  1996;	  Welsh	  et	  al.,	  1987).	  	  	   Like	  the	  EAE	  model,	  TMEV	  infection	  allows	  for	  the	  study	  of	  the	  pathogenesis	  of	  MS;	   however,	   it	   is	   unique	   in	   that	   it	   also	   provides	   a	  model	   of	   viral	   persistence	  within	   the	   CNS.	   	   Given	   that	   CNS	   viruses	   have	   been	   linked	   to	   the	   development	   of	  human	  multiple	   sclerosis,	   this	   is	   significant.	   The	   initial	   innate	   immune	   response	  results	  in	  the	  secretion	  of	  cytokines	  that	  control	  the	  rate	  of	  viral	  infection	  as	  well	  as	  shape	  the	  development	  of	  the	  adaptive	  immune	  response	  that	  ultimately	  clears	  the	  virus	   (Biron	   et	   al.,	   1998;	   Olson	   and	   Miller,	   2009).	   	   Although	   inflammation	   is	  generally	  pathological	   in	  the	  chronic,	  demyelinating	  phase	  of	  TMEV	  infection,	   it	   is	  important	   during	   the	   initial	   response	   to	   infection.	   For	   example,	   it	   has	   been	  demonstrated	   that	   early	   release	   of	   IFN	   is	   necessary	   for	   effective	   viral	   clearance,	  such	  that	  IFN-­‐KO	  mice	  exhibit	  fatal	  encephalitis	  following	  TMEV	  infection	  (Fiette	  et	  al.,	  1995;	  Jin	  et	  al.,	  2010;	  Kaminsky	  et	  al.,	  1987).	   Jin	  et	  al.	  (2010)	  suggest	  that	  this	  effect	   is	   due	   to	   IFN’s	   role	   in	  mediating	   CNS	   immune	   cell	   infiltration	   and	   shaping	  local	  T	  cell	  responses.	  The	   early	   adaptive	   immune	   response	   to	   TMEV	   infection	   determines	   viral	  persistence	   and,	   consequently,	   severity	   of	   chronic	   phase	   demyelinating	   disease	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(Borrow	  et	  al.,	  1992;	  Borrow	  et	  al.,	  1993;	  Johnson	  et	  al.,	  2006).	  	  Although	  T	  cells	  are	  implicated	  in	  the	  induction	  of	  demyelination	  during	  chronic	  phase	  disease	  (Clatch	  et	  al.,	  1987;	  Rodriguez	  et	  al.,	  1988),	  as	  is	  observed	  in	  MS,	  they	  are	  essential	  during	  the	  acute	  phase	  for	  viral	  clearance.	  	  If	  an	  inadequate	  CD8+	  and	  CD4+	  T	  cell	  response	  occurs	   early	   in	   the	   acute	   phase	   of	   the	   disease,	   the	   chronic	   phase	   is	   exacerbated	  (Borrow	  et	  al.,	  1992;	  Murray	  et	  al.,	  1998;	  Welsh	  et	  al.,	  1987).	  	  Data	   evaluating	   the	   relationship	   between	   acute	   and	   chronic	   phase	  symptoms	  has	  shown	  that	  behavioral	  measures	  correlate	  with	  both	  chronic	  phase	  disease	   symptoms	   and	   physiological	  measures	   (Johnson	   et	   al.,	   2006;	   Sieve	   et	   al.,	  2004).	   	   For	   example,	   hindlimb	   impairment	   at	   day	   seven	   correlates	   with	   chronic	  phase	  hindlimb	  impairment,	  horizontal	  movement,	  and	  vertical	  movement	  as	  well	  as	   antibody	   to	   TMEV,	   MOG33-­‐55,	   and	   MBP	   (Johnson	   et	   al.,	   2006).	   Furthermore,	  chronic	  phase	  behavioral	  signs	  correlates	  with	  overall	  meningitis	  and	  perivascular	  cuffing	  (Sieve	  et	  al.,	  2004).	  This	  suggests	   that	  an	  evaluation	  of	  behavior	   is	  related	  useful	  tool	  to	  assessing	  and	  predicting	  disease	  severity.	  Studies	  of	  acute	  phase	  TMEV	  infection	  allows	  for	  the	  examination	  of	  factors	  that	  contribute	   to	  viral	  persistence	  and	   later	  chronic	  phase	  disease	  exacerbations	  (Aubert	   et	   al.,	   1987;	   Brahic	   et	   al.,	   1981;	   Rodriguez	   et	   al.,	   1996).	   Therefore,	   this	  model	  allows	  for	  the	  evaluation	  of	  the	  mechanisms	  by	  which	  environmental	  factors	  increase	   CNS	   viral	   persistence	   and	   demyelination.	   	   As	   is	   observed	  with	  multiple	  sclerosis,	   stress	   generally	   exacerbates	   TMEV	   infection	   (Johnson	   et	   al.,	   2006;	  Johnson	   et	   al.,	   2004b;	   Meagher	   et	   al.,	   2007;	   Mi	   et	   al.,	   2006b;	   Sieve	   et	   al.,	   2004;	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Steelman	   et	   al.,	   2009).	   Examining	   the	   mechanism	   by	   which	   stress	   exacerbates	  TMEV	  infection	  has	  provided	  some	  insight	  into	  how	  stress	  may	  affect	  MS,	  however,	  much	  is	  still	  unknown.	  
	  
Stress	  	   Broadly	   defined,	   stress	   is	   the	   non-­‐specific	   response	   of	   the	   body	   to	   any	  demand	   for	   change.	   By	   this	   definition	   stress,	   encompasses	   real	   or	   perceived	  psychological	  and	  physiological	  stressors.	  	  Psychological	  stress	  can	  be	  defined	  as	  a	  perceived	   discrepancy	   between	   personal	   resources	   and	   the	   demands	   of	   the	  situation,	   whereas	   physiological	   stressors	   are	   demands	   on	   the	   body	   that	   do	   not	  require	   a	   cognitive	   appraisal	   of	   the	   event	   and	   includes	   stimuli	   such	   as	   intense	  physical	  exertion,	  injury,	  or	  even	  bacterial	  or	  viral	  infection.	  These	  stressors	  appear	  to	   differentially	   activate	   stress	   pathways;	   based	   on	   these	   differences	   they	   have	  been	   classified	   as	   processive	   and	   systemic	   (Emmert	   and	  Herman,	   1999;	   Herman	  and	  Cullinan,	  1997).	  	  Processive,	  or	  psychological,	  stressors	  are	  those	  that	  have	  no	  inherent	   physical	   cause	   and	   thus	   require	   comparison	   with	   prior	   experience	   to	  achieve	   biological	   significance.	   	   Therefore,	   it	   is	   likely	   that	   such	   stressors	   require	  stimulus	   processing	   in	   brain	   regions	   that	   regulate	  memory	   and	   emotion.	   	   On	   the	  other	   hand,	   systemic	   or	   physiological	   stressors	   disrupt	   internal	   homeostasis	   and	  can	  activate	  a	  stress	  response	  without	  being	  channeled	  through	  limbic	  and	  cortical	  structures.	  Clearly	  these	  types	  of	  stressors	  are	  not	  necessarily	  mutually	  exclusive.	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Both	  forms	  of	  stressors	  can	  be	  acute	  or	  chronic.	  Acute	  stress	  is	  defined	  as	  a	  stress	   lasting	   for	   a	   period	   of	   minutes	   to	   hours;	   it	   can	   result	   from	   demands	   and	  pressures	  of	  the	  recent	  past	  or	  the	  anticipated	  future.	  	  It	  can	  be	  mild	  to	  severe,	  but	  passes	  quickly.	  Chronic	  stress,	  which	  persists	   for	  several	  hours	  per	  day	  for	  weeks	  or	  months,	  is	  the	  grinding	  stress	  that	  persists	  and	  wreaks	  havoc	  on	  the	  body.	  	  It	  can	  occur	   in	   response	   to	   a	   variety	   of	   stimuli	   including	   abuse,	   poverty,	   family	  dysfunction,	   or	   a	   dead-­‐end	   job.	   	   Research	   suggests	   that	   acute	   stressors	   tend	   to	  enhance	   immunity	   by	   increasing	   immune	   cell	   trafficking	   and	   enhancing	  immunological	  memory	   (Dhabhar	  and	  McEwen,	  1999;	  Dhabhar	  and	  Viswanathan,	  2005;	   Viswanathan	   and	   Dhabhar,	   2005);	   in	   contrast,	   chronic	   stressors	   are	  more	  likely	   to	   suppress	   immune	   function	   (Blecha	   et	   al.,	   1982;	   Campbell	   et	   al.,	   2001;	  Campisi	  and	  Fleshner,	  2003;	  Dobbs	  et	  al.,	  1993;	  Johnson	  et	  al.,	  2006;	  Sheridan	  et	  al.,	  1998;	  Sieve	  et	  al.,	  2004).	  It	   is	   suggested	   that	   stressors	   exert	   profound	   physiological	   responses	  intended	   to	   maintain	   an	   individual’s	   internal	   balance	   or	   homeostasis	   (McEwen,	  2000).	   Most	   notably	   the	   activation	   of	   the	   hypothalamic-­‐pituitary-­‐adrenal	   (HPA)	  axis	  and	  the	  sympathetic	  nervous	  system	  (SNS)	  occur	   in	  response	  to	  stress.	   	   	  The	  limbic	   system,	   of	   which	   the	   hypothalamus	   is	   part,	   is	   a	   complex	   set	   of	   brain	  structures	  that	  are	  highly	  responsive	  to	  emotional	  stimuli,	  such	  as	  psychological	  or	  processive	   stress.	   Direct	   activation	   by	   systemic	   stress	   or	   activation	   via	   cortico-­‐limbic	  system	  structures	  by	  processive	  stress	  of	  the	  paraventricular	  nucleus	  of	  the	  hypothalamus	   results	   in	   the	   synthesis	   and	   secretion	   of	   corticotropin	   releasing	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hormone	   (CRH).	  The	  CRH	  acts	  on	   the	  pituitary	  gland	  causing	  adrenocorticotropic	  hormone	  (ACTH)	  to	  be	  released	  into	  the	  bloodstream.	  	  In	  response	  to	  the	  ACTH,	  the	  adrenal	   cortex	   produces	   glucocorticoids	   (GCs),	   such	   as	   cortisol	   in	   humans	   and	  corticosteroids	   in	   rodents.	   	   GCs	   have	   widespread	   effects	   on	   the	   body	   because	  almost	   all	   cells	   express	   glucocorticoid	   receptors.	   	   One	   of	   their	   functions	   is	   to	  mediate	  metabolic	  processes,	  acting	  to	  stimulate	  glucose	  release	  in	  the	  liver	  and	  fat	  break	  down	  in	  adipose	  tissue.	  	  Tight	  regulation	  of	  their	  release	  is	  important	  due	  to	  the	  powerful	  effects	  they	  can	  exert.	  	  Therefore,	  secretion	  of	  GCs	  is	  suppressed	  by	  a	  negative	  feedback	  loop;	  hypothalamus	  secretion	  of	  CRH	  is	  inhibited	  by	  GCs	  (see	  Fig.	  1).	   Activation	   of	   the	   sympathetic	   branch	   of	   the	   autonomic	   nervous	   system	  results	   in	   release	   of	   norepinephrine	   from	   sympathetic	   neurons	   and	   triggers	   the	  adrenal	   medulla	   to	   synthesize	   and	   secrete	   epinephrine	   and	   norepinephrine	   into	  circulation.	   This	   results	   in	   the	   activation	   of	   the	   fight-­‐or-­‐flight	   response,	   first	  described	  by	  Walter	  Cannon	  (1914)	  who	  suggests	  that	  states	  the	  SNS	  activation	  is	  designed	  to	  prepare	  an	  animal	  facing	  danger	  to	  engage	  (fight)	  or	  avoid	  (flight)	  the	  threatening	   stimuli.	   	   Epinephrine	   release	   affects	   almost	   all	   organ	   systems;	   to	  mention	   a	   few,	   it	   increases	   heart	   rate,	   contracts	   blood	   vessels,	   and	   dilates	   air	  passages.	   Furthermore,	   immune	   cells	   can	   respond	   to	   hormones	   released	   by	   the	  SNS.	  	  For	  example,	  it	  has	  been	  suggested	  that	  norepinephrine	  can	  trigger	  microglia	  to	  release	  proinflammatory	  cytokines	  (Blandino	  et	  al.,	  2006).	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Stress	  has	  been	  shown	  to	  suppress	  immune	  function	  and,	  thereby,	  increase	  susceptibility	   to	   infections	   and	   cancer.	   Paradoxically,	   stress	   can	   also	   exacerbate	  diseases	   characterized	   by	   exaggerated	   immune	   activation,	   such	   as	   allergic,	  autoimmune,	   and	   inflammatory	   diseases.	   	   This	   suggests	   that	   stress	   may	   also	   be	  capable	   of	   enhancing	   immune	   function.	  	   These	   effects	   appear	   to	   be	  mediated	   by	  stress-­‐induced	   hormones	   (Dhabhar	   and	  McEwen,	   1999).	   	   Research	   suggests	   that	  stress	   hormones	   affect	   the	   efficacy	   of	   both	   the	   innate	   and	   adaptive	   immune	  response.	  It	  is	  through	  this	  mechanism	  that	  stress	  is	  likely	  to	  exert	  its	  effects	  on	  the	  pathogenesis	  of	  MS	  and	  Theiler’s	  Virus	  induced	  demyelination	  (TVID).	  	  	  
Glucocorticoids	  and	  Immune	  Function	  It	  has	  been	  well	  demonstrated	  that	  GCs	  affect	  immune	  system	  responses.	  It	  is	   generally	   accepted	   that	   GCs	   act	   to	   suppress	   immune	   function,	   such	   that	  	  exogenous	  glucocorticoids	  (e.g.,	  methylprednisolone, prednisone, and dexamethasone)	  are	   commonly	   used	   to	   treat	   diseases	   caused	   by	   over-­‐activation	   of	   immune	  functions,	   including	   autoimmune	   and	   inflammatory	   diseases	   like	   MS.	   This	   effect	  appears	   to	   occur	   through	   the	   inhibition	   of	   gene	   transcription.	   For	   example,	  suppressing	   proinflammatory	   pathways,	   such	   as	   NF-­‐κβ	   and	   c-­‐Jun,	   within	  macrophages	  and	  microglia	  leads	  to	  a	  reduction	  in	  inflammation	  (see	  Fig.	  2). 
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 Fig.	  1.	  The	  Hypothalamic-­‐Pituitary-­‐Adrenal	  axis.	  	  When	  a	  stressor,	  physiological	  or	  psychological,	  is	  assessed	   the	   hypothalamus,	   within	   the	   brain,	   releases	   corticotrophin	   releasing	   hormone	   (CRH),	  which	   acts	   on	   the	   pituitary	   gland.	   	   The	   pituitary	   gland	   releases	   adrenocorticotropic	   hormone	  (ACTH)	   to	   be	   released	   into	   the	   bloodstream,	   	   Once	   in	   the	   blood	   stream	   ACTH	   is	   able	   to	   act	  peripherally	  and	  cause	  the	  adrenal	  cortex	  to	  release	  glucocorticoids	  (GCs),	  cortisol	   in	  humans	  and	  corticosterone	   in	   rodents.	   	   	   Importantly,	   GCs	   form	   a	   negative	   feedback	   loop	   that	   acts	   centrally	   to	  inhibit	  hypothalamic	  release	  of	  CRH.	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 Fig.	  2.	  	  The	  impact	  of	  GCs	  on	  inflammation.	  	  	  GCs,	  such	  as	  cortisol,	  act	  on	  GC	  receptors,	  which	  are	  G-­‐protein	  coupled	  receptor,	  that	  initiates	  a	  variety	  of	  intracellular	  processes	  leading	  to	  the	  inhibition	  of	  inflammation.	  	  In	  this	  figure	  solid	  lines	  are	  activational	  pathways,	  while	  doted	  lines	  are	  inhibitory	  pathways.	  	  For	  example,	  cortisol	  inhibits	  the	  NF-­‐κβ	  and	  c-­‐Jun	  inflammatory	  pathways.	  	  Furthermore,	  stimulation	   of	   the	   GC	   receptor	   results	   in	   the	   activation	   of	  MAPK	   phophatase,	  which	   results	   in	   an	  inhibition	  of	  c-­‐Jun	  and	  MAPKs.	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  Furthermore,	   GCs	   can	   simultaneously	   antagonize	   these	   pathways	   by	  inducing	   release	   of	  MAPK	  phosphatase	   I,	  which	   inhibits	  MAP	   and	   Jun	  N-­‐terminal	  kinases	   and,	   consequently,	   reduces	   inflammation	   (Rhen	   and	   Cidlowski,	   2005).	  However,	   it	   has	   been	   demonstrated	   that	   in	   some	   cases	   GCs	   can	   act	   to	   enhance	  inflammation.	   	   For	   example,	   GCs	   facilitate	   prostaglandin	   and	   leukotriene	   sythesis	  (Garcia-­‐Fernandez	  et	  al.,	  2000),	  are	  necessary	  for	  HSV	  to	  cause	  brain	  inflammation	  (Ben-­‐Hur	   et	   al.,	   2001),	   and	   increase	   infiltration	   of	   inflammatory	   cells	   in	   the	  hippocampus	  following	  excitotoxic	  seizures	  (Dinkel	  et	  al.,	  2003).	  	  Not	   only	   do	   GCs	   affect	   the	   inflammatory	   response,	   they	   can	   also	   modify	  adaptive	   immune	   responses.	   	   These	   effects	   appear	   to	   occur	   through	   direct	   and	  indirect	   routes.	   	   Given	   that	   T	   cells	   have	   GC	   receptors	   they	   may	   lead	   to	   a	   direct	  suppression	  or	   even	   induce	   apoptosis	   of	  T	   cells	   (Ashwell	   et	   al.,	   2000;	  Gold	   et	   al.,	  2001).	  They	  may	  also	   functionally	   impair	  T	  cells	   through	  disrupting	  natural	  killer	  cell	   priming	   of	   T	   cells	   (Elftman	   et	   al.,	   2010)	   or	   by	   affecting	   the	   selection	   and	  development	   of	   T	   cells	   within	   the	   thymus	   (Stojic-­‐Vukanic	   et	   al.,	   2009).	  	  Furthermore,	   it	   has	   been	   demonstrated	   that	   stress	   can	   alter	   the	   CD4+	   T	   cell	  differentiation	  (e.g.,	  a	  Th1/Th2	  shift)(Cannarile	  et	  al.,	  2006).	  	  The	  immunosuppressive	  actions	  of	  GCs	  can	  result	  in	  the	  activation	  latent	  or	  persistent	   viruses	   (Cacioppo	   et	   al.,	   2002;	   Guliani	   et	   al.,	   1999;	  Mayer	   et	   al.,	   2006;	  Noisakran	   et	   al.,	   1998;	   Pastoret	   et	   al.,	   1980).	   	   Given	   that	   it	   is	   hypothesized	   that	  multiple	   sclerosis	   is	   associated	  with	   the	   activation	   of	   latent	   or	   persistent	   viruses	  within	  the	  CNS,	  this	  may	  be	  one	  mechanism	  by	  which	  stress	  is	  associated	  with	  the	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onset	  of	  MS.	  However,	  immunosuppression	  after	  disease	  onset	  (e.g.,	  administration	  of	   exogenous	   GCs)	   may	   be	   protective	   because	   it	   suppresses	   the	   action	   of	  autoreactive	  T	   cells.	   	  This	  may	  also	  explain	  why	   severe	   stressors,	  which	   result	   in	  high	   levels	   of	   glucocorticoids,	   may	   reduce	   disease	   relapses	   in	   MS	   patients	  (Nisipeanu	  and	  Korczyn,	  1993).	  	  However,	  the	  body	  can	  develop	  resistance	  to	  the	  immunosuppressive	  effects	  of	   glucocorticoids,	   a	   phenomenon	   known	   as	   GC	   resistance	   (GCR).	   	   This	   effect	  appears	   to	   occur	   in	   response	   to	   social	   processive	   stressors	   (i.e.,	   social	   disruption	  stress),	  not	  non-­‐social	  stressors	  (i.e.,	  restraint	  stress),	  and	  has	  been	  demonstrated	  in	  various	  species	  (Avitsur	  et	  al.,	  2001;	  Cohen	  et	  al.,	  1997;	  Miller	  et	  al.,	  2002;	  Quan	  et	   al.,	   2001;	   Raison	   and	  Miller,	   2003).	   	  With	   chronic	   high-­‐level	   exposure	   to	   GCs,	  immune	   cells	   compensate	   by	   down-­‐regulating	   the	   expression	   and	   function	   of	   GC	  receptors,	   thereby	  making	  cells	  more	  resistant	   to	   the	  anti-­‐inflammatory	  effects	  of	  GCs.	  This	  resistance	  has	  been	  demonstrated	  to	  develop	  in	  the	  immune	  cells	  of	  the	  blood,	   spleen,	   and	   brain	   in	   response	   to	   SDR	   (Avitsur	   et	   al.,	   2001;	   Johnson	   et	   al.,	  2004b;	  Meagher	  et	  al.,	  2007;	  Miller	  and	  Chen,	  2006;	  Quan	  et	  al.,	  2001).	  For	  example,	  Quan	  et	  al.	   (2001)	  demonstrated	  that	  SDR	  results	   in	  a	  reduction	  of	  glucocorticoid	  receptor	   mRNA	   in	   the	  spleen	  and	   brain	  as	   well	   as	   induce	   functional	   GCR	   in	  splenocytes.	  Although	  there	  may	  be	  circumstances	  when	  GCR	  is	  adaptive,	  it	  appears	  that	   it	   may	   be	   one	   mechanism	   by	   which	   social	   stress	   increases	   vulnerability	   to	  inflammatory	  diseases,	  such	  as	  MS.	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Catecholamines	  and	  Immune	  Function	  	   In	   addition	   to	  mediating	   the	   fight	  or	   flight	   response,	   catecholamines	   affect	  the	   immune	   response.	   	   They	   are	   particularly	   important	   in	   the	   regulation	   of	   pro-­‐inflammatory	   cytokines.	   Epinephrine	   and	   norepinephrine	   exert	   their	   effects	   by	  acting	   on	   β2	   adrenergic	   receptors	   spread	   widely	   throughout	   the	   body.	   	   These	  receptors	  are	  located	  on	  immune	  cells	  as	  well,	  providing	  an	  avenue	  by	  which	  SNS	  activation	  might	   influence	   immune	   function.	   	   For	   example,	   they	   are	   expressed	   in	  high	   levels	   on	   macrophages.	   	   Activation	   of	   the	   β2	   adrenergic	   receptor	   on	  macrophages	  results	  in	  the	  production	  of	  proinflammatory	  cytokines,	  such	  as	  IL-­‐6	  and	   IL-­‐1β	   (Blandino	   et	   al.,	   2009;	   Gornikiewicz	   et	   al.,	   2000;	   Mohamed-­‐Ali	   et	   al.,	  2001;	  Nguyen	  et	  al.,	  1998;	  Steptoe	  et	  al.,	  2001;	  Takaki	  et	  al.,	  1994;	  Tan	  et	  al.,	  2007).	  	  Furthermore,	   it	   has	   been	   suggested	   that	   microglia	   become	   activated	   by	  stress	   (Frank	   et	   al.,	   2007;	   Nair	   and	   Bonneau,	   2006;	   Sugama	   et	   al.,	   2007),	  presumably	   through	   activation	   of	   the	   β2	   adrenergic	   receptor.	   	   Microglia	   are	   the	  resident	  macrophages	  of	  the	  CNS	  and	  their	  activation	  results	  in	  the	  release	  a	  variety	  of	   proinflammatory	   factors.	   	   Unlike	   the	   all-­‐or-­‐nothing	   activational	   profile	   of	  neurons,	  microglia	  have	  a	  graded	  activational	  profile.	   	  In	  their	  basal	  state	  they	  are	  highly	  branched	  and	  constantly	  sample	  from	  the	  extracellular	  environment.	  	  When	  microglia	   encounter	   an	   activational	   signal	   (e.g.,	   tissue	   damage,	   virus,	   bacteria,	  proinflammatory	  cytokines),	  they	  undergo	  morphological	  and	  phenotypic	  changes	  designed	  to	  address	  the	  situation.	  	  These	  changes	  usually	  include	  the	  release	  of	  pro-­‐inflammatory	   cytokines,	   and	   in	   their	   highest	   activational	   state	   microglia,	   they	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become	   like	   macrophages,	   having	   an	   amoeboid	   morphology	   and	   engaging	   in	  phagocytosis	  and	  antigen	  presentation.	  	  	  	  
Cytokines	  and	  the	  Stress	  Response	  
	   The	   relationship	   between	   cytokines	   and	   stress	   is	   complex.	   Not	   only	   can	  stress	  alter	  systemic	  and	  CNS	  proinflammatory	  cytokine	  levels	  (Bartolomucci	  et	  al.,	  2003;	  Blandino	  et	  al.,	  2006;	  Deak	  et	  al.,	  2005a;	  Johnson	  et	  al.,	  2004a;	  Johnson	  et	  al.,	  2006;	  Meagher	  et	  al.,	  2007;	  Merlot	  et	  al.,	  2003;	  Merlot	  et	  al.,	  2004a;	  Mi	  et	  al.,	  2006a;	  Minami	  et	  al.,	  1991;	  Miyahara	  et	  al.,	  2000;	  Nguyen	  et	  al.,	  1998;	  Nguyen	  et	  al.,	  2000;	  O'Connor	   et	   al.,	   2003b;	   Quan	   et	   al.,	   2001;	   Shintani	   et	   al.,	   1995a;	   Shintani	   et	   al.,	  1995b;	  Stark	  et	  al.,	  2002),	   cytokine	   (e.g.,	  TNF-­‐α,	   IL-­‐1,	   IL-­‐6,	  and	   IL-­‐12)	  release	  can	  also	  initiate	  the	  release	  of	  stress	  hormones	  (Maier	  and	  Watkins,	  1998;	  Watkins	  and	  Maier,	  2000).	   It	  has	  been	  demonstrated	  that	  stress	  and	  cytokines	  have	  significant	  bi-­‐directional	  communication.	  Proinflammatory	  cytokines	  within	  the	  CNS,	  released	  in	  response	  to	   immune	  system	  activation,	  can	  activate	  the	  HPA	  axis	  (Bethin	  et	  al.,	  2000;	   Turnbull	   and	   Rivier,	   1999).	   	   This	   is	   a	   potential	   mechanism	   by	   which	   a	  systemic	  stressor	  activates	  stress	  pathways.	  Furthermore,	  cytokine	  release	  results	  in	  stereotyped	  sickness	  behaviors,	  including	  anorexia,	  anhedonia,	  reduced	  general	  activity	   and	   social	   activity,	   increased	   pain	   behavior,	   and	   learning	   and	   memory	  impairments	  (Barrientos	  et	  al.,	  2002;	  Maier	  and	  Watkins,	  1998;	  Pugh	  et	  al.,	  1999).	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   Furthermore,	  proinflammatory	  cytokine	  release	  can	  be	  sensitized*	  by	  stress-­‐and	   immune-­‐induced	  proinflammatory	  cytokines	  (Cunningham	  et	  al.,	  2005;	  Frank	  et	  al.,	  2007;	  Johnson	  et	  al.,	  2002;	  Johnson	  et	  al.,	  2004a;	  Perry	  et	  al.,	  2003;	  Quan	  et	  al.,	  2001).	   	   For	   example,	   in	   a	   model	   of	   prion	   disease,	   a	   challenge	   with	  lipopolysaccharide	  (LPS;	  a	  cell	  wall	  component	  of	  gram	  negative	  bacteria)	  results	  in	  a	  dramatic	  increase	  in	  IL-­‐1β	  expression,	  as	  well	  as	  increased	  neutrophil	  infiltration	  and	  inducible	  nitric	  oxide	  synthase	  (iNOS)	  expression,	  in	  the	  brain	  parenchyma	  of	  prion	   disease	   infected	   mice	   compared	   to	   non-­‐infected	   mice	   (Cunningham	   et	   al.,	  2005).	  Furthermore,	  administration	  of	  IL-­‐6	  sensitizes	  stress-­‐induced	  expression	  of	  IL-­‐6	  within	  the	  hypothalamus	  (Matsumoto	  et	  al.,	  2006).	  	  Increases	  in	  inflammation	  also	  results	  in	  increases	  in	  sickness	  behavior	  (Dantzer,	  2006;	  Watkins	  et	  al.,	  1994).	  	  This	   suggests	   that	   a	   shared	   neural	   substrate	   may	   be	   primed	   by	   either	   stress	   or	  immune	   activation.	   	   Given	   that	   microglia	   are	   the	   primary	   producers	   of	   CNS	  inflammation,	   they	  may	   be	   the	   underlying	  mechanism	   (Cunningham	   et	   al.,	   2005;	  Frank	  et	  al.,	  2007;	  Nair	  and	  Bonneau,	  2006;	  Perry	  et	  al.,	  2003;	  Sugama	  et	  al.,	  2007).	  	   Given	  that	  CNS	  inflammation	  is	  associated	  with	  sickness	  behavior	  (Dantzer, 
2006; Watkins et al., 1994)	   and	   MS	   is	   associated	   with	   exaggerated	   levels	   of	  proinflammatory	  cytokines	  within	  the	  CNS	  (Hauser	  and	  Oksenberg,	  2006;	  Martino	  et	  al.,	  2002),	  it	  is	  not	  unexpected	  that	  patients	  commonly	  report	  fatigue,	  depression,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  *	  Within	   the	   field	   of	   psychology,	   sensitization	   refers	   to	   an	   experience	   dependent	  enhancement	   in	   response,	   as	   observed	   in	   non-­‐associative	   learning.	   This	   is	   in	  contrast	  to	  its	  immunological	  definition,	  which	  refers	  to	  the	  acquired	  ability	  of	  the	  immune	  system	   to	   respond	   to	  a	   foreign	  substance	  upon	  re-­‐exposure.	  Throughout	  this	  dissertation	  “sensitization”	  will	  be	  used	  by	  its	  psychological	  definition. 
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pain,	   and	   cognitive	   dysfunction	   (Braley	   and	   Chervin,	   2010;	   Chiaravalloti	   and	  DeLuca,	  2008;	  Kargiotis	  et	  al.,	  2010;	  Krupp	  et	  al.,	  2010;	  Nurmikko	  et	  al.,	  2010).	  	  It	  is	  also	   no	   surprise	   that	   an	   environmental	   stimulus	   that	   exacerbates	   inflammation,	  such	   as	   psychological	   stress	   or	   viral	   infection,	   would	   be	   sufficient	   to	   exacerbate	  disease	  processes.	  	  However,	  the	  exact	  mechanism	  underlying	  this	  effect	  is	  not	  fully	  understood.	  This	  complex	  relationship	  is	  simpler	  to	  disentangle	  in	  animal	  models	  of	  MS,	  such	   as	  TMEV	   infection.	   	   As	   previously	   suggested,	   the	   nature	   of	   a	   stressful	   event	  determines	   the	  physiological	  response	  to	   the	  stressor.	   	  For	  example,	  social	  stress,	  but	   not	   restraint	   stress,	   reduces	   the	   sensitivity	   of	   immune	   cells	   to	   the	   anti-­‐inflammatory	   effects	   of	   glucocorticoids	   (Avitsur	   et	   al.,	   2001;	   Miller	   et	   al.,	   2002;	  Quan	   et	   al.,	   2001;	   Sheridan	   et	   al.,	   2000;	   Stark	   et	   al.,	   2002).	   This	   SDR-­‐induced	  glucocorticoid	   resistance	   (GCR)	   diminishes	   the	   ability	   of	   stress-­‐induced	  glucocorticoids	  to	  inhibit	  proinflammatory	  cytokines.	  Consequently,	  chronic	  social	  stress	  may	  be	  more	  likely	  to	  enhance	  inflammation	  than	  a	  chronic	  physical	  stressor,	  such	  as	  restraint	  stress.	  	  	  	  
Restraint	  Stress	  Restraint	   is	   a	   common	   procedure	   for	   studying	   the	   effect	   of	   stress	   in	  laboratory	   animals	   and	   involves	   placing	   mice	   in	   well-­‐ventilated	   tubes	   overnight	  (Pare	   and	   Glavin,	   1986).	   	   Acute	   restraint	   stress	   has	   been	   shown	   to	   enhance	  leukocyte	  (e.g.,	  neutrophil,	  macrophage,	  NK	  cell,	  and	  T	  cell)	  infiltration	  in	  response	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to	   surgery	   or	   immune	   cell	   activation	   (Viswanathan	   and	   Dhabhar,	   2005).	  Furthermore,	  it	  has	  been	  demonstrated	  that	  two	  to	  five	  hours	  of	  acute	  stress	  result	  in	  an	  enhancement	  of	  antigen-­‐specific,	  cell-­‐mediated	  immune	  responses,	  known	  as	  a	   delayed	   type	   hypersensitivy	   (DTH)	   response	   (Dhabhar	   and	  McEwen,	   1997).	   In	  contrast,	  when	  this	  stressor	  was	  administered	  chronically	  (6	  h	  for	  3	  to	  5	  weeks)	  it	  resulted	  in	  a	  suppression	  of	  the	  DTH	  response.	  	  Similarly,	  chronic	  restraint	  stress	  has	  been	  shown	  to	  suppress	  the	   immune	  response	  to	  TMEV	  infection	  (Campbell	  et	  al.,	  2001;	  Mi	  et	  al.,	  2006a;	  Steelman	  et	  al.,	  2009;	   Welsh	   et	   al.,	   2004).	   	   In	   this	   paradigm	   restraint	   was	   administered	   nightly	  beginning	  the	  night	  prior	  to	  infection	  and	  continuing	  until	  day	  eight	  post-­‐infection.	  This	  stressor	  has	  been	  shown	  to	  enhance	  glucocorticoid	  secretion	  without	   loss	  of	  GC	  sensitivity,	  exacerbate	  sickness,	  decrease	  viral	  clearance,	  and	  increase	  mortality	  following	   TMEV	   infection	   (Campbell	   et	   al.,	   2001).	   	   It	   has	   also	   been	   shown	   to	  decrease	   innate	   immune	   function,	   as	  measured	  by	   a	   reduction	   in	  NK	   cell	   activity	  (Welsh	  et	  al.,	  2004)	  as	  well	  as	  lower	  cytokine	  expression	  in	  the	  spleen	  and	  CNS	  (Mi	  et	   al.,	   2006a).	   	   Recently	   it	   has	   been	   demonstrated	   that	   restraint	   also	   suppresses	  virus	  specific	  CD4+	  and	  CD8+	  T	  cell	  function	  (Steelman	  et	  al.,	  2009).	  	  
Social	  Disruption	  Stress	  Although	  restraint	  stress	  provides	  insight	  into	  how	  the	  activation	  of	  the	  HPA	  axis	   influences	  disease	  course,	   its	   translational	  value	  may	  be	   limited.	   It	   is	  unclear	  what	   human	   stressor	  may	   be	   comparable	   to	   restraint	   stress	   in	  mice.	   	   Given	   that	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stressors	   do	   not	   necessarily	   exert	   uniform	   change,	   it	   is	   important	   to	   establish	  models	  that	  are	  more	  readily	  translated	  to	  human	  conditions.	  Due	  to	  the	  propensity	  and	   ubiquitous	   nature	   of	   social	   stress	   (Blanchard	   et	   al.,	   2001),	   it	   is	   seems	   to	   be	  important	   to	   evaluate	   the	   immunological	   consequences	   of	   social	   stress	   in	   animal	  models.	  	  	  Social	   disruption	   (SDR)	   stress	   is	   an	   animal	   model	   of	   social	   stress	   that	  consists	  of	  introducing	  a	  dominant	  male	  mouse	  into	  the	  home	  cage	  of	  younger	  male	  mice.	   	   The	   intruder	   displays	   dominance	   (e.g.,	   tail	   shaking,	   chasing,	   mounting,	   or	  biting)	  and	  requires	  the	  other	  mice	  in	  the	  cage	  to	  display	  submissive	  behavior	  (e.g.,	  standing	  on	  hindlimbs	  with	  ventral	  body	  surface	  exposed	  and	  forelegs	  raised).	  	  This	  disrupts	  the	  established	  hierarchy	  and	  results	  in	  glucocorticoid	  release	  (Johnson	  et	  al.,	  2004b;	  Quan	  et	  al.,	  2001).	  	  When	  the	  stressor	  is	  administered	  chronically	  (six	  2-­‐hour	  sessions	  within	  one	  week),	  GCR	  develops	  (Avitsur	  et	  al.,	  2001;	  Johnson	  et	  al.,	  2004b).	   	   Furthermore,	   subjects	   exposed	   to	   SDR	   prior	   to	   an	   immune	   challenge	  demonstrated	  an	  enhanced	  inflammatory	  response	  (Quan	  et	  al.,	  2001).	  	  Similarly,	  it	  has	   been	   demonstrated	   that	   SDR	   results	   in	   enhanced	   serum	   levels	   of	   IL-­‐6	   in	  response	   to	   TMEV	   infection	   (Johnson	   et	   al.,	   2006),	   contrary	   to	   what	   has	   been	  observed	  in	  response	  to	  restraint	  stress	  (Mi	  et	  al.,	  2006a).	   	  However,	  this	  increase	  in	   inflammation	   is	   consistent	   with	   reports	   that	   circulating	   levels	   of	   IL-­‐6	   are	  elevated	  in	  humans	  with	  major	  depression	  and	  chronic	  stress	  (Kiecolt-­‐Glaser	  et	  al.,	  2003;	  Maes	  et	  al.,	  1999;	  Maes	  et	  al.,	  1998).	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IL-­‐6	  is	  a	  pleiotropic	  cytokine	  produced	  by	  a	  panoply	  of	  cells,	   including,	  but	  not	   limited	   to,	   macrophages,	   microglia,	   astrocytes,	   T	   cells,	   and	   endothelial	   cells.	  	  Furthermore,	  it	  can	  be	  released	  due	  to	  a	  variety	  of	  stimuli,	  including	  cytokines	  (e.g,	  IL-­‐1,	  TNF-­‐α),	  bacterial	  and	  viral	   infection,	  disease	  (e.g.,	  MS,	  cancer,	  heart	  disease),	  and	  stress.	  	  Upon	  release,	  it	  can	  act	  as	  both	  pro-­‐	  and	  anti-­‐inflammatory.	  	  IL-­‐6	  plays	  a	  key	   role	   in	   inflammation	   through	   induction	   of	   factors	   such	   as	   C-­‐reactive	   protein.	  Furthermore,	  IL-­‐6	  influences	  acquired	  immune	  function	  through	  induction	  of	  T	  cell	  growth	  and	  cytotoxic	  T	  cell	  differentiation.	  	  An	  over	  production	  of	  IL-­‐6	  is	  generally	  related	  to	  inflammatory-­‐mediated	  disease	  and	  is	  accompanied	  by	  an	  increase	  in	  IL-­‐1β.	  Despite	  the	  negative	  impact	  of	  high	  levels	  of	  IL-­‐6,	  blocking	  this	  cytokine	  can	  also	  have	  pro-­‐inflammatory	  effects	  suggesting	  anti-­‐inflammatory	  actions	  of	  IL-­‐6	  as	  well.	  Research	  reveals	  that	  it	  serves	  as	  negative	  feedback	  for	  proinflammatory	  cytokines.	  	  Previous	  research	  has	  also	  demonstrated	  that	  exposure	  to	  chronic	  SDR	  prior	  to	   TMEV	   infection	   exacerbates	   both	   acute	   and	   chronic	   phases	   of	   the	   disease	  (Johnson	   et	   al.,	   2006;	   Johnson	   et	   al.,	   2004b;	   Meagher	   et	   al.,	   2007).	   	   It	   results	   in	  increased	   inflammatory	   cell	   infiltration	   in	   the	   spinal	   cord	   and	   brain,	   an	  exacerbation	  of	  motor	  impairment,	  enhanced	  sickness	  behaviors,	  and	  a	  disruption	  of	  viral	  clearance	  from	  CNS.	  Furthermore,	  it	  results	  in	  increased	  levels	  of	  circulating	  antibodies	   to	  Theiler’s	   virus	   and	  myelin	  during	   the	   chronic	   phase.	   	   This	   suggests	  that	  social	  stress	  alters	  both	  the	   immune	  response	  and	  the	  autoimmune	  response	  to	   infection.	   	  Moreover,	   it	  has	  been	  demonstrated	  that	  central	  administration	  of	  a	  neutralizing	   antibody	   to	   IL-­‐6	   during	   the	   stress	   exposure	   period	   can	   reverse	   the	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adverse	   effects	   of	   stress	   on	   acute	   phase	   disease	   (Meagher	   et	   al.,	   2007).	   Although	  these	  findings	  suggest	  that	  IL-­‐6	  partially	  mediates	  the	  deleterious	  effects	  of	  SDR	  on	  sickness/motor	   behaviors	   and	   immunity	   during	   acute	   TMEV	   infection,	   the	   exact	  mechanism	   remains	   unknown.	   	   Based	   on	   this	   data,	   this	   dissertation	   tested	   the	  hypothesis	   that	   stress-­‐induced	   enhancement	   of	   IL-­‐6	   release	   results	   in	   an	   altered	  inflammatory	   response	   to	   infection	   and,	   subsequently,	   disrupts	   the	   adaptive	  immune	  response,	  which	  would	  exacerbate	  TMEV	  pathogenesis.	  	  	  
	  
Experimental	  Hypotheses	  The	  central	  hypothesis	  of	  this	  dissertation	  was	  that	  prior	  exposure	  to	  social	  disruption	   stress	   exacerbates	   TMEV	   infection	   by	   dysregulating	   the	   innate	   and	  adaptive	  immune	  response	  to	  acute	  infection.	  	  Specifically,	  I	  hypothesized	  that	  prior	  exposure	   to	   chronic	   social	   stress	   results	   in	   virus-­‐induced	   enhancement	   of	  inflammatory	  cytokine	  expression	  and	  suppression	  of	  the	  T	  cells	  production	  within	  the	  CNS	  during	  the	  acute	  phase	  of	  TMEV	  infection.	  	  The	  dysregulation	  of	   the	   innate	   immune	   response	   is	   addressed	   in	  Chapter	  III.	  Prior	  data	  suggest	  that	  stress-­‐induced	  IL-­‐6	  mediates	  the	  adverse	  effects	  of	  SDR	  on	   TMEV	   disease	   course	   (Meagher	   et	   al.,	   2007).	   	   Therefore,	   this	   series	   of	  experiments	   sought	   to	   determine	   if	   stress	   results	   in	   an	   enhancement	   of	   CNS	  inflammation,	   a	   priming	   of	   TMEV	   infection	   induced	   inflammation,	   and	   if	   the	  protection	   conferred	   by	   neutralizing	   IL-­‐6	   during	   the	   stress	   exposure	   period	   is	  through	   the	   inhibition	   of	   this	   enhancement	   in	   virus-­‐induced	   inflammation.	   Prior	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research	   demonstrated	   that	   exposure	   to	   stress	   can	   potentiate	   or	   enhance	   the	  release	  of	  proinflammatory	  cytokines	   following	  an	   immune	  challenge	   (Johnson	  et	  al.,	  2002;	   Johnson	  et	  al.,	  2006;	  Merlot	  et	  al.,	  2004b;	  Quan	  et	  al.,	  2001).	  Given	   that	  prior	   research	   has	   shown	   that	   IL-­‐6	   neutralizing	   antibody	   treatment	   during	   the	  stress	  exposure	  period	  reverses	  the	  adverse	  effects	  of	  stress	  on	  TMEV	  infection,	  it	  seems	  plausible	  that	  SDR-­‐induced	  increases	  in	  central	  IL-­‐6	  production	  may	  be	  one	  mechanism	  by	  which	  stress	  exacerbates	  acute	  and	  chronic	  TMEV	  infection.	  	  Furthermore,	  given	  that	  it	  has	  been	  demonstrated	  that	  stress	  can	  lead	  to	  the	  activation	  of	  microglia	  (Frank	  et	  al.,	  2007;	  Nair	  and	  Bonneau,	  2006;	  Sugama	  et	  al.,	  2007),	   these	   experiments	   indirectly	   assessed	   the	   potential	   role	   of	   microglia	   in	  mediating	  the	  enhancement	  in	  neuroinflammation	  by	  examining	  the	  expression	  of	  CD11b,	   a	  marker	   of	  microglia	   activation.	   These	   experiments	   began	   by	   seeking	   to	  replicate	  prior	  data	   showing	   that	   social	  disruption	  stress	   can	  exacerbate	   sickness	  behavior	   in	   response	   to	   Theiler’s	   virus	   infection	   (Chapter	   III,	   experiment	   one	  [Experiment	   3.1]).	   	   Experiment	   3.2	   evaluated	   SDR-­‐induced	   changes	   in	   levels	   of	  inflammatory	   cytokine	   expression	   and	   CD11b	   within	   the	   hippocampus.	   It	   was	  hypothesized	  that	  stress	  will	  lead	  to	  an	  increase	  in	  proinflammatory	  cytokines	  and	  microglia	   activation	   within	   the	   hippocampus.	   	   The	   hippocampus	   was	   selected	  based	  upon	  its	  role	  in	  regulating	  stress	  responses.	  	  Finally,	  Chapter	  III	  examined	  if	  stress,	   prior	   to	   infection,	   enhances	   the	   central	   and	   peripheral	   inflammatory	  response	   to	   viral	   infection	   and	   if	   the	   protective	   effects	   conferred	   by	   IL-­‐6	  neutralizing	   antibody	   treatment	   during	   the	   stress	   exposure	   period	   acts	   by	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reversing	  this	  enhancement	  in	  inflammatory	  cytokine	  expression	  (Experiment	  3.3).	  	  The	  dysregulation	  of	  the	  adaptive	  immune	  response	  is	  examined	  in	  Chapter	  IV.	  Although	  prior	  data	  demonstrated	  that	  restraint	  stress	  results	  in	  a	  suppression	  of	  virus	   specific	  CD4+	  and	  CD8+	  T	  cells	   (Steelman	  et	  al.,	  2009),	   it	   is	   important	   to	  determine	   if	   a	   SDR	   similarly	   altered	  T	   cell	   expression.	   	  Despite	   the	  differences	   in	  stressor	  types,	  it	  was	  hypothesized	  that	  social	  disruption	  stress	  would	  also	  result	  in	  a	  suppression	  of	  virus	  specific	  T	  cells.	  	  This	  hypothesis	  is	  based	  upon	  the	  reduction	  in	  viral	  clearance	  observed	  in	  response	  to	  SDR.	  	  Although	  prior	  work	  on	  the	  role	  of	  SDR	   in	   TMEV	   infection	   was	   carried	   out	   in	   BALB/cJ	   mice	   (Johnson	   et	   al.,	   2006;	  Johnson	   et	   al.,	   2004b;	   Meagher	   et	   al.,	   2007;	   Skulina	   et	   al.,	   2004),	   this	   series	   of	  experiments	  was	  carried	  out	  in	  SJL/J	  mice.	  	  This	  change	  was	  based	  primarily	  upon	  the	   fact	   that	  no	  suitable	  viral	  peptides	  exist	   for	   the	  assessment	  of	  Theiler’s	  virus-­‐specific	   T	   cell	   activity	   in	   BALB/cJ	   mice.	   	   Furthermore,	   this	   allows	   for	   the	  generalizablity	  of	  the	  SDR	  effect	  to	  be	  examined.	  	  	  My	  dissertation	  began	  by	  determining	  if	  that	  SDR	  prior	  to	  infection	  disrupts	  viral	  clearance	  (Experiment	  4.1)	  and	  enhances	  sickness	  behavior	  (Experiment	  4.2	  and	  4.3)	  in	  SJL/J	  mice.	  	  Next,	  it	  examined	  the	  expression	  of	  CD4+	  and	  CD8+	  T	  cells	  within	  the	  cortex	  via	  RT-­‐PCR	  to	  determine	  if	   infection	  increases	  expression	  and	  if	  SDR	  results	  in	  a	  blunting	  of	  this	  increase	  (Experiment	  4.2).	  	  Finally,	  Experiment	  4.3	  sought	  to	  determine	  if	  infection	  increases	  Theiler’s	  virus-­‐specific	  CD4+	  and	  CD8+	  T	  cell	  activity	  within	  the	  CNS	  and	  periphery	  and	  if	  SDR	  attenuates	  this	  effect.	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CHAPTER	  II	  GENERAL	  METHODS	  	  
Subjects	  	  Male	   BALB/cJ	   and	   SJL/J	   mice	   (22-­‐24-­‐days-­‐old;	   Jackson	   Labs,	   Bar	   Harbor,	  ME)	   were	   maintained	   on	   a	   12-­‐h	   light/dark	   cycle	   (lights	   off	   at	   17:00	   h)	   with	  continuous	  white	  noise	  (64	  dB)	  and	  ad	  libitum	  access	  to	  food	  and	  water.	   	  Animals	  were	  individually	  housed	  until	  they	  recovered	  from	  cannulation	  surgery,	  at	  which	  time	   they	  were	  group	  housed,	   two	   to	   three	  per	  cage.	   	   Intruder	  mice	  were	  retired	  male	  breeders	  of	  the	  same	  strains	  (Jackson	  Labs,	  Bar	  Harbor,	  ME).	  All	  animal	  care	  protocols	  were	   in	   accordance	  with	   the	  Texas	  A&M	  University	   Laboratory	  Animal	  Care	  and	  Use	  Committee	  (ULACC).	  	  	  
	  
Cannulation	  and	  IL-­6	  Neutralization	  For	  studies	  in	  Chapter	  III,	  mice	  underwent	  cannulation	  surgery	  the	  day	  after	  they	   arrived.	   They	   were	   placed	   into	   an	   induction	   chamber	   and	   exposed	   to	   5%	  isoflurane	   gas.	   	   After	   induction	   they	  were	  moved	   to	   a	   stereotaxic	   apparatus	   and	  maintained	  on	  2%	  isoflurane.	  	  A	  33-­‐gauge	  guide	  cannula	  (PlasticsOne,	  Roanoke,	  VA,	  C315GS-­‐2/SPC)	  was	   stereotaxically	   implanted	   into	   the	   left	   lateral	   ventricle	   (+1.0	  mm	  lateral	  and	  -­‐0.4	  mm	  rostral	  to	  bregma,	  and	  1.75	  mm	  from	  the	  top	  of	  the	  skull).	  	  They	  were	  provided	  with	  softened	   food	  and	  acetaminophen	   treated	  water	   (162.5	  mg/L)	  for	  at	  least	  48	  h	  prior	  to	  being	  group	  housed.	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To	   block	   the	   effects	   of	   stress-­‐induced	   IL-­‐6	   in	   the	   brain,	   IL-­‐6	   neutralizing	  antibody	  was	  administered	  intracereboventricularly	  (icv)	  four	  hours	  prior	  to	  each	  session	   of	   SDR.	   	   This	  method	   has	   been	   used	   previously	   to	   reverse	   the	   effects	   of	  specific	  cytokines	  in	  the	  brains	  of	  mice	  and	  rats	  (Jean	  Harry	  et	  al.,	  2003;	  Meagher	  et	  al.,	   2007;	   Nadeau	   and	   Rivest,	   2003).	   	   IL-­‐6	   neutralizing	   antibody	   (polyclonal	   goat	  anti-­‐mouse;	   10	   ng;	   R&D	   Systems,	   Madison,	   WI;	   AF-­‐406-­‐NA)	   or	   vehicle	   (goat	   Ig;	  Santa	  Cruz	  Biotechnology,	  Inc	  #SC-­‐2342)	  was	  infused	  in	  a	  2	  µL	  volume	  at	  a	  rate	  of	  1	  
µL/min	  via	  the	  implanted	  guide	  cannula	  and	  a	  microinjection	  pump.	  	  
	  
Social	  Disruption	  Stress	  	   Cages	  were	  randomly	  assigned	  to	  either	  the	  control	  or	  SDR	  condition.	  	  SDR	  began	  at	  the	  onset	  of	  the	  dark	  cycle	  (17:00	  h).	   	  During	  the	  SDR	  procedure	  control	  mice	   remained	   undisturbed	   in	   their	   home	   cage,	   while	   SDR	  mice	   were	  moved	   to	  another	  room	  and	  an	  aggressive	  male	  intruder	  was	  introduced	  to	  the	  cage	  for	  two	  hours.	   	  This	  occurred	  for	  a	  total	  of	  six	  sessions,	  three	  consecutive	  nights,	  then	  one	  off,	  followed	  by	  three	  consecutive	  nights	  (Avitsur	  et	  al.,	  2001;	  Johnson	  et	  al.,	  2006;	  Johnson	  et	  al.,	  2004b;	  Stark	  et	  al.,	  2001).	  To	  minimize	  habituation	  to	  social	  defeat,	  a	  new	   intruder	  was	   used	   for	   each	   session.	   	   The	   sessions	  were	  monitored	   by	   video	  camera	   to	   ensure	   that	   the	   intruder	   demonstrated	   dominant	   behavior	   and	   the	  residents	  demonstrated	  submissive	  behavior.	  	  If	  an	  intruder	  failed	  to	  attack	  within	  10	  min,	   they	  were	  replaced	  and	  the	  session	  was	  continued	   for	   the	  remaining	  two	  hours.	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To	  systematically	  assess	  the	  degree	  of	  wounding	  induced	  by	  SDR,	  we	  used	  a	  measure	  adapted	  from	  Merlot	  et	  al.	  (2003).	   	  Prior	  to	  the	  onset	  of	  SDR	  all	  subjects	  were	   assigned	   a	   fur	   score	   from	   one	   to	   five,	   as	   follows:	   1	   (well	   groomed	   and	  polished),	  1.5	   (fur	  not	  well	  polished,	   looking	  a	  bit	   ruffled	  or	  dirty),	  2	   (bristling	  of	  the	  fur),	  2.5	  (one	  small	  bite),	  3	  (more	  than	  one	  fur	  marks	  with	  bristling	  of	  the	  fur),	  and	   4	   (one	   or	   more	   visible	   wounds	   where	   the	   fur	   was	   obviously	   disrupted).	  	  Immediately	  following	  each	  session	  of	  SDR	  mice	  were	  examined	  under	  a	  red	  light	  for	  gross	  wounding.	  	  	  
Virus	  and	  Infection	  	   The	   BeAn	   strain	   of	   Theiler’s	   virus	  was	   kindly	   provided	   by	   Dr.	   H.L.	   Lipton	  (Department	   of	  Microbiology-­‐Immunology,	   University	   of	   Illinois,	   Chicago,	   IL)	   and	  was	   propagated	   in	   L2	   cells	   (Welsh	   et	   al.,	   1987).	   	   Mice	   were	   anesthetized	   with	  isoflurane	  (Vecco	  Inc.,	  St	  Joseph,	  MS)	  and	  inoculated	  with	  5x104	  pfu	  of	  TMEV	  in	  a	  20	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Weight	  Loss	  A	   drop	   in	   body	   weight	   and	   food	   consumption	   is	   generally	   observed	  immediately	  following	  infection	  with	  TMEV.	   	  Furthermore,	  it	  has	  been	  shown	  that	  initial	   weight	   loss	   is	   associated	  with	   some	   chronic	   phase	   behaviors	   (Sieve	   et	   al.,	  2004).	  	  Therefore,	  we	  assessed	  body	  weight	  and	  food	  weight	  daily	  at	  09:00	  h	  using	  a	  scale	  sensitive	  to	  0.01g	  (Scout®	  Pro	  Portable	  Balance,	  Ohaus,	  Pine	  Brook,	  NJ).	  	  
	  
Anhedonia	  	  Anhedonia,	   a	   loss	   of	   interest	   in	   pleasure	   seeking,	   was	   assessed	   by	  evaluating	  preference	  for	  a	  sucrose	  solution	  (Maier	  and	  Watkins,	  1998;	  Pollak	  et	  al.,	  2000).	   	   Anhedonia	   is	   thought	   to	   be	   mediated	   by	   increased	   CNS	   inflammatory	  cytokines	   (Dantzer	   et	   al.,	   1999;	   Dantzer	   et	   al.,	   2001)	   and	   has	   previously	   been	  shown	  to	  occur	  in	  TMEV	  infected	  animals	  previously	  exposed	  to	  stress	  (Meagher	  et	  al.,	  2007).	  Throughout	  experiments	  mice	  were	  provided	  with	  two-­‐bottle	  choice,	  one	  bottle	  contained	  a	  2%	  sucrose	  solution	  and	   the	  other	  contained	   tap	  water	   (bottle	  position	  was	  alternated	  in	  order	  to	  prevent	  the	  development	  of	  a	  place	  preference).	  	  Sucrose	   preference	   was	   defined	   as	   a	   60%	   or	   greater	   preference	   for	   the	   sucrose	  solution,	  calculated	  by	  dividing	  the	   intake	  of	  sucrose	  solution	  by	  total	   fluid	   intake	  and	  multiplying	   by	   100.	   	   Only	   cages	   that	   exhibited	   a	   sucrose	   preference	   prior	   to	  infection	  were	  included	  in	  data	  analysis.	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Mechanical	  Sensitivity	  Prior	   research	   has	   demonstrated	   that	   stress	   exposure	   can	   result	   in	  enhancements	   of	   virus-­‐induced	   sensitivity	   to	   typically	   non-­‐noxious	   stimuli,	   also	  known	   as	   allodynia	   (Bardin	   et	   al.,	   2009;	   Chung	   et	   al.,	   2007;	   Khasar	   et	   al.,	   2005;	  Young	  et	  al.,	   in	  preparation).	  Specifically,	   it	  has	  been	  shown	  that	  SDR	  exacerbates	  TMEV-­‐induced	   allodynia	   (Meagher	   et	   al.,	   2007).	   Although	   the	   exact	   mechanism	  mediating	   this	   effect	   is	   unknown,	   research	   suggests	   that	   an	   upregulation	   of	   CNS	  cytokines	   and	  microglia	   mediate	   this	   effect	   (Bradesi	   et	   al.,	   2009;	   Sweitzer	   et	   al.,	  1999;	  Watkins	  and	  Maier,	  2005;	  Wen	  et	  al.,	  2009).	  	  In	   this	   study	  mechanical	   allodynia	  was	   assessed	   prior	   to	   infection	   and	   on	  day	   one	   and	   seven	   post-­‐infection	   by	   placing	   the	   mice	   in	   transparent	   circular	  chambers	  positioned	  on	  a	  raised	  mesh	  screen	  (2	  mm	  gauge),	  and	  nylon	   filaments	  (von	  Frey	  monofilaments;	  Stoelting,	  Wooddale,	  IL;	  0.008	  –	  2.0	  grams)	  were	  applied	  to	  the	  hindpaw	  to	  determine	  their	  withdrawal	  threshold.	  Starting	  with	  the	  smallest	  filament,	   each	   filament	   was	   applied	   to	   the	   left	   and	   right	   hindpaws	   in	   an	   ABBA	  manner.	   	  Mice	  received	  three	  trials:	  ascending,	  descending,	  and	  ascending	  (Dixon,	  1980).	  Mice	  were	  habituated	  to	  the	  apparatus	  for	  20	  min	  prior	  to	  each	  test.	  	  
	  
Open	  Field	  Activity	  	   Given	   that	   another	   consequence	   of	   enhanced	   CNS	   proinflammatory	  cytokines	  is	  reduced	  activity,	  this	  study	  also	  evaluated	  subject’s	  activity	  in	  an	  open	  field	  (Dantzer,	  2006).	  SDR	  prior	  to	  infection	  has	  previously	  been	  shown	  to	  suppress	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horizontal	   activity	   in	   an	   open	   field	   (Meagher	   et	   al.,	   2007).	   	   Therefore,	   open	   field	  horizontal	   activity	  was	   assessed	   using	   six	   optical	   beam	   activity	  monitors	   (Model	  RXYZCM-­‐16).	   Each	   equipped	   with	   two	   banks	   of	   eight	   photocells	   per	   wall.	   	   The	  boxes	  are	  interfaced	  with	  digital-­‐multiplexors	  and	  Versamax	  software	  (Model	  DCM-­‐4,	  Omnitech	  Electronics,	  Columbus,	  OH).	  Mice	  were	  habituated	  to	  the	  chambers	  for	  60	  min	  prior	  to	  baseline	  data	  collection.	  Test	  sessions	  were	  conducted	  in	  the	  dark	  beginning	   at	   15:00	   h	   for	   30	   min	   with	   white	   noise	   (64	   dB)	   to	   mask	   extraneous	  disturbances.	  	  
	  
Hindlimb	  Impairment	  and	  Clinical	  Scores	   	  Furthermore,	   it	   has	   previously	   been	   shown	   that	   SDR	   prior	   to	   infection	  results	  in	  increased	  hindlimb	  impairment	  (HLI)	  and	  clinical	  scores	  (Meagher	  et	  al.,	  2007).	  	  Therefore,	  these	  measures	  were	  assessed	  at	  baseline	  and	  on	  day’s	  one,	  four,	  and	   seven	   post-­‐infection	   by	   a	   rater	   blind	   to	   experimental	   condition.	   	   Details	   on	  these	   scales	   have	   been	   presented	   elsewhere	   (Johnson	   et	   al.,	   2004b).	   	   Briefly,	   the	  hindlimb	   impairment	   scale	   was	   developed	   to	   quantify	   the	   behavior	   of	   BALB/cJ	  mice	   after	   infection	   with	   TMEV.	   	   This	   scale	   assesses	   weakness	   and	   paresis	   by	  observing	  alterations	  in	  locomotor	  function	  on	  an	  inverted	  grid.	   	  A	  separate	  score	  was	   given	   to	   each	   hindlimb	   (0=healthy;	   1=slight	   weakness	   in	   grip;	   2=clear	  weakness	   in	   grip;	   3=slight	   paralysis;	   4=moderate	  paralysis;	   5=complete	  paralysis	  with	  muscle	  tone;	  6=complete	  paralysis	  with	  no	  muscle	  tone).	  	  The	  two	  scores	  were	  summed	  to	  achieve	  the	  HLI	  score.	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Clinical	   scores	   were	   given	   on	   a	   0-­‐4	   scale	   that	   considers	   the	   degree	   of	  hunched	   posture	   and	   piloerection,	   which	   are	   non-­‐specific	   signs	   of	   sickness.	  	  Hunching	  was	  scored	  on	  a	  scale	  of	  zero	  (no	  hunching)	  to	  six	  (having	  a	  sharp,	  high	  bump	   between	   the	   shoulder	   blades	   with	   the	   rear	   hind	   quarters	   abnormally	  dropped	  to	  the	  ground).	  Piloerection,	  or	  ruffling,	  was	  also	  scored	  on	  a	  scale	  of	  zero	  to	   six,	  with	  0	  being	   smooth	   fur	   and	  6	  being	  oily,	   clumped	   fur	   covering	   the	   entire	  body.	  	  	  	  	  	  	  
Analysis	  of	  Changes	  in	  Gene	  Expression	  
Tissue	  Collection	  At	  the	  termination	  of	   the	  study	  the	  experimental	  subject	  was	   injected	  with	  50-­‐mg/kg	   pentobarbital	   and	   perfused	   via	   the	   left	   ventricle	  with	   cold	   RNase-­‐Free	  water.	  	  Serum,	  brain,	  and	  spleen	  were	  collected.	  	  Tissue	  was	  flash	  frozen	  and	  stored	  at	  -­‐80°C	  until	  analysis.	  	  A	  mouse	  brain	  matrix	  (PlasticsOne,	  Roanoke,	  VA)	  was	  used	  to	  assist	  with	  the	  microdissection	  of	  the	  hippocampus	  in	  Experiment	  3.1.	  	  
	  
Real	  Time	  RT-­PCR	  For	   real	   time	  RT-­‐PCR	  analysis	   total	  RNA	   from	  CNS	   tissue	  and	   spleen	  were	  homogenized	  in	  QIAzol.	   	  RNA	  was	  isolated	  and	  purified	  through	  the	  use	  of	  Qiagen	  lysis	  reagent	  and	  RNeasy	  kit	  (Qiagen)	  with	  on-­‐column	  DNase	  digestion	  according	  to	  manufacturer’s	   instructions.	   	   cDNA	  was	  generated	   through	   the	  use	  of	   an	  RNA-­‐to-­‐cDNA	   kit	   (Applied	   Biosystems,	   Carlsbad,	   CA)	   according	   to	   the	   manufacturer’s	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instructions.	   	   RT-­‐PCR	   was	   run	   to	   assess	   mRNA	   expression	   levels	   on	   markers	   of	  inflammation,	   including	  IL-­‐6,	   IL-­‐1β,	   IL-­‐10,	  TNF-­‐α,	  CD11b,	  and	  IFN-­‐γ,	  and	  for	  T	  cell	  expression,	  CD4+	  and	  CD8+.	  	  TaqMan	  probes	  and	  primers	  from	  Applied	  Biosystems	  were	   used,	   and	   β-­‐actin	   was	   used	   as	   a	   control.	   The	   2(-­‐ΔΔCT)	   method	   was	   used	   to	  determine	  fold	  difference	  in	  expression.	  	  
	  
Serum	  Cytokine	  Levels	  	  Serum	  was	  collected	  at	  the	  termination	  of	  Experiment	  3.3	  in	  Chapter	  III	  for	  analysis	   of	   IL-­‐6	   and	   IL-­‐1β	   protein	   levels.	   Commercially	   available	  ELISA	  Kits	  were	  purchased	  (R&D	  Systems,	  Minneapolis,	  MN;	  M6000B	  &	  MLB00B)	  and	  run	  per	   the	  manufacturer’s	  instructions.	  
	  
Viral	  Titer	  Assay	  Viral	  load	  peaks	  within	  one	  to	  two	  weeks	  after	  infection,	  and	  a	  reduced	  rate	  of	  viral	  clearance	  is	  associated	  with	  exacerbated	  disease	  course	  (Welsh	  et	  al.,	  1987).	  Therefore,	   viral	   titers	   were	   assessed	   at	   day	   eight	   post-­‐infection.	   Subjects	   were	  injected	   with	   a	   lethal	   dose	   of	   Beuthanasia	   special	   150-­‐mg/kg	   (Schering-­‐Plough	  Animal	  Health)	  (Welsh	  et	  al.,	  2004).	  	  Mice	  were	  perfused	  through	  the	  left	  ventricle.	  Brain	  and	  spinal	  cords	  were	  collected,	  homogenized	  in	  Dulbecco's	  modified	  Eagles’	  medium	  DMEM	  (Gibco	  BRL,	  Grand	  Island,	  NY),	  and	  centrifuged.	   	  Supernatant	  was	  collected	  and	  used	  for	  this	  assay.	  	  BHK-­‐21	  cells	  were	  grown	  in	  Dulbecco's	  modified	  Eagles’	  medium	  (DMEM)	  supplemented	  with	  10%	  fetal	  bovine	  serum	  (FBS)	  (Irvine	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Scientific,	  Irvine,	  CA)	  and	  maintained	  in	  BMEM	  with	  1%	  FBS	  post	  inoculation.	  	  The	  titration	  of	  viruses	  was	  performed	  in	  BHK-­‐21	  cells	  by	  cytopathic	  effect	  (CPE).	  	  Cells	  were	  seeded	  in	  96-­‐well	  plates	  at	  a	  concentration	  of	  105	  cells	  per	  well.	  	  When	   the	   cells	   reached	   confluency,	   each	  well	   was	  washed	   once	  with	   serum-­‐free	  Iscove’s	  Modified	  Dulbecco’s	  Media	   (IMDM)	  and	   then	   inoculated	   in	  quadruplicate	  with	   0.05	   µL	   virus	   suspension	  per	  well	   in	   tenfold	   dilutions	   in	  DMEM.	  	   After	   viral	  adsorption	  the	  cells	  were	  washed	  in	  serum-­‐free	  IMDM	  and	  incubated	  with	  1%	  FBS-­‐containing	  IMDM.	  	  The	  CPE	  was	  assessed	  daily	  and	  the	  TCID-­‐50	  was	  calculated	  by	  the	  Reed	  and	  Muench	  formula	  (Reed	  and	  Muench,	  1938).	  
	  
Determination	  of	  Virus-­Specific	  T	  Cell	  Responses	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Preparation	  of	  Feeder	  Cells	  	  Spleens	   were	   aseptically	   removed	   from	   aged-­‐matched	  unstressed/uninfected	  controls.	  	  Feeder	  cells	  were	  irradiated	  with	  3000	  rads	  (CO60	  source,	   College	   of	   Veterinary	   Medicine	   and	   Biomedical	   Sciences,	   Texas	   A&M	  University).	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ELISPOT	  Assay	  	  
	  The	   effects	   of	   social	   disruption	   stress	   on	  T	   cell	   effector	   function	   to	  TMEV	  were	  assessed,	   in	  part,	   by	   the	  ability	   to	  CNS-­‐ILs	   to	  generate	   IFN-­‐γ	   in	   response	   to	  either	   the	   immunodominant	   CD4+	   or	   CD8+	   T	   cell	   specific	   peptide	   (VP274-­‐86	   or	  VP3159-­‐166,	   respectively).	   	   In	   this	   assay,	   96-­‐well	   filtration	   plates	   (MAIPS4510)	  containing	  PVDF	  membranes	  (Millipore,	  Bedfirdm	  NA)	  were	  coated	  with	  1.0	  mg	  (in	  100	   µL	   sterile	   PBS)	   of	   anti-­‐mouse	   IFN-­‐γ	   capture	   antibody	   (AN-­‐18;	   eBioscience)	  overnight	   at	   4°C.	   	   The	  plates	  were	  blocked	  with	  200	  µL	   complete	  RPMI-­‐1640	   for	  two	   h	   at	   room	   temperature.	   	   Then	   2.0	   x	   104	   CNS-­‐ILs	   were	   mixed	   with	   1	   x	   106	  irradiated	  feeder	  cells,	  in	  150	  µL	  of	  complete	  RPMI-­‐1640	  with	  a	  final	  concentration	  of	   2.0	   mM	   peptide	   (CD4+,	   CD8+,	   or	   non-­‐specific)	   and	   then	   added	   to	   the	   plate.	  	  Following	   an	   incubation	   at	   37°C	   and	   5.0%	  CO2	   for	   24	   h,	   the	   plates	  were	  washed	  with	   PBS	   containing	   0.05%	   Tween-­‐20	   and	   rinsed	   once	   with	   water	   purified	   by	  reverse	   osmosis	   (RO	   H2O).	   	   One-­‐hundred	   µL	   assay	   diluent	   (PBS	   with	   10%	   FBS)	  containing	   0.1	   mg	   of	   the	   biotin	   labeled	   anti-­‐INF-­‐γ	   detection	   antibody	   (R4-­‐6A2;	  eBioscience)	   was	   added	   to	   each	   well,	   and	   the	   plates	   were	   incubated	   at	   room	  temperature	  for	  two	  h.	  	  After	  the	  incubation,	  the	  plates	  were	  washed	  six	  times	  with	  wash	  buffer	  (PBS	  with	  0.05%	  Tween-­‐20).	  	  Next,	  100	  µL	  of	  avidin-­‐HRP	  (horseradish	  peroxidase)	  (eBioscience)	  diluted	  1/1000	  in	  assay	  diluent	  was	  added	  to	  each	  well	  and	   the	   plates	   were	   incubated	   for	   30	   mins	   at	   room	   temperature.	   	   Plates	   were	  washed	  six	  times	  with	  wash	  buffer,	  spots	  were	  developed	  using	  100	  µL	  of	  3-­‐amino-­‐9-­‐ethyl-­‐carbazole	  (AEC)	  substrate	  solution	  (1.0mL	  AEC,	  1.0mL	  dimethylformamide,	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14	  mL	  0.1M	  citrate-­‐phosphate	  buffer	  pH	  5.0,	  and	  10.0	  µL	  H2O2).	  	  Plates	  were	  rinsed	  three	   times	  with	  200	  µL	  of	  RO	  H2O	   and	   read	  with	   an	  ELISPOT	  plate	   reader	   (AID	  EliSpot	  Reader	  System,	  Straberg,	  Germany).	  	  	  The	  effects	  of	  SDR	  on	  splenic	  T	  cell	  effector	  function	  were	  determined	  using	  the	  methods	  described	  above.	  	  However,	  for	  these	  assays,	  1.0	  X	  106	  isolated	  spleen	  cells	  were	  used	   in	   the	  absence	  of	   feeder	  cells.	   	  All	   samples	  were	  run	   in	   triplicate.	  	  The	   generation	   of	   spots	   to	   the	   non-­‐specific	   peptide	   was	   used	   as	   a	   measure	   of	  background	  and	  was	  subtracted	  from	  CD4+	  and	  CD8+	  T	  cell	  virus-­‐specific	  peptide	  responses.	  	  	  	  	  	  
Statistical	  Analysis	  	   Data	   are	   presented	   as	   mean+/-­‐SEM.	   	   Analysis	   of	   variance	   (ANOVA)	   for	  studies	  with	  more	   than	   two	  groups	  or	  student’s	   t-­‐tests	  were	  used	   to	  determine	   if	  statistically	   significant	  difference	  emerged	  across	   conditions.	   	  Repeated	  measures	  ANOVA	   and	   multivariate	   ANOVA	   (MANOVA)	   were	   used	   as	   appropriate.	   	   These	  analyses	  were	  followed	  by	  post	  hoc	  analysis	  with	  Fisher’s	  LSD,	  where	  appropriate.	  	  A	  p-­‐value	  less	  than	  0.05	  was	  considered	  significant	  for	  all	  studies.	  	  	  
	   48	  
CHAPTER	  III	  SOCIAL	  DISRUPTION	  SENSITIZES	  CNS	  INFLAMMATORY	  RESPONSE	  TO	  	  THEILER’S	  VIRUS	  INFECTION	  	  
Introduction	  	  Prior	   research	   suggests	   that	   SDR	   exacerbates	   acute	   and	   chronic	   TMEV	  infection	   (Johnson	   et	   al.,	   2006;	   Johnson	   et	   al.,	   2004b;	   Meagher	   et	   al.,	   2007).	  	  However,	  the	  mechanism(s)	  by	  which	  stress	  exerts	  these	  effects	  has	  yet	  to	  be	  fully	  elucidated.	   	  It	  has	  been	  demonstrated	  that	  SDR	  leads	  to	  an	  increase	  in	  serum	  IL-­‐6	  post-­‐infection	   (Johnson	   et	   al.,	   2006)	   and	   neutralization	   of	   IL-­‐6	   during	   SDR	   can	  reverse	  the	  adverse	  effects	  of	  stress	  (Meagher	  et	  al.,	  2007).	  	  This	  suggests	  that	  SDR	  may	   alter	   disease	   course	   by	   enhancing	   inflammation.	   	   Although	   the	  immunosuppressive	  properties	  of	  stress	  are	  better	  understood,	  recent	  studies	  have	  demonstrated	   that	   stress	   is	   capable	   of	   augmenting	   inflammation	   (Badowska-­‐Szalewska	  et	  al.,	  2009;	  Blandino	  et	  al.,	  2009;	  Curry	  et	  al.,	  2010;	  Deak	  et	  al.,	  2005b;	  Johnson	   et	   al.,	   2003;	  Minami	   et	   al.,	   1991;	  Muhling	   et	   al.,	   2001;	   New	   et	   al.,	   2001;	  Nguyen	   et	   al.,	   1998;	  Nguyen	   et	   al.,	   2000;	   O'Connor	   et	   al.,	   2003a;	   O'Connor	   et	   al.,	  2003b;	  Quan	  et	  al.,	  2001;	  Shintani	  et	  al.,	  1995a;	  Shintani	  et	  al.,	  1995b;	  Steptoe	  et	  al.,	  2001).	  	  Based	  upon	  these	  data,	   it	  was	  hypothesized	  that	  the	  adverse	  effects	  of	  SDR	  on	   TMEV	   infection	   are	   mediated	   by	   the	   sensitization	   of	   virus-­‐induced	   cytokine	  expression.	  	  More	  specifically,	  it	  was	  hypothesized	  that	  social	  stress	  enhances	  levels	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of	   CNS	   inflammation	   at	   the	   time	   of	   infection	   resulting	   in	   an	   exaggerated	  inflammatory	  response	  to	  viral	  infection.	  Furthermore,	  given	  that	  microglia	  are	  the	  primary	  producers	  of	  CNS	  inflammation	  and	  that	  stress	  exposure	  has	  been	  shown	  to	   activate	  microglia	   (Frank	   et	   al.,	   2007;	  Nair	   and	   Bonneau,	   2006;	   Sugama	   et	   al.,	  2007),	   it	   is	   hypothesized	   that	   stress-­‐induced	   potentiation	   of	   virus-­‐induced	  inflammation	  occurs	  through	  the	  priming	  of	  microglia.	  	  
	  
Experiment	  3.1:	  Social	  Disruption	  Exacerbates	  Sickness	  Behavior	  in	  BALB/cJ	  
Mice	  Infected	  with	  Theiler’s	  Virus	  Experiment	  3.1	  sought	  to	  replicate	  previously	  observed	  behavioral	  findings	  that	   suggest	   that	   SDR	   exacerbates	   the	   behavioral	   manifestations	   of	   sickness	   in	  response	  to	  TMEV	  infection.	  	  Although	  it	  has	  been	  shown	  that	  SDR	  prior	  to	  infection	  induces	  anhedonia,	  increases	  motor	  impairment,	  enhances	  allodynia,	  and	  decreases	  activity	  (Johnson	  et	  al.,	  2006;	  Johnson	  et	  al.,	  2004b;	  Meagher	  et	  al.,	  2007),	  the	  ability	  to	   replicate	   these	   findings	   at	   a	   different	   time	   point,	   by	   another	   investigator,	   and	  under	   different	   conditions	   further	   establishes	   this	   relationship.	   A	   failure	   to	  replicate	   previous	   finding	   would	   suggests	   that	   these	   behavioral	   changes	   were	  coincidental	   or	   could	   be	   explained	   by	   other	   factors	   (e.g.,	   seasonal	   variation	   or	  extraneous	  stressors	  increasing	  the	  magnitude	  of	  sickness	  behavior).	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Procedure	  Subjects	   were	   assigned	   to	   either	   the	   SDR	   or	   non-­‐SDR	   condition	  counterbalanced	  by	  weight	  (N=22).	  	  Two	  hours	  following	  the	  final	  SDR	  session,	  all	  subjects	  were	   infected	   intracranially	  with	   TMEV	   (Welsh	   et	   al.,	   1987).	   Behavioral	  measures	   previously	   demonstrated	   to	   be	   sensitive	   to	   the	   effects	   of	   SDR	   (e.g.,	  sucrose	   preference,	   mechanical	   sensitivity,	   open	   field	   activity,	   and	   hindlimb	  impairment)	  were	  collected	  prior	  to	  infection	  and	  for	  seven	  days	  post-­‐infection.	  
	  
Results	  	  As	   previously	   described,	   SDR	   significantly	   enhances	   infection-­‐realted	  sickness	  behavior.	  Repeated	  measures	  ANOVAs	  revealed	  significant	  main	  effects	  of	  SDR	  on	  mechanical	  sensitivity,	  clinical	  score,	  hind	  limb	  impairment,	  and	  open	  field	  horizontal	  activity,	  all	  Fs	  >	  4.687,	  ps	  <	  0.05.	   	  Furthermore,	  significant	  day	  by	  SDR	  interactions	  were	  observed	  for	  open	  field	  activity	  and	  mechanical	  sensitivity	  (data	  not	  shown).	   	  Post	  hoc	  analyses	  confirmed	  that	  on	  day	  one	  and	   four	  post-­‐infection	  mice	   pre-­‐exposed	   to	   SDR	   exhibited	   enhanced	  mechanical	   sensitivity,	  p<0.05	   (Fig.	  3A).	   	  Furthermore,	  on	  day	   four	  post-­‐infection	  a	  reduction	   in	  open	   field	  horizontal	  activity	   p<0.001,	   (Fig.	   3B)	   and	   increased	   hind	   limb	   impairment	   p<0.05,	   (Fig.	   3C)	  and	  clinical	  scores,	  p<0.05	  (Fig.	  3D)	  were	  observed	  in	  subject	  pre-­‐exposed	  to	  SDR.	  	  The	  effects	  of	  stress	  on	  hindlimb	  impairment,	  clinical	  score,	  and	  horizontal	  activity	  persisted	  though	  day	  seven	  post-­‐infection,	  all	  ps	  <	  0.05.	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  Fig.	  3.	  SDR	  exacerbates	  sickness	  behaviors	  during	  acute	  TMEV	  infection.	  SDR	  resulted	  in	  increased	  mechanical	   sensitivity	   (A),	   decreased	   open	   field	   horizontal	   activity	   (B),	   and	   increased	   hindlimb	  impairment	  (C)	  and	  clinical	  score	  (D).	  	  Asterisks	  indicate	  significant	  differences	  between	  groups.	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  Fig.	  4.	  Fur	  score	  in	  response	  to	  SDR.	  There	  were	  no	  significant	  effect	  of	  SDR	  on	  fur	  score,	  suggesting	  that	  SDR	  in	  BALB./cJ	  mice	  results	  in	  less	  wounding	  than	  more	  aggressive	  mouse	  strains	  (Avitsur	  et	  al.,	  2001;	  Merlot	  et	  al.,	  2003).	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Contrary	   to	   previous	   data,	   the	   effect	   of	   sucrose	   preference	   failed	   to	   reach	  significance	  (p>0.05).	  	  However,	  this	  may	  be	  due	  to	  the	  significantly	  smaller	  group	  size	  than	  used	  in	  previous	  studies.	  The	  current	  study	  had	  less	  than	  half	  the	  subjects	  per	  group	  than	  did	  Meagher	  et	  al.	  (2007).	  	  The	  effect	  of	  sucrose	  preference	  may	  be	  subtle,	  such	  that	  group	  size	  in	  this	  study	  may	  have	  been	  insufficient	  to	  pull	  out	  the	  effect.	   In	   addition	   to	   increasing	   group	   size,	   another	   method	   that	   may	   allow	   this	  effect	  to	  be	  statistically	  resolved	  would	  be	  through	  the	  addition	  of	  a	  concurrent	  SDR	  group.	  	  Prior	  studies	  by	  Johnson	  et	  al.	  (2004;	  2006)	  have	  demonstrated	  that	  when	  SDR	  is	  administered	  concurrent	  to	  infection,	  rather	  than	  prior	  to	  infection,	  a	  benefit	  is	   observed	   such	   that	   concurrent	   SDR	   improves	  disease	   course.	   	  This	   group	  adds	  statistical	  power	  to	  the	  analysis	  and,	  if	  added,	  may	  allow	  this	  effect	  to	  be	  resolved.	  	  	   In	   addition	   to	   the	   replication	   of	   most	   previously	   observed	   findings,	  wounding	  and	  fur	  score	  data	  were	  evaluated	  in	  this	  experiment.	  	  Prior	  data	  suggest	  that	   wounding	   may	   be	   necessary	   for	   the	   adverse	   effects	   of	   SDR	   to	   be	   observed	  (Avitsur	  et	  al.,	  2001;	  Merlot	  et	  al.,	  2003).	  	  However,	  personal	  observations	  suggest	  that	  little	  wounding	  is	  observed	  during	  SDR	  in	  BALB/cJ	  mice.	  	  This	  was	  confirmed	  by	  daily	  analysis	  of	  fur	  scores	  (see	  Fig.	  4),	  which	  showed	  a	  non-­‐significant	  effect	  of	  SDR	   (p>0.05).	   	   	   Furthermore,	   although	   ruffling	   of	   fur	   was	   noted	   immediately	  following	   the	   sessions	  of	   SDR,	  only	  one	   tail	   bite	  was	  observed	  over	   the	   course	  of	  SDR.	   	   This	   level	   of	   wounding	   is	   significantly	   less	   than	   that	   observed	   in	   other	  laboratories	  and	  suggests	  that	  the	  effect	  of	  SDR	  on	  TMEV	  infection	  is	  not	  dependent	  upon	  wounding.	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Experiment	   3.2:	   Social	   Disruption	   Alters	   Central	   Inflammatory	   Cytokine	  
Expression	  Prior	  research	  has	  demonstrated	  that	  IL-­‐6	  is	  elevated	  in	  serum	  and	  brain	  in	  response	   to	   SDR	   in	   BALB/cJ	   mice	   (Meagher	   et	   al.,	   2007).	   	   Furthermore,	   central	  administration	   of	   IL-­‐6	   neutralizing	   antibody	   during	   the	   stress	   exposure	   period	  reverses	  the	  adverse	  effect	  of	  SDR	  on	  sickness/motor	  behaviors,	  CNS	  inflammation,	  and	   viral	   clearance	   during	   acute	   TMEV	   infection	   (Meagher	   et	   al.,	   2007).	   This	  suggests	   a	   role	   for	   IL-­‐6	   in	  mediating	   the	   deleterious	   effect	   of	   SDR,	   but	   the	   exact	  mechanisms	  remain	  undetermined.	   	  One	  possibility	   is	   that	  SDR-­‐induced	   increases	  in	  CNS	  inflammation	  sensitize	  the	  neuroinflammatory	  response	  to	  TMEV	  infection,	  resulting	  in	  a	  dysregulation	  of	  innate	  and	  acquired	  immune	  responses	  to	  infection.	  	  Specifically,	   it	   is	  hypothesized	   that	   chronic	  SDR	  will	   result	   in	  an	  elevation	  of	   IL-­‐6	  mRNA	   expression	   within	   the	   hippocampus.	   To	   test	   this	   hypothesis,	   the	   present	  experiment	  examined	  whether	  SDR	  increases	  markers	  of	   inflammation	  within	  the	  hippocampus	  of	  BALB/cJ	  mice	  during	  the	  stress	  exposure	  period.	  The	  hippocampus	  is	   a	   component	   of	   the	   limbic	   system	   involved	   in	   the	   assessment	   of	   processive	  stressors.	   It	   was	   targeted	   in	   this	   study	   because	   it	   has	   been	   shown	   to	   be	   highly	  sensitive	   to	   the	   effects	   of	   stress	   (Alonso	   et	   al.,	   2004;	   Badowska-­‐Szalewska	   et	   al.,	  2009).	   Furthermore,	   it	   	   is	   essential	   in	   the	   regulation	   of	   stress-­‐induced	  neuroinflammation	  due	  to	  its	  high	  levels	  of	  glucocorticoid	  receptors	  (De	  Kloet	  et	  al.,	  1998;	  Frank	  et	  al.,	  2007).	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Procedure	  The	   levels	   of	   inflammatory	  markers	  were	   compared	   between	   acute	   stress	  (SDR-­‐1),	   chronic	   stress	   (SDR-­‐6),	   and	   home	   cage	   controls	   (N=54).	   Subjects	   were	  sacrificed	  immediately	  following	  SDR	  (19:00	  h),	  two	  hours	  following	  SDR	  (21:00h),	  or	   12	   hours	   post-­‐SDR	   (07:00	   h).	   	   The	   hippocampus	   was	   microdissected	   and	  analyzed	  for	  IL-­‐6,	  IL-­‐1β,	  and	  CD11b	  mRNA	  expression.	  For	  analysis	  all	  groups	  were	  compared	  to	  the	  0-­‐hour	  home	  cage	  control	  condition.	  	  
Results	  The	  data	  demonstrate	   that	   IL-­‐6	   is	   sensitized	  by	  SDR,	  while	   IL-­‐1β	  was	  only	  increased	   following	   acute	   SDR.	   An	   ANOVA	   revealed	   a	   significant	   effect	   of	   SDR	  condition	  on	  IL-­‐6	  mRNA	  expression	  levels,	  F(2,50)=20.487,	  p	  <	  .001	  (Fig.	  5A).	  	  Post	  
hoc	  analyses	  reveal	  that	  the	  chronic	  SDR	  condition	  was	  exhibited	  significantly	  more	  IL-­‐6	  mRNA	  than	  the	  home	  cage	  control	  mice.	   	  Further	  post	  hoc	  analyses	   indicated	  that	  at	  0-­‐hours	  chronic	  SDR	  results	  in	  a	  significant	  increase	  in	  IL-­‐6	  mRNA	  compared	  to	  the	  non-­‐SDR	  and	  acute	  SDR	  conditions.	  	  Furthermore,	  the	  chronic	  SDR	  condition	  had	  elevated	  IL-­‐6	  mRNA	  expression	  levels,	  compared	  to	  home	  cage	  controls,	  at	  12	  h	  post-­‐SDR	  in	  the	  chronic	  SDR	  condition.	   	  There	  were	  no	  significant	  changes	  in	  IL-­‐6	  mRNA	   expression	   following	   a	   single	   session	   of	   SDR.	   	   This	   suggests	   that	   the	   IL-­‐6	  response	  to	  SDR	  was	  only	  enhanced	  by	  repeated	  exposure	  sessions	  and	  remained	  elevated	  for	  at	  least	  12	  h	  following	  the	  last	  session	  of	  chronic	  SDR.	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A	  significant	  effect	  of	  time,	  F(2,49)=11.063	  (p	  <	  .001),	  and	  a	  significant	  time	  by	   SDR	   condition	   interaction,	   F(4,49)=1.838,	   (p<.001),	   was	   observed	   	   for	   IL-­‐1β	  mRNA	   levels	   (Fig.	   5B).	   	   Post	   hoc	   analysis	   indicated	   that	   there	   was	   a	   significant	  elevation	   in	   IL–1β	   12	   hours	   after	   a	   single	   session	   of	   SDR	   compared	   to	   all	   other	  groups	  at	  all	  other	  time	  points.	  	   	  No	  significant	  changes	  in	  IL-­‐1β	  mRNA	  expression	  were	  observed	  following	  chronic	  SDR.	  	  	  Thus,	  while	  SDR	  induced	  an	  increase	  in	  the	  IL-­‐1β	  response	  after	  one	  session	  of	  SDR,	  the	  IL-­‐1β	  response	  appears	  to	  habituate	  by	  the	  sixth	  session	  of	  SDR.	  	  	  Furthermore,	  an	  ANOVA	  revealed	  a	  significant	  effect	  of	  time,	  F(2,49)=6.447	  (p<.01)	   on	   CD11b,	   a	   marker	   associated	   with	   the	   activation	   of	   microglia	   and	  macrophages.	  	  This	  time	  effect	  indicates	  that	  higher	  levels	  of	  CD11b	  were	  detected	  at	  2	  and	  12	  hours	  post-­‐SDR.	  The	  time	  by	  SDR	  condition	  interaction	  failed	  to	  reach	  significance	  (p=.16),	  however,	   the	   trend	  suggested	  that	  repeated	  exposure	  to	  SDR	  results	  in	  an	  increase	  in	  CD11b	  mRNA	  expression,	  a	  marker	  of	  microglia	  activation	  (Fig.	  5C).	  Stress	   did	   not	   result	   in	   significant	   differences	   on	   body	  weight,	  mechanical	  sensitivity,	  food	  consumption,	  or	  sucrose	  preference.	  A	  repeated	  measures	  ANOVA	  looking	  at	  sucrose	  preference	  suggested	  a	  potential	  trend	  (p=0.22)	  toward	  a	  subtle	  reduction	  in	  sucrose	  preference	  due	  to	  SDR	  (Fig.	  6).	  	  It	  is	  possible	  that	  increases	  in	  the	  size	  of	  these	  groups	  would	  allow	  this	  effect	  to	  become	  significant.	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  Fig.	  5.	  SDR	  alters	  CNS	  inflammatory	  cytokine	  expression.	  IL-­‐6	  is	  elevated	  by	  exposure	  to	  chronic	  SDR	  (SDR-­‐6)	   (A),	   while	   a	   single	   session	   of	   SDR	   (SDR-­‐1)	   resulted	   in	   an	   elevation	   of	   IL-­‐1β	   (B).	   	   No	  significant	   change	   in	   CD11b,	   a	   marker	   associated	   with	   microglia/macrophage	   activation,	   was	  observed	  (C).	  Asterisks	  indicate	  significant	  differences	  between	  groups.	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  Fig.	  6.	  SDR	  does	  not	  significantly	  alter	  sucrose	  preference.	  Although	  a	  trend	  was	  observed,	  SDR	  did	  not	  result	  in	  a	  significant	  reduction	  in	  sucrose	  preference.	  	  It	  is	  possible	  that	  larger	  group	  size	  would	  allow	  this	  effect	  to	  reach	  significance.	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Experiment	   3.3:	   Social	   Disruption-­Induced	   Sensitization	   of	   the	   CNS	  
Inflammatory	   Response	   to	   Theiler’s	   Virus	   Infection	   Depends	   Upon	   Stress-­
Induced	  IL-­6	  Release	  	  	   Prior	   data	   suggests	   that	   central	   cytokine	   release	   contributes	   to	   the	  deleterious	   effects	   of	   social	   stress	   on	   TMEV	   disease	   progression	   (Johnson	   et	   al.,	  2004a;	   Johnson	   et	   al.,	   2006;	   Meagher	   et	   al.,	   2007).	   	   Social	   stress	   increases	   CNS	  inflammatory	   lesions,	   including	  microgliosis,	   perivascular	   cuffing,	   and	  meningitis	  (Johnson	   et	   al.,	   2004a;	   Meagher	   et	   al.,	   2007).	   	   Furthermore,	   it	   has	   been	  demonstrated	  that	  SDR	  increases	  central	  and	  peripheral	  IL-­‐6	  expression	  during	  the	  stress	   exposure	   period	   and	   this	   exacerbation	   can	   be	   reversed	   through	   IL-­‐6	  neutralizing	   antibody	   administration	   (Meagher	   et	   al.,	   2007).	   Furthermore,	   IL-­‐6	  neutralizing	   antibody	   during	   the	   stress-­‐exposure	   period	   can	   also	   reverse	   SDR-­‐induced	  exacerbation	  of	  TMEV	  infection	  (Meagher	  et	  al.,	  2007).	  	  This	  suggests	  that	  SDR-­‐induced	   increases	   in	   inflammation	   mediate	   the	   adverse	   effects	   of	   SDR	   on	  disease	   progression.	   	   Therefore,	   this	   experiment	   was	   designed	   to	   test	   the	  hypothesis	   that	   SDR-­‐exacerbates	   disease	   by	   sensitization	   of	   virus-­‐induced	  proinflammatory	  cytokine	  expression	  and	  the	  protective	  effects	  of	  IL-­‐6	  neutralizing	  antibody	  occur	  by	  reversing	  this	  sensitization.	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Procedure	  A	  two	  (SDR	  and	  Non-­‐SDR)	  by	  two	  (nAbTx	  and	  Vehicle)	  experimental	  design	  was	   used	   (N=48).	   	   Subjects	   received	   microinjections	   of	   either	   IL-­‐6	   neutralizing	  antibody	  or	  vehicle	  four	  hours	  prior	  to	  each	  SDR	  session.	  Two	  hours	  after	  the	  final	  session	  of	  SDR	  all	  subjects	  were	  intracranially	  infected	  with	  Theiler’s	  virus	  (Welsh	  et	  al.,	  1987).	  Clinical	  score	  and	  hindlimb	  impairment	  were	  collected	  as	  readouts	  of	  the	  effects	  of	  SDR	  and	  antibody	  treatment	  on	  infection.	  Subjects	  were	  sacrificed	  on	  day	  eight	  post-­‐infection	  and	  brain,	  spleen,	  and	  plasma	  were	  collected	  for	  analysis	  of	  inflammatory	  markers.	  	  
Results	  Behavior.	  As	  anticipated,	  a	  one-­‐sample	  t-­‐test	  indicated	  a	  significant	  drop	  in	  body	   weight	   on	   day	   one	   post-­‐infection,	   t=-­‐8.457,	   p<.001	   (data	   not	   shown).	  However,	   no	   significant	   differences	   between	   groups	   in	  weight	   loss	   amount	  were	  observed.	   	   	   Also	   consistent	   with	   prior	   data,	   SDR	   enhanced	   clinical	   score	   and	  hindlimb	   impairment	   on	   day	   four	   post-­‐infection	   and	   IL-­‐6	   neutralizing	   antibody	  treatment	  reversed	  these	  effects	  (Fig.	  7).	  	  A	  repeated	  measures	  ANOVA	  on	  hindlimb	  impairment	   revealed	   a	   significant	   main	   effect	   of	   time,	   neutralizing	   antibody	  treatment,	   and	   SDR,	   all	   Fs	   >	   4.8,	   ps<	   .01,	   and	   a	   significant	   time	   by	   neutralizing	  antibody	  treatment	  condition	  interaction,	  F(2,88)	  =	  4.817,	  p	  ≤	  .01.	  For	  clinical	  score,	  a	   repeated	   measures	   ANOVA	   revealed	   significant	   main	   effects	   of	   time	   and	   SDR	  condition,	  Fs	  >	  6.1,	  ps	  <.05,	  and	  a	  significant	  interaction	  between	  SDR	  condition	  and	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neutralizing	  antibody	  condition,	  F(1,44)=7.488,	  p	  <	  .01.	  These	  results	  confirm	  prior	  data	   indicating	   that	   SDR	   exacerbates	   disease	   and	   IL-­‐6	   neutralizing	   antibody	  treatment	  is	  protective.	  Central	   Cytokine	   Expression.	   	   An	   ANOVA	   conducted	   on	   IL-­‐6	   mRNA	  expression	   levels	   in	   the	  brain	   revealed	  a	   significant	   interaction	  between	  SDR	  and	  neutralizing	  antibody	  condition,	  F(1,43)=4.135,	  p<.05	  (Fig.	  8A).	   	  Post	  hoc	  analyses	  revealed	  that	   the	  SDR-­‐Vehicle	  group	  has	  a	  significantly	  higher	   level	  of	   IL-­‐6	  mRNA	  expression	   than	   all	   other	   groups.	   Similarly,	   analysis	   of	   IL-­‐1β	   mRNA	   expression	  levels	   in	   the	   brain	   revealed	   a	   significant	   SDR	   condition	   by	   neutralizing	   antibody	  condition	  interaction,	  F(1,42)=7.586,	  	  p<.01	  (Fig	  8B).	  	  	  	  Post	  hoc	  analyses	  reveal	  that	  the	  SDR-­‐vehicle	  group	  had	  significantly	  higher	  levels	  of	  IL-­‐1β	  mRNA	  than	  the	  Non	  SDR-­‐vehicle	   group	   and	   the	   SDR-­‐neutralizing	   antibody	   group.	   	   This	   suggests	   that	  administration	  of	  neutralizing	  antibody	   to	   IL-­‐6	  during	   the	   stress	  exposure	  period	  reverses	  the	  sensitizing	  effect	  of	  stress	  on	  the	  proinflammatory	  cytokines,	  IL-­‐6	  and	  IL-­‐1β.	  	  Analysis	   of	   the	   CD11b	   mRNA	   expression	   levels	   in	   the	   brain	   revealed	   no	  significant	   main	   effects	   or	   interactions	   (p>.05),	   however	   the	   mRNA	   expression	  pattern	   is	   similar	   to	   that	   of	   IL-­‐6	   and	   IL-­‐1β,	   with	   an	   elevation	   in	   the	   SDR-­‐vehicle	  group	  compared	  to	  all	  other	  groups	  (Fig.	  8C).	  Brain	  TNF-­‐α,	  INF-­‐γ,	  and	  IL-­‐10	  mRNA	  levels	   were	   also	   examined,	   however,	   no	   significant	   main	   effects	   or	   interactions	  were	  observed.	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  Fig,	  7.	  Neutralizing	  antibody	  to	  IL-­‐6	  (nAbTx)	  prevents	  the	  adverse	  effects	  of	  SDR	  on	  acute	  TMEV	  infection.	  	  SDR	  exacerbates	  both	  hindlimb	  impairment	  (A)	  and	  clinical	  score	  (B)	  and	  administration	  of	  IL-­‐6	  neutralizing	  antibody	  reversed	  these	  adverse	  effects.	  Asterisks	  indicate	  significant	  differences	  between	  groups.	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  Fig.	  8.	  Neutralizing	  antibody	  to	  IL-­‐6	  (nAbTx)	  prevents	  the	  SDR	  enhancement	  of	  virus-­‐induced	  CNS	  inflammation.	   On	   day	   eight	   post-­‐infection	   real	   time	   RT-­‐PCR	   analyses	   demonstrated	   that	   SDR	  increases	  CNS	  IL-­‐6	  (A)	  and	  IL-­‐1	  β	  (B)	  mRNA	  expression	  and	  that	  these	  effects	  were	  reversed	  by	  IL-­‐6	  nAbTx.	   	   A	   similar,	   but	   non-­‐significant	   pattern	   was	   observed	   for	   CD11b	   mRNA	   expression	   (C),	   a	  marker	  of	  microglia	  activation.	  	  No	  significant	  main	  effects	  or	  interactions	  were	  observed	  for	  IFN-­‐γ	  (D),	  IL-­‐10	  (E),	  and	  TNF-­‐α	  (F).	  Asterisks	  indicate	  significant	  differences	  between	  groups.	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Peripheral	  Cytokine	  Expression.	  These	  same	  markers	  were	  evaluated	  in	  the	  spleen.	  Contrary	  to	   the	   interactions	  observed	  with	   IL-­‐6	  and	  IL-­‐1β	   in	   the	  brain,	  no	  significant	   interactions	  between	  SDR	  and	  neutralizing	   antibody	  were	  observed	   in	  the	   periphery,	   suggesting	   that	   the	   protective	   effect	   of	   IL-­‐6	   neutralizing	   antibody	  treatment	  is	  centrally	  mediated.	  	  However,	  a	  significant	  main	  effect	  of	  SDR	  on	  IL-­‐1β,	  
F(1,40)=8.663,	  p<.01,	  and	  TNF-­‐α,	  F(1,38)=8.83,	  p<.01,	  was	  observed	  indicating	  that	  SDR	   prior	   to	   infection	   results	   in	   increased	  mRNA	   expression	   of	   these	   cytokines.	  	  Furthermore,	   there	  was	   a	   significant	  main	   effect	   of	   IL-­‐6	  neutralizing	   antibody	  on	  INF-­‐γ	   mRNA	   expression	   levels,	   F(1,38)=5.242,	   p<.05,	   such	   that	   IL-­‐6	   neutralizing	  antibody	  	  resulted	  in	  increased	  	  levels	  	  (data	  summarized	  in	  Table	  1).	  	  	  ELISAs	  were	  performed	  to	  measure	  serum	  level	  of	   IL-­‐6	  and	  IL-­‐1β	   (Fig.	  9).	   	  No	  significant	  main	  effects	  or	  interactions	  were	  observed	  at	  eight	  days	  post-­‐infection.	  	  
Discussion	  	   The	  present	  findings	  replicate	  prior	  work	  showing	  that	  SDR	  exacerbates	  the	  behavioral	   response	   to	  TMEV	   infection.	   	   Furthermore,	   it	   demonstrates	   that	   these	  effects	   are	   based	   on	   the	   psychological/processive	   stress	   of	   SDR	   rather	   than	   the	  physical/systemic	   stress	   of	   wounding.	   	   These	   results	   may	   differ	   from	   those	   of	  Avistur	  et	  al.	  	  (2001)	  	  due	  	  to	  	  the	  strain	  differences	  (BALB/cJ	  vs.	  C57BL/6).	  	  BALB/c	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Table	  1.	  Summary	  of	  main	  effects	  and	  interactions	  of	  SDR	  and	  IL-­‐6	  neutralizing	  antibody	  treatment	  (nAbTx)	   on	   TMEV	   infection-­‐induced	   cytokines	   at	   day	   eight	   post-­‐infection.	   In	   general,	   the	   data	  indicates	   that	   SDR	   exacerbates	   both	   central	   and	   peripheral	   inflammation,	   but	   IL-­‐6	   nAbTx	   only	  reverses	   these	   central	   increases.	   	  	   =	   significant	   increase,	  =	   significant	   decrease,	   and	   -­‐-­‐	   =	   no	  significant	  change	  in	  mRNA	  expression.	  	  
	   Brain	   Spleen	  	   SDR	   nAbTx	   SDR	  x	  nAbTx	   SDR	   nAbTx	   SDR	  x	  nAbTx	  IL-­‐6	   -­-­	   -­-­	    	   -­-­	   -­-­	   -­-­	  IL-­‐1β	   -­-­	   -­-­	    	    	   -­-­	   -­-­	  CD11b	   -­-­	   -­-­	   -­-­	   -­-­	   -­-­	   -­-­	  INF-­‐γ	  	   -­-­	   -­-­	   -­-­	   -­-­	    	   -­-­	  IL-­‐10	   -­-­	   -­-­	   -­-­	   -­-­	   -­-­	   -­-­	  TNF-­‐α	   -­-­	   -­-­	   -­-­	    	   -­-­	   -­-­	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Fig.	  9.	  No	  significant	  difference	  in	  serum	  levels	  of	  proinflammatory	  cytokines	  was	  observed	  on	  day	  8	  post-­‐infection.	  	  The	  level	  of	  IL-­‐6	  (A)	  and	  IL-­‐1β	  (B)	  in	  serum	  was	  determined	  by	  ELISA	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  mice	   generally	   exhibit	   a	   more	   hyper-­‐reactive	   phenotype	   (Belzung	   and	   Griebel,	  2001;	  Millstein	   et	   al.,	   2006;	  Willott	   et	   al.,	   2003)	   and,	   therefore,	   they	  may	   exhibit	  deficits	  at	  lower	  levels	  of	  stress.	  	  	  	   Furthermore,	  SDR	  enhanced	  levels	  of	  proinflammatory	  cytokines	  within	  the	  brain.	   This	   provides	   further	   support	   for	   the	   hypothesis	   that	   social	   stress	  exacerbates	   TMEV	   infection	   by	   priming	   the	   inflammatory	   response	   to	   the	   virus.	  These	   effects	   are	   subtle,	   such	   that	   they	   were	   insufficient	   to	   exert	   statistically	  significant	   effects	   on	   behavior.	   The	   nature	   of	   this	   change	   in	   cytokine	   expression	  evolves	  across	  the	  sessions	  of	  SDR.	  Following	  a	  single	  session	  of	  SDR	  a	  significant	  increase	  in	  IL-­‐1β	  mRNA	  expression	  was	  observed.	  	  However,	  by	  the	  sixth	  session	  no	  measurable	   increase	  was	  detected.	   	   Conversely,	   following	  a	   single	   session	  of	   SDR	  there	   is	  no	  change	   in	   IL-­‐6	  mRNA	  expression,	  however,	   following	  the	  sixth	  session	  there	  was	  a	  significant	  increase	  that	  lasted	  for	  at	  least	  12	  hours	  post	  SDR.	  	  	  Given	   that	   infection	   occurs	   two	   hours	   following	   the	   final	   session	   of	   SDR,	  these	   data	   suggest	   that	   IL-­‐6	   mRNA	   is	   significantly	   up	   regulated	   at	   the	   time	   of	  infection	   in	   subjects	  pre-­‐exposed	   to	   social	  disruption	   stress.	   	  These	   results,	   along	  with	   prior	   data	   showing	   that	   administration	   of	   IL-­‐6	   neutralizing	   antibody	   during	  the	  stress	  exposure	  period	  reverses	  the	  adverse	  effects	  of	  SDR	  on	  TMEV	  infection	  (Meagher	   et	   al.,	   2007),	   supports	   the	  hypothesis	   that	   SDR	  may	  exacerbate	  disease	  through	  the	  up-­‐regulation	  of	  virus-­‐induced	  inflammation.	  	  Further	  support	  for	  this	  comes	  from	  Experiment	  3.3,	  which	  demonstrated	  that	  SDR	  prior	  to	  TMEV	  infection	  enhances	  the	  inflammatory	  cytokine	  response	  to	  infection	  by	  increasing	  the	  mRNA	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expression	   of	   IL-­‐6	   and	   IL-­‐1β	   in	   the	   brain	   and	   IL-­‐1β	   and	   TNF-­‐α	   in	   the	   spleen.	  	  Furthermore,	   IL-­‐6	   neutralizing	   antibody	   treatment	   reverses	   this	   enhancement	   in	  inflammation	  in	  the	  CNS	  but	  not	  in	  the	  spleen.	  Given	  that	  IL-­‐6	  neutralizing	  antibody	  can	   protect	   against	   the	   adverse	   effects	   of	   SDR	   on	   TMEV	   infection,	   a	   central	  enhancement	   in	  proinflammatory	   cytokines	  may	  drive	   the	  adverse	  effects	  of	   SDR	  on	  TMEV	  infection.	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CHAPTER	  IV	  SOCIAL	  DISRUPTION	  RESULTS	  IN	  A	  SUPPRESSION	  OF	  THE	  ADAPTIVE	  IMMUNE	  RESPONSE	  TO	  ACUTE	  THEILER’S	  VIRUS	  INFECTION	  	  
Introduction	  	   TMEV	   infection	   is	   capable	   of	   inducing	   a	   demyelinating	   disease	   similar	   to	  multiple	   sclerosis	   in	   susceptible	   strains	   of	   mice	   (e.g.	   BALB/cJ	   and	   SJL/J).	  	  Susceptible	  strains	  are	  unable	  to	  effectively	  clear	  TMEV	  from	  the	  CNS	  during	  early	  infection.	  This	   results	   in	  CNS	  viral	   persistence	   and,	   eventually,	   immune-­‐mediated	  demyelination	   (Clatch	   et	   al.,	   1990;	   Theiler,	   1937;	   Zheng	   et	   al.,	   2001).	   Effective	  clearance	  of	  TMEV	  appears	   to	  depend	  on	  mounting	  an	  effective	  adaptive	   immune	  response.	  For	  example,	  it	  has	  been	  shown	  that	  depletion	  of	  CD8+	  T	  cell	  populations	  or	  altering	  the	  functionality	  of	  these	  cells	  increases	  disease	  susceptibility	  (Borrow	  et	   al.,	   1992).	   The	   CD4+	   T	   cells	   response	   has	   also	   been	   implicated	   in	   the	   in	  pathogenesis	  of	  TMEV.	   	   It	  has	  been	  demonstrated	  that	  mice	  with	  reduced	  CD4+	  T	  cell	   populations	   show	   more	   severe	   inflammation,	   demyelination	   and	   axonal	  degeneration	  (Lin	  et	  al.,	  2004;	  Murray	  et	  al.,	  1998)	  as	  well	  as	   increased	  mortality	  (Welsh	  et	  al.,	  1987).	  	  Further	   evidence	   for	   the	   role	   of	   the	   adaptive	   immune	   response	   in	   the	  pathogenesis	   of	   Theiler’s	   virus	   induced	   demyelination	   (TVID)	   includes	   genetic	  factors.	   	   Susceptibility	   to	   disease	   appears	   to	   be	   associated	   with	   the	   MHC	   class	   I	  locus,	  H-­‐2D	   (Lipton	   and	  Melvold,	   1984;	   Lipton	   et	   al.,	   1995;	  Rodriguez	   and	  David,	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1985).	   	   Mutations	   of	   the	   H-­‐2D	   gene	   are	   associated	   with	   poorer	   viral	   clearance	  during	  the	  acute	  phase	  of	  TMEV	  infection	  and	  increased	  viral	  persistence	  (Lipton	  et	  al.,	  1995).	  Given	  that	  MHC	  class	  I	  is	  involved	  in	  antigen	  presentation	  to	  CD8+	  T	  cells,	  this	  suggests	  a	  role	  for	  CD8+	  T	  cells	  in	  the	  clearance	  of	  TMEV	  from	  the	  CNS.	  	  	   Furthermore,	  recent	  research	  has	  demonstrated	  that	  restraint	  stress,	  which	  exacerbates	  disease	  pathogenesis,	  results	   in	  a	  suppression	  of	  virus	  specific	  T	  cells	  in	   the	   spleen	   and	   CNS	   of	   SJL/J	   mice	   (Steelman	   et	   al.,	   2009).	   	   In	   this	   study	  lymphocytes	  from	  the	  brain	  and	  spleen	  were	  stimulated	  with	  virus-­‐specific	  CD4+	  or	  CD8+	  peptides.	  These	  peptides	  cause	  T	  cells	   to	   release	   IFN-­‐γ;	   thus	   the	  number	  of	  cells	  producing	  IFN-­‐γ	  can	  be	  used	  to	  determine	  T	  cell	  effector	  function.	  Steelman	  et	  al.	   (2009)	   demonstrated	   that	   infection	   increases	   both	   CD4+	   and	   CD8+	   T	   cell	  effector	  function	  and	  that	  restraint	  stress	  results	  in	  a	  suppression	  of	  virus	  specific	  CD4+	  and	  CD8+	  T	  cells	  in	  the	  spleen	  and	  CD8+	  T	  cells	  in	  the	  CNS.	  	  	  Therefore,	   this	   dissertation	   sought	   to	   determine	   if	   SDR	   prior	   to	   infection	  also	  disrupts	  T	  cell	  function.	  Given	  that	  SDR	  inhibits	  viral	  clearance	  (Johnson	  et	  al.,	  2006;	  Johnson	  et	  al.,	  2004b;	  Meagher	  et	  al.,	  2007),	  it	  is	  hypothesized	  that	  SDR	  will	  suppress	  virus	  specific	  CD4+	  and	  CD8+	  T	  cells.	  	  In	  contrast	  to	  the	  anti-­‐inflammatory	  effects	   of	   restraint	   stress,	   SDR	   is	   pro-­‐inflammatory.	   Prior	   data	   suggests	   that	   an	  enhanced	   innate	   immune	   response	   is	   capable	   of	   increasing	   (Pullen	   et	   al.,	   1994;	  Turrin,	   2008)	   or	   decreasing	   (Olson	   and	   Miller,	   2009)	   vulnerability	   to	   TMEV	  infection.	  Thus	  it	  is	  also	  possible	  that	  SDR	  may	  inhibit	  or	  enhance	  T	  cell	  expression.	  	  It	  is	  also	  possible	  that	  no	  change	  in	  T	  cells	  would	  be	  observed,	  suggesting	  that	  SDR	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exacerbates	   TMEV	   disease	   course	   by	   a	   different	   pathway	   than	   restraint	   stress.	  	  Therefore,	   the	   impact	   of	   SDR	   on	   adaptive	   immune	   function	   is	   evaluated	   in	   this	  chapter.	  	  	  These	   experiments	   use	   SJL/J	   mice	   instead	   of	   BALB/cJ	   mice.	   There	   are	  several	   reasons	   underlying	   this	   transition.	   	   The	   primary	   advantage	   is	   that	   virus	  specific	  peptide,	  such	  as	  those	  used	  by	  Steelman	  et	  al.	  (2009),	  are	  available	  for	  SJL/J	  mice,	   but	   not	   for	   BALB/cJ	   mice.	   	   Furthermore,	   this	   transition	   allows	   for	   the	  generality	  of	   the	  adverse	  effects	  of	  SDR	  on	  TMEV	  infection	  to	  be	  examined.	   	  Prior	  work	   focused	   on	   BALB/cJ	  mice	   due	   to	   their	   pronounced	   acute	   phase	   symptoms.	  However,	  SJL/J	  mice	  develop	  more	  pronounced	  TVID	  at	  a	  more	  rapid	  time	  course;	  SJL/J	   mice	   develop	   chronic	   phase	   symptoms	   in	   2-­‐3	   months	   (McGavern	   et	   at	   al.,	  1999)	   in	   about	   half	   the	   time	   it	   takes	   BALB/cJ	   mice	   to	   express	   symptoms	  (approximately	   4-­‐5	   months)	   (Johnson	   et	   al.,	   2006).	   	   	   Therefore,	   if	   their	   disease	  course	  is	  also	  exacerbated	  by	  SDR	  exposure,	  as	   is	  observed	  in	  BALB/cJ	  mice,	  they	  would	   provide	   a	   more	   efficient	   model	   of	   SDR-­‐induced	   exacerbation	   of	   chronic	  phase,	  demyelinating	  disease.	  	  	  	  	  The	   subsequent	   experiments	   evaluated	   if	   SDR	   inhibits	   viral	   clearance	   in	  SJL/J	  mice.	   	   Furthermore,	   it	   sought	   to	   determine	   if	   SDR	   prior	   to	   TMEV	   infection	  enhances	   acute	   phase	   sickness	   behavior.	   	   Then	   the	   effect	   of	   stress	   on	   infection-­‐related	  central	  T	  cell	  mRNA	  expression	  was	  evaluated.	  Finally,	   the	   levels	  of	  virus-­‐specific	  T	  cells	  were	  evaluated	  within	  the	  brain	  and	  spleen.	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Experiment	   4.1:	   Social	  Disruption	  Prior	   to	  Theiler’s	   Virus	   Infection	   Impairs	  
CNS	  Viral	  Clearance	  in	  SJL/J	  Mice	  Effective	  viral	  clearance	  during	   the	  acute	  phase	   is	  related	  to	  chronic	  phase	  disease	  course.	   	  Prior	  studies	  have	  demonstrated	  that	  viral	   titers	   in	   the	  CNS	  peak	  one	   to	   two	  weeks	  post-­‐infection	   and	  by	   three	   to	   four	  weeks	   it	   is	   cleared	   to	   non-­‐detectable	  levels	  (Welsh	  et	  al.,	  1987).	  Subjects	  that	  fail	  to	  completely	  clear	  the	  virus	  from	   the	   CNS	   during	   the	   acute	   phase	   later	   develop	   chronic	   phase,	   autoimmune-­‐mediated	  TVID	   (Aubert	  et	  al.,	  1987).	   	  Prior	   research	  has	  demonstrated	   that	  prior	  exposure	  to	  SDR	  inhibits	  viral	  clearance	  within	  the	  CNS	  in	  BALB/cJ	  mice,	  such	  that	  at	  day	  21	  post-­‐infection	  animals	  pre-­‐exposed	  to	  SDR	  had	  viral	  titers	  equal	  to	  their	  day	  7	  levels	  (Johnson	  et	  al.,	  2006;	  Johnson	  et	  al.,	  2004b;	  Meagher	  et	  al.,	  2007).	  	  This	  experiment	  was	  designed	   to	  determine	   if	   exposure	   to	   SDR	  prior	   to	   infection	   also	  impairs	  viral	  clearance	  in	  SJL/J	  mice.	  	  	  
Procedure	  Subjects	  were	  exposed	  to	  either	  SDR	  or	  remained	  undisturbed	  in	  their	  home	  cage	  (N=12).	   	  All	  mice	  were	  infected	  two	  hours	  following	  the	  final	  session	  of	  SDR.	  	  On	  day	  eight	  post-­‐infection,	  brain	  and	   spinal	   cord	   samples	  were	   collected	   for	   the	  determination	  of	  viral	  titer	  by	  TCID-­‐50.	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Results	  A	  Student’s	   t-­‐test	   revealed	  significantly	  higher	  CNS	  viral	   titers	  at	  day	  eight	  post-­‐infection	  in	  subjects	  exposed	  to	  SDR	  prior	  to	  infection,	  t	  =	  4.589,	  p	  <	  0.01	  (Fig.	  10).	   	   This	   demonstrates	   that	   SDR	   also	   inhibits	   viral	   clearance	   in	   SJL/J	   mice.	  Furthermore,	   it	   provides	   further	   evidence	   SDR	   modifying	   the	   adaptive	   immune	  response.	  	  	  
	  
Experiment	   4.2:	   Social	   Disruption	   Exacerbates	   Sickness	   Behavior	   and	  
Decreases	   Cortical	   T	   Cell	   mRNA	   Expression	   in	   Response	   to	   Theiler’s	   Virus	  
Infection	  	  Viral	  clearance	  occurs	  through	  the	  action	  of	  the	  adaptive	  immune	  response,	  primarily	   the	   actions	   of	   helper	   (CD4+)	   and	   cytotoxic	   (CD8+)	  T	   cells.	   	   The	   poorer	  viral	  clearance	  observed	  in	  mice	  exposed	  to	  SDR	  prior	  to	  TMEV	  infection	  suggests	  that	  SDR	  is	  disrupting	  T	  cell	  function.	  This	  hypothesis	  is	  supported	  by	  Steelman	  et	  al.	  (2009)	  who	  demonstrate	  that	  restraint	  stress	  attenuates	  virus	  specific	  CD4+	  and	  CD8+	  T	  cells	  within	  the	  spleen	  and	  CD8+	  T	  cells	  within	  the	  CNS	  at	  day	  eight	  post-­‐infection.	  	  To	  begin	  to	  evaluate	  the	  impact	  of	  SDR	  on	  adaptive	  immune	  function	  the	  impact	   of	   SDR	   prior	   to	   infection	   on	   overall	   cortical	   T	   cell	  mRNA	   expression	  was	  assessed.	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Procedure	  A	   two	   (infected	   verses	   uninfected)	   by	   two	   (SDR	   verses	   Non-­‐SDR)	  experimental	  design	  was	  employed	  (N=24).	   	  Mice	  were	  either	  exposed	   to	  chronic	  SDR	  or	  left	  undisturbed	  in	  their	  home	  cage.	  	  Two	  hours	  following	  the	  final	  session	  of	  SDR,	  mice	  were	  infected	  with	  TMEV	  or	  sham	  infected	  with	  sterile	  saline.	   	  Basic	  sickness	   behavior	   (e.g.,	   body	   weight,	   sucrose	   preference,	   clinical	   scores,	   and	  mechanical	   sensitivity)	   was	   assessed	   following	   infection.	   	   At	   eight	   days	   post-­‐infection	   subjects	  were	   sacrificed	   and	   CNS	   cortical	   tissue	  was	  microdissected	   for	  analysis	   by	   RT-­‐PCR.	   Given	   that	   infiltrating	   T	   cells	   are	   generally	   found	   in	   the	  meningies	   of	   the	   brain,	   we	   focused	   on	   examining	   cortical	   tissue,	   which	   should	  include	  the	  meningies.	  	  	  
Results	  Behavior.	   In	   order	   to	   determine	   if	   SDR	   exacerbates	   sickness	   behavior	   in	  response	  to	  TMEV	  infection	  in	  SJL/J	  mice,	  body	  weight,	  sucrose	  preference,	  clinical	  score,	  and	  mechanical	  sensitivity	  were	  assessed.	  	  Behavioral	  data	  from	  Experiments	  4.2	  and	  4.3	  were	  combined	  to	  enhance	  statistical	  power.	  	  The	  acute	  phase	  of	  TMEV	  infection	  typically	  results	  in	  an	  asymptomatic	  infection	  in	  SJL/J	  mice,	  though	  small	  reductions	   in	  body	  weight	  have	  been	  previously	   reported	  (Steelman	  et	  al.,	  2009).	  	  Similarly	   the	   present	   study,	   demonstrated	   that	   exposure	   to	   social	   disruption	  exacerbated	  weight	   loss	   following	  TMEV	  infection.	   	  An	  ANOVA	  showed	  significant	  main	  effects	  of	  stress,	  F(1,	  44)	  =	  7.025,	  p	  <	  0.05,	  and	  infection,	  F(1,	  44)	  =	  22.310,	  p	  <	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0.001,	  as	  well	  as	  a	  significant	  stress	  by	   infection	   interaction,	  F(1,	  44)	  =	  7.838,	  p	  <	  0.01,	   on	   change	   in	   body	   weight	   at	   day	   one	   post-­‐infection	   (Fig.	   11A).	   	   Post	   hoc	  analyses	  indicate	  that	  subjects	  exposed	  to	  stress	  prior	  to	  infection	  lost	  significantly	  more	  weight	  than	  all	  other	  groups.	  Furthermore,	  exposure	   to	  SDR	  prior	   to	   infection	  resulted	   in	  a	   reduction	   in	  sucrose	  preference,	  an	  indicator	  of	  anhedonia,	  at	  day	  one	  post-­‐infection	  (Fig.	  11B).	  	  An	   ANOVA	   confirmed	   a	   significant	  main	   effect	   of	   infection,	  F(1,	   12)	   =	   5.822,	  p	   <	  0.05).	   	   Post	   hoc	   analysis	   indicates	   that	   the	   effect	   of	   infection	   may	   be	   partially	  explained	   significant	   differences	   between	   the	   SDR/infected	   subjects	   and	   the	  uninfected	  subjects	   (both	   stressed	  and	  non-­‐stressed).	   	  No	  significant	  effects	  were	  observed	  for	  clinical	  score	  or	  mechanical	  sensitivity.	  T	  Cell	  mRNA	  Expression.	  Furthermore,	  TMEV	  infection	  resulted	  in	  increased	  cortical	   T	   cell	   mRNA	   expression	   at	   day	   eight	   post-­‐infection	   and	   SDR	   prior	   to	  infection	   significantly	   attenuated	   this	   increase.	   An	   ANOVA	   for	   CD4+	   mRNA	  expression,	   showed	   a	   significant	   effect	   of	   infection,	  F(1,21)	   =	   4.726,	  p	   <.05,	   such	  that	   infection	   increased	   the	   level	   of	   CD4+	   mRNA	   expression.	   Post	   hoc	   analysis	  showed	   that	   the	   infected	   non-­‐stressed	   condition	   drives	   this	   effect,	   such	   that	  infected	   non-­‐stressed	   subjects	   had	   higher	   levels	   of	   CD4+	   mRNA	   than	   all	   other	  groups.	  The	  main	  effect	  of	  stress	  and	  the	  stress	  (p	  =	  .187)	  by	  infection	  interaction	  (p	  =	  .160)	  failed	  to	  reach	  significance.	  An	  ANOVA	  for	  CD8+	  mRNA	  expression	  showed	  no	  significant	  effects,	  	  however,	  there	  was	  a	  trend	  	  (p	  	  =	  	  .106)	  	  	  toward	  	  an	  	  infection	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  Fig.	  11..	  SDR	  exacerbates	  TMEV	  infection	  related	  sickness	  behavior	   in	  SJL/J	  mice.	   	  SDR	  results	   in	  a	  significant	   condition	   by	   infection	   interaction	   on	   body	   weight	   loss	   on	   day	   one	   post-­‐infection,	  suggesting	  that	  the	  SDR	  prior	  to	  infection	  exacerbates	  weight	  loss	  	  (A).	  	  Furthermore,	  only	  the	  SDR-­‐infected	  group	  observed	  a	  loss	  in	  sucrose	  preference	  (B).	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  Fig.	  12.	  SDR	  attenuates	  infection	  related	  increase	  in	  T	  cell	  mRNA	  expression.	  	  A	  MANOVA	  revealed	  a	  significant	  interaction	  of	  infection	  by	  stress.	  	  As	  anticipated,	  the	  data	  indicated	  that	  infection	  results	  in	  an	  increase	  in	  central	  T	  cell	  levels	  and	  that	  SDR	  prior	  to	  infection	  inhibits	  this	  up-­‐regulation.	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related	   increase	   in	  CD8+	  mRNA	  expression.	   	  However,	  when	  analyzed	   together,	   a	  MANOVA	  revealed	  a	  significant	  stress	  by	  infection	  interaction,	  F(2,	  21)	  =	  3.644,	  p	  <	  0.05,	   on	   the	   cortical	   levels	   of	   CD4+	   and	   CD8+	  mRNA	   expression	   (Fig.	   12).	   	   This	  interaction	   indicates	   that	   SDR	   attenuates	   virus-­‐induced	   enhancement	   in	   T	   cell	  number.	  	  	  	  	  
Experiment	  4.3:	  Social	  Disruption	  Impairs	  Virus-­Specific	  Adaptive	   Immunity	  
in	  the	  CNS	  but	  Not	  the	  Spleen	  T	  cell	  responses,	  particularly	  the	  CD8+	  T	  cell	  response,	  have	  been	  shown	  to	  play	  a	  vital	  role	  in	  the	  clearance	  of	  TMEV	  from	  the	  CNS.	  	  Given	  that	  prior	  research	  has	   demonstrated	   that	   restraint	   stress	   attenuates	   virus	   specific	   T	   cell	   responses	  (Steelman	   et	   al.,	   2009),	   this	   study	   sought	   to	   determine	   if	   SDR	   also	   affects	   T	   cell	  response.	  	  It	  has	  been	  demonstrated	  that	  SDR	  disrupts	  viral	  clearance	  and	  reduces	  T	  cell	  number,	  however,	  it	  is	  possible	  that	  a	  general	  reduction	  does	  not	  necessarily	  result	   in	   a	   reduction	   in	   virus	   specific	   T	   cells.	   Therefore,	   this	   study	   evaluated	   the	  effect	   SDR	   on	   virus-­‐specific	   T	   cells	   through	   the	   use	   of	   the	   ELISPOT	   assay.	   	   This	  assay	  evaluates	  IFN-­‐γ	  secretion	  by	  virus	  specific	  T	  cells	  by	  stimulating	  lymphocytes	  from	   the	   spleen	   and	   the	   CNS	  with	   Theiler’s	   virus	   specific	   CD4+	   and	   CD8+	   T	   cell	  peptides.	  	  Each	  peptide	  will	  cause	  virus	  specific	  T	  cells	  to	  produce	  IFN-­‐γ	  that	  can	  be	  quantified.	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Procedure	  A	   two	   (infected	   verses	   uninfected)	   by	   two	   (SDR	   verses	   Non-­‐SDR)	  experimental	  design	  was	  employed	  (N=24).	   	  Mice	  were	  either	  exposed	   to	  chronic	  SDR	  or	  left	  undisturbed	  in	  their	  home	  cage.	  	  Two	  hours	  following	  the	  final	  session	  of	   SDR,	  mice	  were	   infected	  with	  TMEV	  or	   sham	   infected	  with	   sterile	   saline.	  Body	  weight,	   sucrose	   preference,	   clinical	   scores,	   and	   mechanical	   sensitivity	   were	  assessed	  following	  infection.	  	  Eight	  days	  post-­‐infection	  subjects	  were	  sacrificed	  and	  the	  brain,	  spinal	  cord,	  and	  spleen	  were	  collected.	  	  Lymphocytes	  from	  the	  spleen	  and	  CNS	  (brain	  and	  spinal	  cord)	  were	  isolated	  and	  an	  ELISPOT	  assay	  was	  performed.	  	  	  
Results	  TMEV	  infection	  increased	  the	  number	  of	  cells	  responding	  to	  both	  CD4+	  and	  CD8+	  immunodominant	  peptide	  while	  SDR	  profoundly	  decreased	  T	  cell	  responses	  in	  the	  CNS.	  Specifically,	  infection	  significantly	  increased	  virus-­‐specific	  CD4+	  cells	  in	  the	   CNS,	   but	   this	   increase	   was	   significantly	   attenuated	   in	   subjects	   previously	  exposed	  to	  social	  disruption.	  	  An	  ANOVA	  verified	  significant	  main	  effects	  of	  stress,	  
F(1,	  20)	  =	  18.668,	  p	  <	  0.001,	  and	  infection,	  F(1,	  20)	  =	  17.552,	  p	  <	  0.001,	  as	  well	  as	  a	  significant	   stress	   by	   infection	   interaction,	   F(1,	   20)	   =	   18.417,	   p	   <	   0.001,	   for	   virus	  specific	  CD4+	  T	  cells	  in	  the	  CNS	  (Fig.	  13A).	  	  Post	  hoc	  analyses	  indicate	  that	  the	  non-­‐stressed	   infected	   subjects	   have	   significantly	   higher	   levels	   of	   virus-­‐specific	   CD4+	  cells	  in	  the	  CNS.	  	  	  
	   81	  
	  Fig.	  13.	  SDR	  suppresses	  CNS	  T	  cell	  effector	  function.	  	  Within	  the	  cortex	  of	  the	  brain	  infection	  results	  in	  a	  significant	  increase	  in	  both	  CD4+	  and	  CD8+	  T	  cell	  effector	  function.	  	  This	  increase	  in	  inflammation	  was	  significantly	  attenuated	  in	  the	  SDR	  group.	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Furthermore,	   infection	   resulted	   in	   a	   significant	   increase	   in	   virus-­‐specific	  CD8+	  cells	  in	  the	  CNS,	  an	  effect	  that	  was	  significantly	  attenuated	  by	  prior	  exposure	  to	   social	   disruption.	   	  ANOVA	  verified	   significant	  main	   effects	   of	   stress,	   F(1,	   20)	  =	  10.197,	  p	  <	  0.01,	  and	  infection,	  F(1,	  20)	  =	  12.338,	  p	  <	  0.01,	  as	  well	  as	  a	  significant	  stress	  	  by	  	  infection	  	  interaction,	  	  F(1,	  20)	  	  =	  10.344,	  	  p	  <	  0.01	  	  (Fig.	  13B).	  	  	  	  Follow	  up	  
post	   hoc	   analyses	   demonstrate	   that	   the	   non-­‐stressed	   infected	   subjects	   have	  significantly	   higher	   levels	   of	   virus-­‐specific	   CD8+	   cells	   in	   the	   CNS	   than	   all	   other	  groups.	  These	  effects	  were	  not	  explained	  by	  SDR-­‐induced	  alterations	  in	  peripheral	  T	  cell	  responses.	  	  Infection	  significantly	  increased	  the	  number	  of	  virus-­‐specific	  CD4+T	  cells	  in	  the	  spleen,	  F(1,	  19)	  =	  8.833,	  p	  <	  0.01,	  but	  this	  increase	  was	  not	  significantly	  altered	  by	  SDR	  exposure	  prior	  to	  infection,	  all	  other	  Fs	  <	  0.862	  (Fig.	  14A).	  	  A	  main	  effect	   of	   infection	   on	   virus-­‐specific	   CD8+	   T	   cell	   populations	   in	   the	   spleen	  approached	  significance,	  F(1,	  18)	  =	  3.905,	  p	  =	  0.064),	  but	  no	  other	  significant	  main	  effects	  or	  interactions	  were	  present,	  	  all	  Fs	  <	  0.574,	  ps	  >	  .05	  (Fig.	  14B).	  	  
Discussion	  These	  experiments	  provide	  compelling	  evidence	  that	  pre-­‐exposure	  to	  social	  stress	  can	  disrupt	  the	  adaptive	  immune	  response	  to	  infection.	  	  They	  are	  the	  first	  to	  demonstrate	   the	   SJL/J	   mice,	   like	   BALB/cJ	   mice,	   infected	   with	   TMEV	   exhibit	  increased	  sickness	  and	  poorer	  viral	  clearance	  when	  pre-­‐exposed	  to	  SDR.	  These	  data	  suggests	  that	  this	  results	  from	  increased	  viral	  load.	  	  It	  was	  also	  demonstrated	  that	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infection	   results	   in	   an	   increase	   in	   CD4+	   and	   CD8+	   T	   cells	   within	   the	   CNS.	   	   This	  increase	   is	   necessary	   for	   clearing	   the	   virus.	   	   Pre-­‐exposure	   to	   SDR	   resulted	   in	   a	  blunting	  of	  infection	  related	  increase	  in	  CNS	  T	  cell	  mRNA	  expression.	  	  Furthermore,	  TMEV	   infection	   resulted	   in	   increases	   in	   IFN-­‐γ	   producing	   virus	   specific	   CD4+	   and	  CD8+	   T	   cells	   in	   the	   CNS,	   and	   SDR	   prior	   to	   infection	   significantly	   blunts	   this	  response.	   	  SDR	  did	  not	  significantly	  alter	   the	   levels	  of	  T	  cells	   in	   the	  spleen	  at	  day	  eight	   post-­‐infection.	   This	   would	   suggest	   that	   the	   adverse	   effects	   of	   SDR	   on	   the	  disease	   course	  of	  TMEV	   infection	  are	  primarily	   centrally	  mediated,	  however,	   it	   is	  possible	   that	   if	   a	   different	   time	   point	   (e.g.,	   day	   two)	   was	   evaluated	   a	   peripheral	  effect	  of	  SDR	  may	  be	  observed.	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  Fig.	  14.	  SDR	  does	  not	  significantly	  impact	  peripheral	  T	  cell	  effector	  function.	  	  There	  was	  a	  significant	  infection	  related	  increase	  in	  CD4+	  T	  cell	  effector	  function	  and	  trend	  toward	  an	  increase	  in	  CD8+	  T	  cell	  	  effector	  function,	  however,	  SDR	  did	  not	  significantly	  alter	  these	  responses.	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CHAPTER	  V	  SUMMARY	  AND	  DISCUSSION	  	   Evidence	   indicates	   that	   a	   prior	   history	   of	   stress	   is	   linked	   to	   onset	   and	  exacerbation	   of	   autoimmune	   diseases,	   such	   as	  multiple	   sclerosis	   and	   rheumatoid	  arthritis,	  (Ackerman	  et	  al.,	  2002;	  Grant	  et	  al.,	  1989;	  Herrmann	  et	  al.,	  2000;	  Mohr	  et	  al.,	  2000;	  Mohr	  et	  al.,	  2004;	  Rimón	  and	  Laakso,	  1985;	  Uno	  et	  al.,	  1989;	  Urrows	  et	  al.,	  1994;	   Warren	   et	   al.,	   1982).	   	   Our	   laboratory	   has	   sought	   to	   understand	   the	  mechanisms	   by	  which	   social	   stress	   exerts	   these	   effects	   using	   TMEV	   infection,	   an	  animal	  model	   of	   MS	   (Johnson	   et	   al.,	   2006;	   Johnson	   et	   al.,	   2004b;	  Meagher	   et	   al.,	  2007).	   	   Prior	   research	  demonstrated	   that	   social	   disruption	   stress	   leads	   to	   higher	  viral	  titers	  and	  increased	  inflammatory	  lesions,	  which	  result	  in	  an	  exacerbation	  of	  behavioral	  and	  immunological	  measures	  of	  the	  acute	  and	  chronic	  phases	  of	  TMEV	  infection	   (Johnson	   et	   al.,	   2006;	   Johnson	   et	   al.,	   2004b;	   Meagher	   et	   al.,	   2007).	  	  Furthermore,	  IL-­‐6	  neutralization	  during	  the	  stress	  exposure	  period	  can	  reverse	  the	  effects	  of	  SDR	  on	  acute	  phase	  TMEV	  infection	  (Meagher	  et	  al.,	  2007).	  	  	  To	   extend	   these	   findings,	   my	   dissertation	   examined	   the	   impact	   of	   SDR	  exposure	   on	   elements	   of	   the	   innate	   and	   adaptive	   immune	   response	   to	   Theiler’s	  virus	  infection.	  Results	  suggest	  that	  the	  adverse	  effects	  of	  social	  stress	  are	  mediated	  by	   stress-­‐induced	   enhancement	   of	   CNS	   cytokines	   and	   suppression	   of	   CNS	   T	   cell	  function.	   First,	   the	   impact	   of	   SDR	   on	   sensitization	   of	   proinflammatory	   cytokines	  during	  the	  stress-­‐exposure	  period	  was	  examined.	  	  It	  was	  demonstrated	  that	  chronic	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SDR	  results	  in	  an	  up-­‐regulation	  of	  IL-­‐6	  mRNA	  expression.	  	  It	  was	  also	  demonstrated	  that	   SDR	   sensitizes	   infection-­‐related	   increases	   in	   central	   and	   peripheral	  proinflammatory	   cytokines.	   	   The	   protective	   effects	   of	   IL-­‐6	   neutralizing	   antibody	  appear	   to	   be	   partially	  mediated	   by	   reversing	   the	   central,	   but	   not	   the	   peripheral,	  increase	   in	   proinflammatory	   cytokine	   expression.	   Next,	   the	   impact	   of	   SDR	   on	  adaptive	  immune	  function	  was	  also	  examined	  by	  evaluating	  T	  cell	  function.	  	  It	  was	  demonstrated	  that	  SDR	  disrupts	  viral	  clearance	  and	  enhances	  sickness	  behavior	  in	  response	   to	   infection.	   	   Furthermore,	   it	   was	   demonstrated	   that	   SDR	   prior	   to	  infection	  attenuates	  infection	  related	  increases	  in	  cortical	  T	  cell	  mRNA	  expression	  and	  central	  CD4+	  and	  CD8+	  T	  cell	  effector	  function.	  	  Overall,	  these	  data	  suggest	  that	  SDR	  prior	  to	  TMEV	  infection	  stimulates	  the	  inflammatory	  component	  of	  the	  innate	  immune	   system,	   while	   suppressing	   the	   virus-­‐specific	   adaptive	   immune	   system	  respone.	  	  
	  
Social	  Disruption	  Induces	  CNS	  Inflammation	  In	  Chapter	  III	  the	  effect	  of	  SDR	  on	  inflammation	  was	  examined.	  	  Prior	  studies	  have	  shown	   that	   social	   stress	   results	   in	  peripheral	   increases	   in	  pro-­‐inflammatory	  cytokines	   (Engler	   et	   al.,	   2008;	  Gaab	  et	   al.,	   2005;	  Merlot	   et	   al.,	   2003;	  Merlot	   et	   al.,	  2004a;	  Stark	  et	  al.,	  2002).	   	  For	  example,	  Stark	  et	  al.	  showed	  that	  social	  disruption	  stress	   results	   in	   an	   increase	   in	   IL-­‐6	   level	   within	   plasma	   and	   liver.	   Additionally,	  Engler	   et	   al.	   (2008)	   demonstrated	   that	   SDR	   results	   in	   an	   increase	   in	   splenic	   and	  hepatic	  IL-­‐1β.	  The	  current	  study	  extends	  this	  research	  by	  showing	  a	  significant	  up-­‐
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regulation	   of	   IL-­‐6	   mRNA	   expression	   in	   the	   hippocampus	   following	   chronic	  exposure	  to	  SDR.	  	  Furthermore,	  it	  was	  demonstrated	  that	  there	  is	  a	  robust	  increase	  of	   hippocampal	   IL-­‐1β	   following	   a	   single	   session	   of	   SDR.	   	   However,	   this	   effect	  appears	   to	   habituate,	   such	   that	   by	   the	   sixth	   session	   of	   SDR	   no	   significant	   up-­‐regulation	  of	  IL-­‐1β	  was	  observed.	  	  	  This	   effect	  may	  be	  driven	  by	   the	  development	   of	   glucocorticoid	   resistance	  (Avitsur	   et	   al.,	   2001;	  Miller	   et	   al.,	   2002;	   Quan	   et	   al.,	   2001;	   Sheridan	   et	   al.,	   2000;	  Stark	  et	  al.,	  2002).	  It	  has	  been	  demonstrated	  that	  chronic	  exposure	  to	  SDR	  results	  in	  a	   blunting	   of	   the	   anti-­‐inflammatory	   effects	   of	   glucocorticoids	   on	   splenocytes	  (Avitsur	  et	  al.,	  2001;	   Johnson	  et	  al.,	  2004b;	  Meagher	  et	  al.,	  2007;	  Miller	  and	  Chen,	  2006;	  Quan	  et	  al.,	  2001).	  Data	  from	  Quan	  et	  al.	  (2001)	  suggest	  that	  the	  blunting	  of	  this	   effect	   may	   occur	   due	   to	   a	   down-­‐regulation	   of	   GC	   receptors.	   It	   has	   been	  suggested	   that	   the	  effect	  of	  GCR	   is	  not	   limited	   to	   the	  spleen,	  as	  a	   reduction	  of	  GC	  receptor	  mRNA	  was	  also	  observed	  in	  the	  brain	  following	  SDR	  (Quan	  et	  al.,	  2001).	  	  Prior	  research	  has	  shown	  that	  GCR	  depends	  upon	  IL-­‐1β	  (Engler	  et	  al.,	  2008).	  Mice	  lacking	  the	  IL-­‐1	  type	  1	  receptor	  showed	  an	  elevation	  in	  serum	  corticosterone,	  but	   did	   not	   shown	   an	   accumulation	   of	   CD11b+	   cells	   in	   the	   spleen	   or	   the	  development	  of	  GCR.	  Despite	  research	  indicating	  that	  SDR	  increases	  IL-­‐6	  release,	  it	  is	  not	  essential	  in	  the	  development	  of	  SDR-­‐induced	  GCR	  within	  the	  spleen	  (Stark	  et	  al.,	   2002).	   Prior	   research	   from	   our	   laboratory	   is	   in	   line	   with	   this,	   showing	   the	  development	   of	   GCR	   even	   when	   IL-­‐6	   neutralizing	   antibody	   is	   administered	  (Meagher	  et	  al.,	  2007).	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The	  development	  of	  GCR	  does	  not	  occur	  following	  all	  stressors,	  but	  appears	  to	  develop	  uniquely	   in	   response	   to	   social	   stress	   (Avitsur	   et	   al.,	   2001;	  Quan	  et	   al.,	  2001).	  	  Chronic	  exposure	  to	  restraint	  stress	  does	  not	  alter	  the	  responsivity	  of	  cells	  to	   the	   anti-­‐inflammatory	   effects	   of	   glucocorticoids	   (Quan	   et	   al.,	   2001).	   	   This	  may	  explain	  why	  social	  disruption	  stress	  has	  proinflammatory	  effects	  (Gaab	  et	  al.,	  2005;	  Merlot	  et	  al.,	  2003;	  Merlot	  et	  al.,	  2004a;	  Stark	  et	  al.,	  2002),	   in	  contrast	  to	  the	  anti-­‐inflammatory	  effects	  of	  restraint	  stress	  (Mi	  et	  al.,	  2004;	  Mi	  et	  al.,	  2006a).	  	  
Social	  Disruption	  Sensitizes	  TMEV-­induced	  Inflammatory	  Responses	  Furthermore,	   this	   dissertation	   sought	   to	   determine	   if	   SDR	   sensitized	  Theiler’s	   virus-­‐induced	   proinflammatory	   cytokine	   release	   and	   if	   the	   protection	  conferred	  by	   IL-­‐6	  neutralizing	  antibody	   is	   through	   reversal	  of	   this	   stress-­‐induced	  sensitization.	   This	   hypothesis	   is	   supported	   by	   a	   growing	   body	   of	   evidence	  suggesting	  prior	  exposure	  to	  social	  stress	  can	  sensitize	  or	  prime	  the	  inflammatory	  pathway,	  such	  that	  a	  subsequent	   inflammatory	  stimulus	  results	   in	  an	  exaggerated	  inflammatory	  response	  (Bailey	  et	  al.,	  2009;	  Dong-­‐Newsom	  et	  al.,	  2010;	  Mays	  et	  al.,	  2010;	   Powell	   et	   al.,	   2011;	   Quan	   et	   al.,	   2001).	   For	   example,	   repeated	   social	  disruption	   stress	   resulted	   in	   increased	   HSV-­‐1	   infection-­‐related	   CD11b+	  macrophages	   and	   proinflammatoy	   cytokines,	   IFN-­‐α	   and	  TNF-­‐α	   (Dong-­‐Newsom	  et	  al.,	   2010).	   	   Furthermore,	   SDR	   enhances	   allergen-­‐induced	   airway	   inflammation	  (Bailey	   et	   al.,	   2009)	   and	   LPS-­‐induced	   proinflammatory	   cytokines	   (Quan	   et	   al.,	  2001).	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It	   has	   also	   been	   shown	   that	   other	   inflammatory-­‐stimuli	   can	   sensitize	   the	  innate	  immune	  response	  to	  a	  challenge	  (Cunningham	  et	  al.,	  2005;	  Deak	  et	  al.,	  2005;	  Johnson	  et	  al.,	  2002;	  Matsumoto	  et	  al.,	  2006;	  Perry,	  2007).	  	  For	  example,	  exposure	  to	  inescapable	  shock	  prior	  to	  administration	  of	  LPS	  results	  in	  enhanced	  plasma	  IL-­‐1β	  (Johnson	  et	  al.,	  2002).	  Additionally,	  administration	  of	  IL-­‐6	  or	  exposure	  to	  stress	  has	   been	   shown	   to	   sensitize	   inflammatory	   response	   to	   a	   stressor	   (Deak	   et	   al.,	  2005b;	  Matsumoto	  et	  al.,	  2006).	  Furthermore,	  exposure	  to	  LPS	  can	  exacerbate	  local	  brain	  inflammation	  in	  prion	  disease	  infected	  mice	  (Cunningham	  et	  al.,	  2005).	  	  	  Previous	   research	   suggests	   that	   SDR	   may	   also	   enhance	   inflammatory	  response	  to	  TMEV	  infection	  (Meagher	  et	  al.,	  2007).	   It	  was	  demonstrated	  that	  SDR	  results	  in	  increased	  IL-­‐6	  in	  sera	  and	  increased	  inflammatory	  lesions	  within	  the	  CNS	  that	  depend	  upon	  stress-­‐induced	  IL-­‐6.	  	  This	  dissertation	  extended	  these	  findings	  by	  demonstrating	   that	   chronic	   SDR	   sensitizes	   the	   inflammatory	   response	   to	   TMEV	  infection.	  	  Exposure	  to	  SDR	  prior	  to	  TMEV	  infection	  resulted	  in	  increased	  infection	  related	  central	  IL-­‐6	  and	  IL-­‐1β	  mRNA	  expression	  and	  increased	  peripheral	  IL-­‐1β	  and	  TNF-­‐α	  mRNA	   expression.	   	   Furthermore,	   the	   protective	   effect	   of	   IL-­‐6	   neutralizing	  antibody	   administration	   during	   the	   stress	   exposure	   period	   reversed	   the	  enhancement	   of	   central	   inflammation,	   but	   not	   peripheral	   inflammation.	   	   This	  suggests	   that	   SDR-­‐induced	   IL-­‐6	   serves	   to	   sensitize	   the	   inflammatory	   pathway.	  	  Furthermore,	   given	   that	   administration	   of	   IL-­‐6	   neutralizing	   antibody	   has	   been	  shown	  to	  reverse	  the	  adverse	  behavioral	  effects	  of	  IL-­‐6	  (Meagher	  et	  al.,	  2007),	  this	  data	   suggests	   that	   the	   sensitization	   of	   neuroinflammatory	   processes	  mediate	   the	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adverse	   effects	   of	   social	   stress	   on	   TMEV	   infection,	   including	   enhanced	   sickness	  behavior,	  increased	  histological	  markers	  of	  CNS	  inflammatory	  lesions,	  and	  reduced	  CNS	  viral	  clearance	  (Meagher	  et	  al.,	  2007).	  	  The	  activation	  of	  microglia	  may	  underlie	   this	  sensitization	  effect.	  Microglia	  are	   the	  primary	   immune	  cells	  of	   the	  brain	  and	  are	   the	  primary	  producers	  of	  CNS	  inflammatory	   cytokines	   (Kreutzberg,	   1996;	   Van	   Dam	   et	   al.,	   1995).	   	   It	   has	   been	  demonstrated	   that	   administration	   of	   minocycline,	   a	   glial	   cell	   inhibitor,	   reverses	  shock-­‐induced	  increases	  in	  central	  proinflammatory	  cytokine	  expression	  (Blandino	  et	   al.,	   2006).	   	   This	   suggests	   that	   they	   are	   important	  mediators	   of	   stress	   induced-­‐neuroinflammation.	   	   It	   has	   also	   been	   demonstrated	   that	   stress	   can	   induce	   a	  hyperinflammatory	   microglial	   phenotype	   (Frank	   et	   al.,	   2007;	   Nair	   and	   Bonneau,	  2006;	   Perry,	   2007;	   Sugama	   et	   al.,	   2007),	   which	   may	   underlie	   stress-­‐induced	  exacerbations	  of	  neuroinflammation	  in	  various	  diseases,	  including	  MS.	  	  	  The	   present	   studies	   examined	   the	   expression	   of	   CD11b,	   a	   Mac-­‐1	   marker	  associated	  with	  microglia	  and	  macrophage	  activation,	   to	   indirectly	  assess	  the	  role	  of	   microglia.	   	   A	   trend	   towards	   an	   increase	   in	   CD11b	   mRNA	   expression	   was	  observed	  in	  the	  chronic	  SDR	  group;	  however,	  the	  effect	  failed	  to	  reach	  significance.	  	  Furthermore,	  although	  the	  interaction	  between	  SDR	  and	  IL-­‐6	  neutralizing	  antibody	  treatment	   for	   CD11b	   was	   not	   statistically	   significant,	   there	   was	   (1)	   a	   trend	  suggesting	  that	  SDR	  may	  increase	  TMEV-­‐induced	  CD11b	  mRNA	  expression	  and	  (2)	  that	   this	   can	   be	   reversed	   with	   IL-­‐6	   neutralization	   during	   the	   stress	   exposure	  period.	   	  However,	  given	   the	   inconclusive	  nature	  of	   this	   finding,	   future	  research	   is	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needed	  to	  determine	   if	  priming	  of	  microglia	   is	   the	  cellular	  mechanism	  underlying	  stress-­‐induced	   sensitization	   of	   TMEV	   infection-­‐induced	   inflammation.	   	   Given	   that	  many	   cell	   types,	   such	   as	   astrocytes	   and	   neurons,	   are	   also	   able	   to	   release	  proinflammatory	   cytokines,	   these	   cells	   may	   also	   be	   involved	   in	   stress-­‐induced	  enhancement	  of	  neuroinflammation.	  
	  
Social	  Disruption	  Attenuates	  Infection	  Related	  Adaptive	  Immune	  Response	  Given	   the	   important	   role	   the	   adaptive	   immune	   system	   has	   in	   the	  pathogenesis	  of	  TMEV	  infection,	  my	  dissertation	  also	  evaluated	  the	  impact	  of	  SDR	  on	  elements	  of	  the	  adaptive	  immune	  system.	  	  The	  adaptive	  immune	  system	  has	  two	  branches:	  cell	  mediated	  immunity	  and	  humoral	  immunity.	  	  Cell	  mediated	  immunity	  includes	  the	  actions	  of	  cytotoxic	  T	  cells	  (CD8+)	  in	  the	  destruction	  of	  infected	  cells,	  while	  humoral	  immunity	  is	  characterized	  by	  B	  cell	  antibody	  production.	   	  Different	  helper	   T	   cell	   (CD4+)	   subtypes	   (see	   Fig.	   15)	   help	   to	   direct	   and	   coordinate	   these	  responses.	   	   For	   example,	  Th1	   cells	   are	   essential	   for	   the	  development	  of	   cytotoxic	  memory	  T	  cells.	  	  Both	  Th1	  and	  cytotoxic	  T	  cells	  produce	  high	  levels	  of	  IFN-­‐γ	  that	  act	  to	  stimulate	  immune	  function	  and	  inhibit	  viral	  replication.	   	  For	  effective	  clearance	  of	  the	  virus,	  this	  process	  should	  occur	  early	  in	  TMEV	  infection.	  	  Th2	  helper	  T	  cells	  assist	  B	  cells	  in	  their	  production	  of	  antibodies.	  	  The	  Th2	  cell	  response	  should	  come	  after	  the	  production	  of	  Th1	  cells	  for	  effective	  viral	  clearance	  to	  occur.	  	  Furthermore,	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  Fig,	   15.	   	   Differentiation	   of	   naïve	   T	   cells.	   	   A	   naïve	   T	   cell	   has	   the	   potential	   to	   become	   one	   of	  many	  phenotypes.	   This	   decision	   is	   based	   upon	   the	   cytokine	   profile	   in	   the	   extracellular	   environment.	  	  Furthermore,	   each	  differentiated	  cell	   type	   results	   in	  a	  different	  profile	  of	   cytokine	   release.	   	   Image	  borrowed	  from	  Zou	  and	  Restifo	  (2010).	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a	   response	   of	   regulatory	   helper	   T	   cells	   (Tregs)	   should	   follow	   the	   Th2	   response.	  Tregs	  act	   to	   suppress	   the	   immune	   response.	  Consequently,	   the	  presence	  of	  Tregs	  improves	   disease	   outcomes	   by	   reducing	   inflammation	   and	   decreasing	   the	  likelihood	  of	  auto-­‐reactive	  T	  cell	  development.	  Prior	   research	   has	   demonstrated	   that	   stress	   is	   capable	   of	   inhibiting	   T	   cell	  function.	  	  For	  example,	  restraint	  stress	  results	  in	  a	  reduction	  in	  TMEV-­‐specific	  IFN-­‐γ	  producing	  CD4+	  and	  CD8+	  T	  cells	  in	  the	  periphery	  and	  CD8+	  T	  cells	  in	  the	  brain	  (Steelman	   et	   al.,	   2009).	   	   	   Furthermore,	   chronic	   social	   stress	   has	   been	   shown	   to	  result	   in	  a	  suppression	  of	  plasma	  IFN-­‐γ	  and	  reduced	  CD8+	  T	  cell	  expansion	  in	  the	  spleen	   (Sommershof	   et	   al.,	   2011).	   This	   effect	   appears	   to	   be	   mediated	   by	   stress-­‐induced	   glucocorticoids.	   To	   determine	   if	   SDR	   suppresses	   the	   adaptive	   immune	  response	   to	   TMEV	   infection,	   Chapter	   IV	   examined	   the	   role	   of	   SDR	   in	   modifying	  TMEV-­‐induced	  T	  cell	  mRNA	  expression	  and	  virus-­‐specific	  IFN-­‐γ	  T	  cell	  production.	  This	  series	  of	  studies	  was	  conducted	  with	  SJL/J	  mice.	  	  Given	  that	  prior	  work	  examining	   the	   impact	   of	   SDR	  on	   disease	   progression	  was	   carried	   out	   in	  BALB/cJ	  mice,	   it	   was	   important	   to	   verify	   that	   SDR	   modifies	   disease	   pathogenesis	   in	   this	  strain.	  	  As	  anticipated,	  SDR	  enhanced	  sickness	  immediately	  following	  infection	  (e.g.,	  increased	  weight	  loss	  and	  decreased	  sucrose	  preference)	  and	  resulted	  in	  increased	  viral	   titers	  at	  day	  eight	  post-­‐infection.	   	  No	  SDR-­‐induce	  differences	  were	  observed	  on	   other	   measures	   of	   sickness	   (i.e.,	   mechanical	   sensitivity	   and	   clinical	   score);	  however,	   this	   is	  not	  surprising	  given	   the	  attenuated	  acute	  phase	  symptomatology	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that	   SJL/J	   mice	   display,	   when	   compared	   to	   BALB/cJ	   mice,	   when	   infected	   with	  TMEV.	  	  	  Prior	  exposure	  to	  SDR	  altered	  central	  T	  cell	  mRNA	  expression	  and	  function	  in	   response	   to	  TMEV	   infection.	   	  As	   anticipated,	   infection	   resulted	   in	   robust	  CD4+	  and	  CD8+	  T	  cell	  mRNA	  expression	  in	  the	  cortex	  on	  day	  eight	  post-­‐infection,	  a	  time	  point	  where	   viral	   titers	   are	   high.	   Prior	   exposure	   to	   SDR	   resulted	   in	   a	   significant	  attenuation	  of	  this	  increase	  in	  mRNA	  expression.	  	  Furthermore,	  infection	  increased	  virus-­‐specific	  CD4+	  and	  CD8+	  T	   cell	   IFN-­‐γ	  production	  and	  prior	   exposure	   to	   SDR	  significantly	  attenuated	  this	  increase.	  	  This	  suppression	  likely	  underlies	  the	  poorer	  viral	   clearance	   and	   increased	   disease	   pathogenesis	   observed	   in	  mice	   exposed	   to	  SDR	  prior	  to	  infection.	  	  A	   stress-­‐induced	  suppression	  of	  T	   cell	   expression	  was	  not	  observed	   in	   the	  periphery	   at	   day	   eight,	   suggesting	   that	   SDR	   may	   affect	   TMEV	   disease	   course	  primarily	  by	  altering	  the	  CNS	  immune	  response	  to	   infection.	   	  However,	  given	  that	  the	   immune	   response	   is	   generally	   initiated	   in	   the	   periphery,	   it	   is	   possible	   that	  assessing	  levels	  at	  day	  eight	  post-­‐infection	  was	  too	  far	  removed	  from	  infection	  such	  that	  the	  peripheral	  alterations	  were	  missed.	  	  Future	  research	  evaluating	  other	  time	  points	  is	  needed	  to	  determine	  if	  the	  effect	  of	  SDR	  on	  T	  cell	  function	  also	  extends	  to	  the	  periphery.	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Interaction	  Between	  the	  Innate	  and	  Adaptive	  Immune	  Systems	  It	   has	   been	   demonstrated	   that	   the	   initial	   innate	   immune	   response	   to	  infection	   shapes	   the	   later	   adaptive	   immune	   response	   (Biron,	   1998;	   Biron,	   1999).	  Thus,	   exaggerated	   infection-­‐related	   neuroinflammation	   might	   have	   cascading	  effects,	   including	   a	   dysregulation	   of	   T	   cell	   and	   antiviral	   responses	   during	   early	  infection.	  	  Furthermore,	  a	  poorer	  antiviral	  response	  during	  the	  acute	  phase	  is	  likely	  to	   result	   in	   increased	   severity	   of	   the	   later	   Theiler	   virus	   induced	   demyelination	  (Lipton	   et	   al.,	   2005;	   Sieve	   et	   al.,	   2004;	   Trottier	   et	   al.,	   2004).	   Given	   that	  administration	  of	   neutralizing	   antibody	   to	   IL-­‐6	   can	   reverse	   the	   adverse	   effects	   of	  SDR	   on	   viral	   clearance,	   it	   appears	   that	   dysregulation	   of	   the	   innate,	   inflammatory	  response	   to	   infection	   results	   in	   a	   dysregulation	   of	   the	   acquired,	   T	   cell	   mediated	  response.	  	  One	   mechanism	   by	   which	   increased	   neuroinflammation	   may	   affect	   T	   cell	  function	  is	  through	  altering	  the	  CD4+	  subtype	  expressed,	  shifting	  the	  balance	  away	  from	  mounting	  the	  most	  effective	  immune	  response.	  There	  is	  evidence	  that	  a	  high	  level	   of	   IL-­‐6	   could	   suppress	   Th1	   responses	   in	   favor	   of	   Th17	   responses.	   A	   Th17	  immune	  response	  can	  be	  induced	  by	  the	  presence	  of	  IL-­‐6	  and	  TGF-­‐β	  (or	  IL-­‐1	  and	  IL-­‐23)	  (Zou	  and	  Restifo,	  2010).	  	  Given	  that	  there	  is	  a	  central	  up-­‐regulation	  of	  IL-­‐6	  and	  IL-­‐1β,	  this	  seems	  a	  likely	  possibility.	  	  The	  Th17	  cells	  release	  IL-­‐17	  and	  IL-­‐21,	  which	  serve	   essential	   functions	   in	   antimicrobial	   immunity	   at	   epithelial	   and	   mucosal	  barriers.	   	   However,	   it	   has	   recently	   been	   demonstrated	   that	   Th17	   promote	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persistent	   TMEV	   infection	   and	   exacerbate	   pathogenesis	   of	   chronic	   phase	  demyelinating	  disease	  (Hou	  et	  al.,	  2009).	  	  	  This	   effect	   may	   be	   through	   the	   promotion	   of	   autoreactive	   T	   cells.	  Interestingly,	   Th17	   has	   also	   been	   linked	   to	   the	   development	   of	   a	   variety	   of	  autoimmune	   diseases,	   including	   multiple	   sclerosis,	   collagen-­‐induced	   arthritis,	  rheumatoid	  arthritis,	  and	  autoimmune	  myocarditis	  (Afzali	  et	  al.,	  2007;	  Bettelli	  et	  al.,	  2006;	   Bettelli	   et	   al.,	   2007;	   Chen	   et	   al.,	   2007;	   Chen	   and	  Wood,	   2007;	   Chen	   et	   al.,	  2006;	  Kleinschek	  et	  al.,	  2007).	  	  Specifically,	  studies	  of	  patients	  with	  MS	  confirm	  the	  presence	   of	   increased	   IL-­‐17	   expression	   in	   active	   brain	   lesions	   (Lock	   et	   al.,	   2002)	  and	   within	   the	   CSF	   (Ishizu	   et	   al.,	   2005;	   Matusevicius	   et	   al.,	   1999).	   Furthermore,	  cytokines	   released	   by	   Th17	   cells	   have	   been	   shown	   to	   be	   associated	  with	   disease	  exacerbation	   in	   the	   EAE	   model	   of	   multiple	   sclerosis	   (Komiyama	   et	   al.,	   2006;	  Vollmer	  et	  al.,	  2005).	  Further	  research	  is	  needed	  to	  determine	  if	  social	  stress	  prior	  to	   infection	  exacerbates	  disease	  by	  shifting	  the	  balance	   from	  an	  efficient	  acquired	  immune	  response	  and	  toward	  Th17.	  	  Another	  mechanism	  by	  which	  SDR-­‐induced	  neuroinflammation	  may	  disrupt	  the	  T	  cell	  response	  to	  disease	  is	  by	  altering	  the	  efficacy	  of	  antigen	  presenting	  cells	  (APCs).	   	  If	  microglia	  and	  other	  CNS	  APCs	  were	  less	  effective	  at	  presenting	  virus	  to	  the	   immune	   system,	   this	  would	   result	   in	   an	   inadequate	  T	   cell	   response.	   	   A	   trend	  toward	   increased	   CD11b	   expression	  would	   be	   suggestive	   of	   increased	   activation	  and	  presumably	  primed	  viral	  clearance.	   	  However,	  research	  is	  beginning	  to	  reveal	  that	  different	  stimuli	  can	  cause	  varied	  microglia	  activational	  profiles.	  For	  example,	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it	  is	  possible	  that	  this	  increase	  may	  not	  represent	  traditionally	  activated	  microglia	  or	   macrophages	   that	   are	   effective	   antigen	   presenting	   cells,	   but	   rather	  CD11b+Ly6C+	  cells.	   	  These	  are	  immature	  myeloid	  cells	  that	  exit	  the	  bone	  marrow	  without	  maturing	  and	  are	  the	  predominant	  innate	  immune	  cell	  to	  infiltrate	  into	  the	  CNS	  after	  infection	  with	  TMEV	  (Bowen	  and	  Olson,	  2009).	  Unlike	  traditional	  Cd11b+	  cells,	  CD11b+Ly6C+	  cells	  have	  been	  shown	  to	  suppress	  T	  cell	  responses	  (Bingisser	  et	   al.,	   1998;	   Delano	   et	   al.,	   2007;	   Movahedi	   et	   al.,	   2008;	   Terabe	   et	   al.,	   2003).	  	  Therefore,	  an	  increase	  in	  CNS	  infiltration	  during	  acute	  phase	  disease	  may	  result	  in	  a	  disruption	  of	  viral	  clearance.	  SDR-­‐induced	  neuroinflammation	  may	  also	  disrupt	  trafficking	  of	  T	  cells	  into	  the	   CNS.	   	   Chemokines	   play	  well-­‐established	   roles	   in	   T	   cell	   trafficking	   and	   can	   be	  suppressed	  by	  glucorticoids	  (Smith	  and	  Herschman,	  1997).	  	  Furthermore,	  restraint	  stress	  results	  in	  a	  suppression	  of	  chemokines	  in	  response	  to	  TMEV	  infection	  (Mi	  et	  al.,	  2004).	  	  Stress-­‐induced	  inflammatory	  cytokines	  may	  alter	  chemokine	  expression	  and,	   subsequent,	   T	   cell	   trafficking.	   	   Experiment	   4.3	   shows	   that	   SDR	   exposure	  reduces	   virus	   specific	   CD4+	   and	   CD8+	   T	   cells	   within	   the	   CNS	   but	   did	   not	   alter	  peripheral	   T	   cell	   response	   to	   infection.	   	   This	   pattern	   could	   be	   explained	   by	   a	  reduction	  in	  chemokine	  activity	  within	  the	  CNS	  decreasing	  migration	  of	  these	  cells	  and,	  thereby,	  impairing	  viral	  clearance.	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Impact	  of	  Stress	  on	  Theiler’s	  Virus	  Induced	  Demyelination	  	  Future	   studies	   are	   needed	   to	   determine	   the	   mechanism	   by	   which	   SDR-­‐induced	   immune	   system	   modifications	   affect	   the	   immune	   response	   during	   the	  chronic	  phase	  of	  TMEV	  infection.	  	  Prior	  research	  has	  shown	  that	  SDR	  prior	  to	  TMEV	  infection	  results	  in	  an	  exacerbation	  of	  chronic	  phase	  disease	  (Johnson	  et	  al.,	  2006).	  	  The	  literature	  suggests	  that	  a	  dysregulated	  adaptive	  immune	  system	  is	  responsible	  for	   viral	   persistence	   and	   chronic	   phase	   disease	   exacerbations.	   Immunological	  manifestations	   of	   chronic	   phase	   disease	   exacerbation	   include	   enhanced	  inflammation	   and	   increased	   autoreactive	   T	   cells.	   	   Increased	   inflammation,	   as	   is	  observed	   in	   TMEV	   infected	   mice	   pre-­‐exposed	   to	   SDR,	   can	   may	   shift	   the	   balance	  from	  Tregs,	  which	  serve	  to	  suppress	  both	  inflammation	  and	  T	  cell	  function,	  toward	  Th17	   cells,	   which	   are	   prone	   to	   autoreactivity.	   Both	   pathways	   require	   TGF-­‐β,	  however,	   increases	   in	   IL-­‐6	   will	   cause	   naïve	   T	   cells	   to	   preferentially	   differentiate	  into	   Th17	   cells	   (see	   Fig.	   15).	   	   The	   combination	   of	   enhanced	   inflammation	   with	  increased	  autoreactive	  T	  cells	  may	  explain	  how	  stress	  exacerbates	  demyelination	  in	  TMEV	  infection.	  	  Furthermore,	  research	  is	  needed	  to	  examine	  the	  effect	  of	  SDR	  presented	  at	  different	  time	  points	  on	  the	  immune	  response	  to	  TMEV	  infection	  and	  TVID.	  The	  MS	  literature	   suggests	   that	   stress	   not	   only	   increases	   susceptibility	   to	   developing	  MS,	  but	   also	   to	   disease	   onset	   and	   exacerbations	   in	   disease	   course	   (Ackerman	   et	   al.,	  2002;	  Brown	  et	  al.,	  2005;	  Brown	  et	  al.,	  2006;	  Grant	  et	  al.,	  1989;	  Li	  et	  al.,	  2004;	  Mohr	  et	  al.,	  2004;	  Mohr,	  2007).	  	  Understanding	  the	  mechanisms	  underlying	  these	  effects	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would	  benefit	  from	  studies	  looking	  at	  the	  timing	  of	  stress	  with	  animal	  models.	  Prior	  data	  has	  shown	  that	  social	  disruption	  stress	  presented	  concurrently	  with	  infection	  improves	   TMEV	   pathogenesis.	   It	   is	   possible	   that	   by	   presenting	   the	   stress	  concurrent	   with	   infection,	   the	   anti-­‐inflammatory	   actions	   of	   stress	   predominated	  and	   shifted	   the	   balance	   toward	   an	   effective	   Th1/Th2	   anti-­‐viral	   response.	  Furthermore,	  given	  that	  T	  cell	  suppression	  is	  observed	  in	  response	  to	  SDR,	  it	  would	  be	   interesting	   to	   evaluate	   the	   effect	   of	   social	   stress	   presented	   during	   the	  demyelinating	   phase	   of	   the	   disease.	   	   Based	   on	   the	   suppression	   of	   the	   acquired	  immune	  response	  it	  may	  improve	  disease,	  however,	  the	  enhance	  inflammation	  and	  possible	  Th17	  switch	  may	  instead	  exacerbate	  disease	  pathogenesis.	  	  
Summary	  and	  Implications	  In	   summary	   this	   dissertation	  demonstrates	   that	   exposure	   to	   SDR	  modifies	  components	   of	   the	   innate	   and	   adaptive	   immune	   response	   to	   Theiler’s	   murine	  encephalomyelitis	   virus	   infection.	   It	   suggests	   that	   SDR-­‐induced	   release	   of	   IL-­‐6	  sensitizes	   virus-­‐initiated	   proinflammatory	   cytokine	   release.	   	   This	   enhanced	   CNS	  proinflammatory	   cytokine	   release	   appears	   to	   initiate	   a	   less	   effective	   adaptive	  immune	  response	  and,	  consequently,	  results	  in	  an	  exacerbation	  of	  disease	  course.	  This	  line	  of	  work	  may	  have	  broad	  implications	  for	  understanding	  the	  role	  of	  stress	   and	   cytokine	   expression	   in	   altering	   vulnerability	   to	   MS	   and	   other	  inflammatory	   neurodegenerative	   diseases.	   Elucidating	   the	  mechanisms	   by	   which	  social	  stress	  exacerbates	  the	  severity	  of	  a	  virally-­‐initiated	  autoimmune	  disease	  may	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lead	   to	   the	   development	   of	   new	   interventions	   to	   prevent	   or	   reverse	   the	   adverse	  effects	   of	   stress.	   This	   line	   of	   research	   suggests	   that	   anti-­‐inflammatory	   behavioral	  and/or	   pharmacological	   interventions	   may	   improve	   neurodegenerative	   and	  inflammatory	   disease	   course.	   Furthermore,	   this	   line	   of	   research	   may	   provide	  insight	  into	  the	  personal	  and	  immunological	  individual	  profile	  that	  is	  more	  likely	  to	  benefit	   from	   particular	   therapeutic	   interventions,	   such	   that	   interventions	   can	   be	  better	  targeted.	  This	  series	  of	  experiments	  brings	  us	  closer	  to	  understanding	  these	  mechanisms	   by	   demonstrating	   that	   social	   disruption	   stress	   sensitizes	   Theiler’s	  virus-­‐induced	   neuroinflammation	   and	   suppresses	   virus-­‐specific	   T	   cell	   function	  within	  the	  CNS.	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